Document:

Exhibit 10.1

   

  EXecution Version

   

  SECURITIES PURCHASE AGREEMENT

   

  This Securities Purchase Agreement (this “Agreement”) is dated as of April 29, 2022, between Tuatara Capital Acquisition Corporation, a Cayman
    Islands exempted company (the “Company”) and the purchasers identified on the signature page hereto (including its successors and assigns, each a “Purchaser”).

   

  WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of
    Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Rule 506(b) thereunder, the Company desires to issue and sell to the Purchaser, and the Purchaser, severally and not jointly, desires to purchase from the Company, Securities
    of the Company as more fully described in this Agreement.

   

  NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
    and adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:

   

  ARTICLE I.

    DEFINITIONS

   

  1.1       Definitions. In addition to the words and terms defined elsewhere in this Agreement, for all purposes of this Agreement, the
    following terms have the meanings set forth in this Section 1.1:

   

  “Acquiring Person” shall have the meaning ascribed to such term in Section 4.5.

   

  “Action” shall have the meaning ascribed to such term in Section 3.1(l).

   

  “Additional Notes” means the $5 million of convertible notes issuable as provided in Section 2.1(c).

   

  “Additional Subscription Amount” means the amount each Purchaser agrees to pay at the Second Tranche Closing as reflected on its signature page.

   

  “Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
    control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

   

  “Board of Directors” means the board of directors of the Company.

   

  “Capital Stock” shall mean, prior the consummation of the Merger, the Ordinary Shares and preferred stock of the Company and, subsequent to the
    Consummation of the Merger, the Common Stock and preferred stock of SpringBig, as defined below.

   

  “Capital Stock Equivalents” shall mean, prior to the consummation of the Merger, the Ordinary Share Equivalents of and, subsequent to the
    Consummation of the Merger, the Common Stock Equivalents of SpringBig. 

  
     

    
      
 

  

  
  “Class A Ordinary Shares” means the Class A ordinary shares of the Company, par value $0.00001 per share.

   

  “Class B Ordinary Shares” means the Class B ordinary shares of the Company, par value $0.00001 per share.

   

  “Closing” means each closing of the purchase and sale of the Securities pursuant to Section 2.1(a).

   

  “Closing Date” means (i) for the First Tranche and the Second Tranche the Trading Day on which all of the Transaction Documents have been executed
    and delivered by the applicable parties thereto, and all conditions precedent to each Purchaser’s obligations to pay the applicable Subscription Amount and (ii) the Company’s obligations to deliver the Securities to be issued and sold, in each case,
    have been satisfied or waived, but in no event later than the second Trading Day following the date on which the Company gives notice to the Purchasers that all conditions of such Closing have been met other than payment and delivery of the Closing
    deliverables required by this Agreement.

   

  “Common Stock” means the common stock of SpringBig, par value $0.0001 per share, and any other class of securities into which such securities may
    hereafter be reclassified or changed.

   

  “Common Stock Equivalents” means any securities of SpringBig or the Subsidiaries which would entitle the holder thereof to acquire at any time
    Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
    Stock.

   

  “Company” means Tuatara prior to the Merger, and, subsequent to the Merger, SpringBig, following Tuatara’s reincorporation as a Delaware
    corporation.

   

  “Company Counsel” means Davis Polk & Wardwell LLP prior to the Merger, and, subsequent to the Merger, Benesch Friedlander Coplan & Aronoff
    LLP.

   

  “Equity Conditions” means all of the following have been met: (i) during the 20 Trading Day period immediately preceding any applicable repayment
    of a Note, the product of the number of shares of Common Stock traded times the average prices of each trade for each such Trading Day as reported by Bloomberg L.P. equals an arithmetic average of at least $500,000 per Trading Day, which is determined
    by multiplying the applicable closing price times the number of shares of Common Stock outstanding on such Trading Day, (ii) the market capitalization remains on the Principal Market above $50,000,000 (except that, solely for the purpose of drawing on
    the Second Tranche, the market capitalization shall be above $75,000,000 and the Resale Registration Statement has registered all the Registrable Securities as that term is defined in the Registration Rights Agreement), (iii) the Common Stock shall be
    listed for trading on the Principal Market, (iv) the Company has complied with all of the conversion and other provisions of the Note and related documents, (v) the Company is current in filing reports with the SEC and there is no pending extension
    under Rule 12b-25 of the Exchange Act, (vi) the Note shall not otherwise be in default or an Event of Default shall not have occurred, (vii) there shall be no public announcement of a Fundamental Transaction or a Change of Control as defined in the
    Notes, (viii) the Common Stock has not been subject to a trading suspension by the SEC or any Trading Market or been delisted by the Trading Market, (ix) the Company’s Common Stock must be DWAC Eligible, (x) the Common Stock shall have not been subject
    to a “chill” or similar event imposed by The Depository Trust Co, (xi) the Company has met each delivery deadline in connection with prior conversions of the Notes and exercises of the Warrants, (xii) the Company has complied with all Transaction
    Documents in all respects, (xiii) the Company shall not have engaged in the sale of any securities under Section 3(a)(10) of the Securities Act, (xiv) the Company shall not provide material non-public information concerning the Company to the Purchaser
    without such Purchaser’s prior written consent, and (xv) for the Second Tranche Closing, the number of Shares issuable under outstanding Notes does not exceed 15% of the market capitalization which is determined by multiplying the applicable closing
    price times the number of shares of Common Stock outstanding. 

  
    2 

    
      
 

  

  “Evaluation Date” shall have the meaning ascribed to such term in Section 3.1(u).

   

  “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

   

  “Exempt Issuance” means the issuance of (a) shares of Capital Stock, restricted stock units or options not to exceed 15% of the shares of Capital
    Stock outstanding at any given time (not in aggregate) and issued to consultants, employees, officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board
    of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) the Capital Stock issued upon conversion of the Other Notes and the Additional Notes, (c)
    securities issued upon the exercise or exchange of or conversion of any securities issued prior to this Agreement and/or, provided that such securities have not been amended since the date of this Agreement to increase the number of such
    securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock dividends, stock splits or combinations) or to extend the term of such securities, (d) securities issued pursuant
    to any merger, acquisition or strategic transaction approved by a majority of the directors of the Company, provided that any such issuance shall not include a transaction in which the Company is issuing securities primarily for the purpose of
    raising capital or to an entity whose primary business is investing in securities, (e) the Equity Line to be entered into in connection with the Merger between the Company and CF Principal Investments LLC or any of its Affiliates and (f) securities
    issued to any underwriter or placement agent with respect to an offering of securities.

   

  “FCPA” means the Foreign Corrupt Practices Act of 1977, as amended.

   

  “First Tranche” means up to $17,000,000 in principal of Notes issuable upon the first Closing, including an $11,000,000 Note issuable to L1
    Capital Global Opportunities Master Fund.

   

  “Fundamental Transaction” shall have the meaning defined in the Notes. 

  
    3 

    
      
 

  

  “GAAP” shall have the meaning ascribed to such term in Section 3.1(j).

   

  “Guaranty Agreement” means the guaranty agreement for the Notes executed by each Subsidiary of The Company in the form attached hereto as Exhibit

      A.

   

  “Indebtedness” shall have the meaning ascribed to such term in Section 3.1(cc).

   

  “Intellectual Property” means all of the following in any jurisdiction throughout the world: (a) all inventions (whether patentable or
    unpatentable and whether or not reduced to practice), all improvements thereto, and all U.S. and foreign patents, patent applications, and patent disclosures, together with all reissuances, continuations, continuations-in-part, revisions, extensions,
    and reexaminations thereof, (b) all trademarks, service marks, brand names, certification marks, trade dress, logos, trade names, domain names, assumed names and corporate names, together with all colorable imitations thereof, and including all
    goodwill associated therewith, and all applications, registrations, and renewals in connection therewith, (c) all copyrights, and all applications, registrations, and renewals in connection therewith, (d) all trade secrets under applicable state laws
    and the common law and know-how (including formulas, techniques, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information, and business and marketing plans and proposals), (e) all computer software
    (including source code, object code, diagrams, data and related documentation), and (f) all copies and tangible embodiments of the foregoing (in whatever form or medium).

   

  “Intellectual Property Rights” has the meaning set forth in Section 3.1(r).

   

  “Joinder” means a joinder in the form of Exhibit J to this Agreement.

   

  “Lead Investor” shall mean L1 Capital Global Opportunities Master Fund.

   

  “Liens” means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

   

  “Material Adverse Effect” shall have the meaning assigned to such term in Section 3.1(c).

   

  “Material Permits” shall have the meaning ascribed to such term in Section 3.1(p).

   

  “Merger” has the meaning specified in Section 3.01(a) of the Merger Agreement.

   

  “Merger Agreement” shall mean that certain Amended and Restated Agreement and Plan of Merger dated April 14, 2022, by and among Tuatara Capital
    Acquisition Corporation, a Cayman Islands exempted company (and the predecessor to the Company), HighJump Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and SpringBig, Inc., a Delaware corporation, as
      may be further amended, supplemented or modified from time to time.

   

  “Notes” mean the 6% Senior Secured Original Issue Discount Convertible Note to be issued to the Purchasers by the Company, subsequent to the
    consummation of the Merger, in the form of Exhibit B attached hereto, which bear interest at the rate of 6% per annum and shall be secured pursuant to a Security Agreement. The form of Additional Notes shall be the same as the Notes. 

  
    4 

    
      
 

  

  “Note Conversion Price” means, $12.00 subject to adjustment as provided in the Notes and further subject to adjustment if during the period
    between the date of this Agreement and the First Tranche Closing Date the Company takes any action which would require an adjustment to the Conversion Price as if the Notes were outstanding. In that event, the Conversion Price shall be adjusted
    proportionately.

   

  “Ordinary Shares” means collectively, the Class A Ordinary Shares and the Class B Ordinary Shares of the Company.

   

  “Ordinary Share Equivalent” means any convertible security or warrant, option or other right to subscribe for or purchase any Ordinary Shares or
    any convertible security convertible into Ordinary Shares.

   

  “Participation Maximum” shall have the meaning ascribed to such term in Section 4.10(a).

   

  “Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
    company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

   

  “Placement Agent” means Cantor Fitzgerald & Co.

   

  “Pledge Agreement” means the pledge agreement of the Company, in the form of Exhibit C, pledging the outstanding common stock and other
    equity instruments of each Subsidiary.

   

  “Pre-Notice” shall have the meaning ascribed to such term in Section 4.10(a).

   

  “Principal Market” means any of the New York Stock Exchange, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Select Market, or the
    Nasdaq Global Market, or any successors of any of these exchanges on which the Capital Stock is listed.

   

  “Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
    proceeding, such as a deposition), whether commenced or threatened.

   

  “Purchaser” has the meaning contained on the first paragraph of this Agreement, and each Purchaser is identified on its respective signature page.
    Any other Purchaser must be approved by L1 Capital Global Opportunities Master Fund, with such approval not to be unreasonably withheld, and the total amount of principal of other First Tranche Notes shall not exceed $6 million.

  

   

  “Purchaser Party” shall have the meaning ascribed to such term in Section 4.8.

   

  “Registration Rights Agreement” means the registration rights agreement by and among with Company and the Purchasers dated the date of this
    Agreement, in the form of which is attached as Exhibit D. 

  
    5 

    
      
 

  

  “Registration Statement” means the Form S-4 Registration Statement, as amended (Registration No. 333-262628), filed by the Company with the SEC.

   

  “Regulation FD” means Regulation FD promulgated by the SEC pursuant to the Exchange Act, as such Regulation may be amended or interpreted from
    time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Regulation.

   

  “Required Approvals” shall mean the consent, waiver, authorization or order of, or the giving of any notice to, or the making of any filing or
    registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required
    pursuant to Section 4.4 of this Agreement, (ii) application(s) to each applicable Principal Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, (iii) filings necessary to perfect the
    Liens in favor of the Purchaser under the Security Agreement, and (iv) such filings as are required to be made under the Securities Act and applicable state securities laws.

   

  “Resale Registration Statement” means any registration statement on Form S-1 or S-3, as applicable, as contemplated in the Registration Rights
    Agreement.

   

  “Rule 144” means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or
    any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.

   

  “SEC” means the United States Securities and Exchange Commission.

   

  “SEC Reports” shall have the meaning ascribed to such term in Section 3.1(j).

   

  “Second Tranche” means $5,000,000 in principal of Notes issuable upon the Second Tranche Closing and which can be drawn down at the Company’s
    discretion, subject to the satisfaction of the conditions set forth herein.

   

  “Securities” means the Notes and the Warrants, and where applicable, the Additional Notes.

   

  “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

   

  “Security Agreement” means the security agreement with the Company, in the form of Exhibit E, providing the Purchaser with a first lien on
    all of the assets of the Company.

   

  “Shares” means the Common Stock of the Company issuable upon conversion of the Notes.

   

  “Sponsor” shall mean TCAC Sponsor, LLC, a Delaware limited liability company, an affiliate of Tuatara Capital L.P. 

  
    6 

    
      
 

  

  “Sponsor Lockup” shall mean that certain lockup agreement among the Sponsor, certain other insiders party
      thereto and the Company, dated as of February 11, 2021, in the form attached hereto as Exhibit F.

   

  “SpringBig” means SpringBig Holdings, Inc., a Delaware corporation and the successor Tuatara after the consummation of the transactions
    contemplated in the Merger Agreement.

   

  “Subject Entity” means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.

   

  “Subscription Amount” means, as to each Purchaser, the aggregate amount to be paid for the Notes and Warrants purchased hereunder as specified
    below the Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription Amount,” in United States dollars and in immediately available funds.

   

  “Subsequent Financing” shall have the meaning ascribed to such term in Section 4.10(a).

   

  “Subsequent Financing Notice” shall have the meaning ascribed to such term in Section 4.10(a).

   

  “Subsidiary” means with respect to any entity at any date, any direct or indirect corporation, limited or general partnership, limited liability
    company, trust, estate, association, joint venture or other business entity of which (A) more than 50% of (i) the outstanding capital stock having (in the absence of contingencies) ordinary voting power to elect a majority of the board of directors or
    other managing body of such entity, (ii) in the case of a partnership or limited liability company, the interest in the capital or profits of such partnership or limited liability company or (iii) in the case of a trust, estate, association, joint
    venture or other entity, the beneficial interest in such trust, estate, association or other entity business is, at the time of determination, owned or controlled directly or indirectly through one or more intermediaries, by such entity, or (B) is
    under the actual control of the Company.

   

  “Trading Day” means a day on which the Principal Market is open for trading.

   

  “Transaction Documents” means this Agreement, the Notes, the Warrants, the Security Agreement, the Pledge Agreement, the Guaranty Agreement, the
    Registration Rights Agreement and any other documents or agreements executed in connection with the transactions contemplated hereunder.

   

  “Transfer Agent” means Continental Stock Transfer & Trust Company and any successor transfer agent of the Company.

   

  “Transfer Agent Issuance Failure” shall have the meaning ascribed to such term in Section 4.13.

   

  “Variable Rate Transactions” shall have the meaning ascribed to such term in Section 4.11(b). 

  
    7 

    
      
 

  

  “VWAP” has the meaning contained in the Notes.

   

  “Warrants” means, collectively, the Warrants of the Company delivered to the Purchasers at each Closing in accordance with Section 2.1 hereof,
    which Warrants shall be immediately exercisable and have a term of exercise equal to five years from such initial exercise date.

   

  “Warrant Exercise Price” means $12.00 per share, as the case may be, subject to adjustments as set forth in the Warrants.

   

  “Warrant Shares” means the shares of Common Stock of the Company issuable upon exercise of the Warrants at the Warrant Exercise Price.

   

  ARTICLE II.

    PURCHASE AND SALE

   

  2.1       Purchase and Sale. The Purchasers, severally and not jointly, agree to purchase from the Company up to a total of $22,000,000 of
    Notes and Warrants in exchange for cash with the amount of each of each Purchaser’s Subscription Amount, First Tranche Note and Second Tranche Note and the number of Warrants for each Purchaser reflected on its respective signature page:

   

  (a)             The First Tranche Notes shall be a total of $17,000,000 of principal in exchange for a total of $15,454,545 in
    Subscription Amounts; and

   

  (b)             The Second Tranche shall be closed 60 Trading Days after the effective date of a Resale Registration Statement with the
    SEC which registers the public sale of the Shares and the Warrant Shares, or at such earlier or later time as mutually agreed upon by each Purchaser and the Company, subject to compliance with this Agreement including the Equity Conditions.

   

  (c)             The Second Tranche Notes shall be a total of $5,000,000, which shall be funded by each Purchaser on a pro rata basis based
    upon the original amount of each First Tranche Note, in exchange for a total of $4,545,454 in Subscription Amounts.

   

  (d)             At each Closing, each Purchaser shall receive a number of Warrants equal to one-half of the principal of its Note or
    additional Note divided by the VWAP on the Trading Day prior to each applicable Closing Date.

   

  2.2       Closing. On the First Tranche Closing Date, upon the terms and subject to the conditions set forth herein each Purchaser shall
    deliver via wire transfer immediately available funds equal to such Purchaser’s Subscription Amount as set forth on the signature page hereto executed by such Purchaser, and the Company shall deliver the Purchaser’s respective Note and Warrants as
    determined pursuant to Section 2.1. On the Second Tranche Closing Date, each Purchaser shall deliver via wire transfer immediately available funds equal to such Purchaser’s Subscription Amount as set forth on the signature page hereto executed by such
    Purchaser, and the Company shall deliver the Purchaser’s respective Note. Upon satisfaction of the covenants and conditions set forth in Sections 2.3 and 2.4, the Closing shall occur at the offices of Company Counsel or such other location as the
    parties shall mutually agree. 

  
    8 

    
      
 

  

   2.3          Deliveries.

   

  (a)          On or prior to each Closing Date except as provided below, the Company shall execute and deliver or cause to be delivered on behalf of
    each Purchaser the following:

   

  (i)          an original Note convertible at the Note Conversion Price registered in the name of each Purchaser;

   

  (ii)         the original Warrants exercisable at the Warrant Exercise Price registered in the name of each Purchaser to purchase up to a
    number of shares of Common Stock as determined by Section 2.1(d);

   

  (iii)        the Registration Rights Agreement only for the First Tranche Closing;

   

  (iv)        a Security Agreement providing the Purchasers with a first lien security interest in the assets of the Company including its
    Subsidiaries executed by the Company and each Subsidiary with the Lead Investor as the collateral agent;

   

  (v)         a Guaranty Agreement executed by each Subsidiary of the Company;

   

  (vi)        a Pledge Agreement pledging the outstanding common stock and other equity instruments of each of Subsidiary of the Company;

   

  (vii)       a reservation letter executed by the Company’s Transfer Agent and the Company in the form attached as Exhibit H; and

   

  (viii)      A bring down of the Company’s representations and warranties contained in this Agreement and updated disclosure schedules to the extent necessary;
    and

   

  (ix)        An opinion of Company Counsel covering the matters on Exhibit I.

   

  (b)          On or prior to each Closing Date, each Purchaser shall cause to be delivered the Purchaser’s Subscription Amount by wire transfer.

   

   2.4          Closing Conditions.

   

  (a)          The obligations of the Company hereunder in connection with each Closing are subject to all obligations, covenants and agreements of
    each Purchaser required to be performed at or prior to the Closing Date shall have been performed. 

  
    9 

    
      
 

  

  (b)        The respective obligations of each Purchaser hereunder in connection with the Closing are subject to the following conditions being met:

   

  (i)          the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or
    Material Adverse Effect, in all respects) when made and on such Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein);

   

  (ii)         all obligations, covenants and agreements of the Company required to be performed at or prior to such Closing Date shall have
    been performed;

   

  (iii)        the delivery by the Company of the items set forth in Section 2.3(a) of this Agreement;

   

  (iv)        all Equity Conditions shall have been met to the extent that they are applicable;

   

  (v)         from the date hereof to each Closing Date trading in the Capital Stock shall not have been suspended by the SEC or the
    Principal Market, and, at any time prior to such Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are
    reported by such service, or on the Principal Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other
    national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of the Purchaser, makes it impracticable or inadvisable to purchase the
    Securities at such Closing;

   

  (vi)       all of the transactions contemplated pursuant to the Merger Agreement, shall have been consummated and all obligations of the
    Company hereunder shall have been assumed by SpringBig by operation of law;

   

  (vii)       for the Second Tranche Closing, the Resale Registration Statement shall have been declared effective at least 60 Trading Days
    prior to such Closing Date unless otherwise agreed upon by each Purchaser and the conditions under the Registration Rights Agreement including such Resale Registration Statement remaining in effect and the Prospectus complies with Sections 5(b) and 10
    of the Securities Act in all respects. If the Equity Conditions, as defined in the Notes, which are applicable are not met on the 60th or other mutually agreed upon date,
    the obligation to fund the Second Tranche Notes shall be extinguished;

   

  (viii)       the Purchasers have received the opinion of Company Counsel in the form annexed as Exhibit I; and 

  

   

  

  (ix)       the Company's stockholders have approved the issuance of all Registrable Securities issuable to the Purchaser as that term is
    defined in the Registration Rights Agreement.  

  
    10 

    
      
 

  

  ARTICLE III.

    REPRESENTATIONS AND WARRANTIES.

   

  3.1         Representations and Warranties of the Company. The Company hereby makes the following representations and warranties to the
    Purchasers as of the date hereof which representations are true and correct and will be true and correct as of each applicable Closing Date:

   

  (a)         Authorization. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
    contemplated by this Agreement. This Agreement has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company
    enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of
    creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

   

  (b)         Merger Agreement Representations and Warranties. All representations and warranties made by the Company in the Merger Agreement are true and correct
    as of the date hereof and may be relied upon by the Purchasers. The Merger Agreement was amended on April 14, 2022, as disclosed in the Company’s public filings, and has not been amended since April 14, 2022.

   

  (c)         No Conflicts. The execution, delivery and performance by the Company of this Agreement will not (i) conflict with or violate any
    provision of the Company’s or any Subsidiary’s operative or other organizational or charter documents, or (ii) constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien
    upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or
    other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) conflict
    with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and
    regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

   

  (d)         Subsidiaries. All of the direct and indirect Subsidiaries of the Company are set forth in the SEC Reports. The Company owns,
    directly or indirectly, all of the Capital Stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of Capital Stock of each Subsidiary are validly issued and are fully paid,
    non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. 

  
    11 

    
      
 

  

  (e)          Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
    validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither
    the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective Certificate of Incorporation, Bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to
    conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified
    or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of
    operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its
    obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and
    authority or qualification.

   

   (f)          Authorization; Enforcement.

   

  (i)       The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by
    each of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors of the Company or the Company’s stockholders
    in connection herewith or therewith other than in connection with the Required Approvals. Subject to obtaining the Required Approvals, this Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been)
    duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by
    general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific
    performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

   

  (ii)       With respect to the Subsidiary Guaranty, each of the Subsidiaries has the requisite corporate power and authority to enter into
    and to consummate the transactions contemplated by such agreement and otherwise to carry out its obligations thereunder. The execution and delivery of the Subsidiary Guaranty and the consummation by the Company of the transactions contemplated thereby
    have been duly authorized by all necessary action on the part of the Company, and no further action is required by the respective Subsidiary, its Board of Directors in connection therewith. The Subsidiary Guaranty has been (or upon delivery
    will have been) duly executed by the respective Subsidiaries and, when delivered in accordance with the terms thereof, will constitute the valid and binding obligation of the respective Subsidiary enforceable against such Subsidiary in accordance with
    its terms, except (A) as listed by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (B) as limited by laws
    relating to the availability of specific performance, injunctive relief or other equitable remedies and (C) insofar as indemnification and contribution provisions may be limited by applicable law. 

  
    12 

    
      
 

  

  (g)         No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
    which the Company is a party, the issuance and sale of the Securities and the consummation by the Company of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company’s or any
    Subsidiary’s Certificate of Incorporation, Bylaws or other organizational or charter documents, or (ii) constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon
    any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other
    instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) conflict with
    or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and
    regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

   

  (h)         Issuance of the Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
    Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Shares, when issued upon conversion of the Notes, and the Warrant Shares, when issued in accordance with the
    terms of the Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. At each applicable Closing, the Company shall reserve from its duly authorized Common Stock a number of shares of Common
    Stock issuable pursuant to the Note and the Warrants equal to the amount set forth in Section 4.9.

   

  (i)           Capitalization.

   

  (i)       The capitalization of the Company is as set forth in the SEC Reports. Except as set forth on Schedule 3.1(i), the
    Company has not issued any Capital Stock since its most recently filed periodic report under the Exchange Act and the Company will not issue any Capital Stock unless disclosed in a periodic report under the Exchange Act within one day after issuance.
    No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as set forth in the SEC Reports, as a result of the purchase
    and sale of the Securities there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for,
    or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of or any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to
    issue additional shares of Common Stock or Common Stock Equivalents or Capital Stock of any Subsidiary. 

  
    13 

    
      
 

  

  (ii)       Following each Closing except as reflected on Schedule 3.1(i) there will be no outstanding options, warrants, scrip
    rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of
    Capital Stock of the Company or any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Capital Stock of the Company or any Subsidiary.

   

  (iii)       The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or
    other securities to any Person (other than each Purchaser) and will not result in a right of any holder of the Company’s securities to adjust the exercise, conversion, exchange or reset price under any of such securities.

   

  (iv)       There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar
    provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation
    rights or “phantom stock” plans or agreements or any similar plan or agreement. All of the outstanding shares of Capital Stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all
    federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of
    Directors or others is required for the issuance and sale of the Securities other than with respect to the Merger. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company’s Capital Stock to which
    the Company is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders. 

  
    14 

    
      
 

  

  (j)           SEC Reports; Financial Statements. The Company has filed all reports, schedules, forms, registration statements and other
    documents required to be filed by the Company under the Securities Act and the Exchange Act including pursuant to Section 13(a) for the two years preceding the date hereof and as of each Closing Date (or such shorter period as the Company was required
    by law or regulation to file such documents) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the “SEC Reports”). For so long as any of the Warrants are
    outstanding, the Company shall not file Form 15 with the SEC or otherwise suspend or terminate its obligation to file any SEC Reports under the Exchange Act. As of their respective dates, the SEC Reports complied in all material respects with the
    requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
    to make the statements therein, in the light of the circumstances under which they were made, not misleading. Except as disclosed on Schedule 3.1(k), the financial statements of the Company included in the SEC Reports comply in all material respects
    with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting
    principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required
    by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case
    of unaudited statements, to normal, immaterial, year-end audit adjustments. Such financial statements do not reflect any transactions which are not bona fide transactions.

   

  (k)          Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements
    included within the SEC Reports, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred, and will not incur, any liabilities
    (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to
    GAAP or disclosed in filings made with the SEC, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or
    made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company equity incentive plans. Except for the
    issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or any Subsidiary or their
    respective businesses, prospects, properties, operations, assets or financial condition, that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been
    publicly disclosed at least one Trading Day prior to the date that this representation is made. 

  
    15 

    
      
 

  

  (l)       Litigation. Except as set forth on Schedule 3.1(l), there is no action, suit, notice of violation, proceeding or
    investigation, inquiry or other similar proceeding involving the Company or any Subsidiary by any federal or state government unit pending and there have been no discussions with the SEC or other state or federal regulators in connection with the
    matters contemplated in the Registration Statement other than copies of SEC comment letters and responses, which have been provided to the Purchasers or, to the knowledge of the Company, threatened against or affecting the Company or any Subsidiary or
    any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”) which (i) adversely affects or challenges the
    legality, validity or enforceability of any of the Transaction Documents or the issuance of the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. The Company has no
    reason to believe that an Action will be filed against it in the future. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any material Action involving a claim of violation of or liability under
    federal or state securities laws or a claim of breach of fiduciary duty. To the knowledge of the Company, there is not pending or contemplated, any investigation by the SEC involving the Company or any current or former director or officer of the
    Company. The SEC has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company under the Securities Act, and the Company has no reason to believe it will do so in the future.

   

  (m)       Compliance. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has
    not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of,
    any Indebtedness, indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived)the Company, (ii) is in
    violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all
    foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result
    in a Material Adverse Effect.

   

  (n)       Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of
    either company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and
    neither the Company nor any Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer or key
    employee of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract
    or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The
    Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices including sexual harassment and discrimination, terms and conditions of employment and
    wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

  
    16 

    
      
 

  

  (o)       Environmental Laws. The Company and its Subsidiaries (i) are in material compliance with all federal, state, local and foreign laws
    relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of
    chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport
    or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved
    thereunder (“Environmental Laws”); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any
    such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.

   

  (p)       Regulatory Permits. The Company and its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
    state or local regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material
    Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.

   

  (q)       Title to Assets. The Company and its Subsidiaries have good and marketable title in fee simple to all real property owned by them
    and good and marketable title in all personal property owned by them that is material to the business of such company, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not
    materially interfere with the use made and proposed to be made of such property by such company, and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the
    payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company or its Subsidiaries are held by them under valid, subsisting and enforceable leases with which such companies are in
    compliance.

   

  (r)       Intellectual Property. The Company and its Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
    trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in
    the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). None of the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual
    Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest
    audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be
    expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and
    its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to
    have a Material Adverse Effect. 

  
    17 

    
      
 

  

  (s)       Insurance. The Company and its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and
    risks and in such amounts as are customary in the businesses in which the Company and its Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither
    the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its
    business without a significant increase in cost.

   

  (t)       Transactions with Affiliates and Employees. Except as set forth in the SEC Reports, none of the officers or directors of the
    Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and
    directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from providing for the borrowing of money from or lending of money to, or
    otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee,
    stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company or any Subsidiary, and (iii) other
    employee benefits, including stock option agreements under any stock option or similar plan of the Company.

   

  (u)       Sarbanes-Oxley; Internal Accounting Controls. Except as disclosed in the SEC Reports, the Company and the Subsidiaries are in
    compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the SEC thereunder that are effective as of the date hereof
    and as of each Closing Date. Except as disclosed in the SEC Reports, the Company and its Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with
    management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in
    accordance with management’s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company
    and its Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
    required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. The Company’s certifying officers have
    evaluated the effectiveness of the disclosure controls and procedures of the Company and its Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The
    Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
    the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) that have materially affected, or is reasonably likely to materially affect, the internal control over
    financial reporting of the Company and its Subsidiaries. 

  
    18 

    
      
 

  

  (v)       Certain Fees. Except for compensation to be owed to the Placement Agent, no commissions are or will be payable by the Company or
    any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents and to be entered into by the Purchasers and the
    Company. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section 3.1(v) that may be due in connection with the transactions
    contemplated by the Transaction Documents.

   

  (w)       Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
    will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940. The Company shall conduct its business in a manner so that it will not become an “investment company” subject to registration under the
    Investment Company Act of 1940.

   

  (x)        Registration Rights. No Person has any right to cause the Company or any Subsidiary to affect the registration under the
    Securities Act of any securities of the Company or any Subsidiary except the Purchasers, except as disclosed on Schedule 3.1(x).

   

  (y)       Listing and Maintenance Requirements. The Capital Stock of the Company is registered pursuant to Section 12(b) of the Exchange Act,
    and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Capital Stock under the Exchange Act nor has the Company received any notification that the SEC is
    contemplating terminating such registration. Except as disclosed on Schedule 3.1(y), the Company has not, in the 12 months preceding the applicable Closing Date, received notice from the Principal Market on which the Capital Stock is or has been listed
    to the effect that the Company is not in compliance with the listing or maintenance requirements of such Principal Market. The Company is and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all
    such listing and maintenance requirements. The Capital Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation, and the Company is current in payment of the fees to the
    Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer. 

  
    19 

    
      
 

  

  (z)       Application of Takeover Protections. The Company and its Board of Directors has taken all necessary action, if any, in order to
    render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under such company’s Certificate of Incorporation (or similar charter
    documents) or the laws of its state of incorporation or other organizational jurisdiction that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under
    the Transaction Documents, including without limitation as a result of the Company’s issuance of the Securities and each Purchaser’s ownership of the Securities.

   

  (aa)      Disclosure. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
    Documents, the Company confirm that neither it nor any other Person acting on its behalf has provided any Purchaser or its agents or counsel with any information that it believes constitutes or might constitute material, non-public information which is
    not otherwise disclosed in the SEC Reports. The Company understands and confirm that each Purchaser will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the
    Company to the Purchasers regarding the Company, and its Subsidiaries, their respective businesses and the transactions contemplated hereby, is true and correct and does not contain any untrue statement of a material fact or omit to state any material
    fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the 12 months preceding the date of this Agreement do not
    contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading.
    The Company acknowledges and agrees that the Purchasers have not made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.

   

  (bb)     No Integrated Offering. Assuming the accuracy of each Purchaser’s representations and warranties set forth in Section 3.2, neither
    the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering
    of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of the Principal Market on which any of the securities of the Company are listed. 

  
    20 

    
      
 

  

  (cc)     Solvency. Based on the consolidated financial condition of the Company as of each Closing Date, after giving effect to the receipt
    by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company’s assets exceeds the amount that will be required to be paid on or in respect of the Company’s existing debts and other liabilities
    (including known contingent liabilities) as they mature, (ii) the Company’s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account
    the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would
    receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not
    intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to
    believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from each respective Closing Date. The SEC Reports set forth the applicable Closing Date all outstanding secured
    and unsecured Indebtedness of the Company, or for which the Company has commitments. For the purposes of this Agreement, “Indebtedness” means (x) any liabilities for borrowed money or amounts owed in excess of $250,000 (other than trade accounts
    payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company’s consolidated balance sheet
    (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $250,000 due under
    leases required to be capitalized in accordance with GAAP. The Company is not in default with respect to any Indebtedness. As used in this Section 3.1 (cc), the Company includes all Subsidiaries.

   

  (dd)     Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
    Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income, value added, and franchise tax returns, reports and declarations required by any jurisdiction
    to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision
    reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any
    jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.

   

  (ee)      Foreign Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company any agent or other person
    acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
    payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any
    person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated any provision of FCPA or any similar laws or rules of any state, local or foreign government.

   

  (ff)       Accountants. The Company’s, auditors is set forth in the SEC Reports. To the knowledge and belief of the Company, such auditors
    (i) are a registered public accounting firm as required by the Exchange Act; and (ii) has expressed its opinion with respect to the financial statements included in the Company’s Annual Report for the years ended December 31, 2020 and December 31,
    2021. 

  
    21 

    
      
 

  

  (gg)     Acknowledgment Regarding each Purchaser’s Purchase of Securities. The Company acknowledges and agrees that each Purchaser is acting
    solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that the Purchaser is not acting as a financial advisor or fiduciary of the
    Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of its respective representatives or agents in connection with the Transaction
    Documents and the transactions contemplated thereby is merely incidental to the Purchaser’s purchase of the Securities. The Company further represents to each Purchaser that the Company’s decision to enter into this Agreement and the other Transaction
    Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.

   

  (hh)     Regulation M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or
    indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation
    for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation
    paid to the Placement Agent in connection with the placement of the Securities.

   

  (ii)       Private Placement. Assuming the accuracy of each Purchaser’s representations and warranties set forth in Section 3.2, no
    registration under the Securities Act is required for the offer and sale of the Securities to each Purchaser as contemplated hereby.

   

  (jj)       No General Solicitation. Neither the Company nor any person acting on behalf of the Company has offered or sold any of the
    Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.

   

  (kk)      No Disqualification Events. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506(b) under the
    Securities Act, none of the Company, , any of its predecessors, any affiliated issuer, any director, executive officer, other officer the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding
    voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale, nor any Person, including a placement
    agent, who will receive a commission or fees for soliciting purchasers (each, an “Issuer Covered Person” and, together, “Issuer Covered Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the
    Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The
    Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to each Purchaser a copy of any disclosures provided thereunder. 

  
    22 

    
      
 

  

  (ll)       Notice of Disqualification Events. The Company will notify each Purchaser and the Placement Agent in writing, prior to the
    Closing Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become a Disqualification Event relating to any Issuer Covered Person, in each case
    of which it is aware.

   

  (mm)    Other Covered Persons. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person)
    that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connections with the sale of any Securities.

   

  (nn)     Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer,
    agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

   

  (oo)     U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the
    meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Purchaser’s request.

   

  (pp)     Bank Holding Company Act. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act
    of 1956 (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent or more of the
    outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or
    Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

   

  (qq)     Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
    applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering
    Laws”), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or
    any Subsidiary, threatened.

   

  (rr)       Seniority. As of each Closing Date, except as disclosed on Schedule 3.1(rr) no Indebtedness or other claim against the
    Company will be senior to the Notes in right of payment, whether with respect to interest or upon liquidation or dissolution, or otherwise, other than indebtedness secured by purchase money security interests (which is senior only as to underlying
    assets covered thereby) and capital lease obligations (which is senior only as to the property covered thereby). 

  
    23 

    
      
 

  

  (ss)      No Disagreements with Accountants and Lawyers. There are no disagreements of any kind presently existing, or reasonably
    anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect to any fees owed to its auditors which could affect the Company’s ability to
    perform any of its obligations under any of the Transaction Documents.

   

  (tt)      Merger Agreement and Registration Statement. The transactions contemplated in the Merger Agreement and the Registration Statement,
    as amended (Registration No. 333-262628) shall have been consummated prior to the First Tranche Closing Date.

   

      3.2       Representations and Warranties of the Purchasers. Each Purchaser for itself and not for any other Purchaser hereby represents
    and warrants as of the date hereof and as of each Closing Date to the Company as follows (unless as of a specific date therein) which representations are true and correct and will be true and correct as of each Closing Date:

   

  (a)       Organization; Authority. The Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in
    good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by this
    Agreement and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and performance by the Purchaser of the transactions contemplated by this Agreement have been duly authorized by all necessary
    corporate, partnership, limited liability company or similar action, as applicable, on the part of the Purchaser. Each Transaction Document to which it is a party has been duly executed by the Purchaser, and when delivered by the Purchaser in
    accordance with the terms hereof, will constitute the valid and legally binding obligation of the Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy,
    insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
    remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

   

  (b)       Understandings or Arrangements. The Purchaser is acquiring the Securities as principal for its own account, for investment and has
    no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting the Purchaser’s right to sell the Securities in compliance with
    applicable federal and state securities laws). The Purchaser is acquiring the Securities hereunder in the ordinary course of its business. The Purchaser understands that the Securities are “restricted securities” and have not been registered under the
    Securities Act or any applicable state securities law and is acquiring such Securities as principal for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or
    any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other
    persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting the Purchaser’s right to sell such Securities in compliance
    with applicable federal and state securities laws). 

  
    24 

    
      
 

  

  (c)       Purchaser Status. At the time the Purchaser was offered the Securities, it was, and as of the date hereof it is, an accredited
    investor within the meaning of Rule 501 under the Securities Act. The Purchaser is not subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1) under the Securities Act (a “Disqualification Event”).

   

  (d)       Experience of the Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication
    and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the
    economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

   

  (e)       Access to Information. The Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
    all exhibits and schedules thereto) and the SEC Reports and has been afforded, subject to Regulation FD, (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the
    terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and
    prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possess or can acquire without unreasonable effort or expense that is necessary to make an informed
    investment decision with respect to the investment. The Purchaser acknowledges and agrees that neither the Company, the Placement Agent nor anyone else has provided the Purchaser with any information or advice with respect to the Securities nor is such
    information or advice necessary or desired. Neither the Placement Agent nor any of its Affiliate has made or makes any representation as to the Company or the quality of the Securities, and the Placement Agent and its Affiliates may have acquired
    non-public information with respect to the Company which the Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to the Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial
    advisor or fiduciary to the Purchaser. The Purchaser further acknowledges and agrees that neither the Placement Agent nor any of its Affiliates, or any control persons, officers, directors, employees, partners, agents or representatives of any of the
    foregoing, shall have any liability to the Purchaser, or to any other Purchaser, pursuant to, arising out of or relating to this Agreement or any agreement related to these Securities, the negotiation hereof or thereof or its subject matter, or the
    transactions contemplated hereby or thereby, including, without limitation, with respect to any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the purchase of the Securities or with respect to any claim
    (whether in tort, contract or otherwise) for breach of this Agreement or in respect of any written or oral representations made or alleged to be made in connection herewith, or for any actual or alleged inaccuracies, misstatements or omissions with
    respect to any information or materials of any kind furnished by the Company, the Placement Agent or any Non-Party Affiliate concerning the Company, the Placement Agent, any of their controlled affiliates, this Agreement or the transactions
    contemplated hereby. For purposes of this Agreement, “Non-Party Affiliates” means each former, current or future officer, director, employee, partner, member, manager, direct or indirect equityholder or Affiliate of the Company or any of the Company’s
    or the Placement Agent’s controlled Affiliates or any family member of the foregoing. 

  
    25 

    
      
 

  

  The Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect the Purchaser’s right
    to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this
    Agreement or the consummation of the transaction contemplated hereby.

   

  ARTICLE IV.

    OTHER AGREEMENTS OF THE PARTIES

   

   4.1          Removal of Legends.

   

  (a)       The applicable Shares, the Warrants and Warrant Shares may only be disposed of in compliance with state and federal securities laws. In
    connection with any transfer of Warrants or Warrant Shares other than pursuant to an effective Resale Registration Statement or Rule 144, to the Company or to an Affiliate of each Purchaser or in connection with a pledge as contemplated in Section
    4.1(b), the Company may require the transferor, provided that the Company shall pay the transferor’s cost thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and
    substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Shares, Warrants or Warrant Shares under the Securities Act.

   

  (b)       Each Purchaser agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Shares, the Warrants or
    Warrant Shares in the following form:

   

  NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
    SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
    SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON
    EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR
    OTHER LOAN SECURED BY SUCH SECURITIES. 

  
    26 

    
      
 

  

  The Company acknowledges and agrees that each Purchaser may from time-to-time pledge pursuant to a bona fide margin agreement with a registered
    broker-dealer or grant a security interest in some or all of the Shares or Warrant Shares to a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of
    this Agreement and, if required under the terms of such arrangement, each Purchaser may transfer pledged or secured Shares or Warrant Shares to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
    and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At each Purchaser’s expense, the Company will execute and deliver such
    reasonable documentation as a pledgee or secured party of Shares and Warrant Shares may reasonably request in connection with a pledge or transfer of the Shares or Warrant Shares.

   

  (c)       Certificates evidencing the Shares or Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b)
    hereof): (i) while a Resale Registration Statement covering the resale of such security is effective under the Securities Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144, when available (assuming cashless exercise of
    the Warrants), or (iii) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall at its expense cause its
    counsel, or at the option of any Purchaser, counsel determined by such Purchaser, to issue a legal opinion to the Transfer Agent to effect the removal of the legend hereunder, subject to compliance with the Securities Act and/or Rule 144, when
    available. For the avoidance of doubt the Company shall pay all costs associated with such opinions. If all or any portion of a Note is converted or Warrant is exercised at a time when there is an effective Resale Registration Statement to cover the
    resale of the Shares or the Warrant Shares, or if such Shares or the Warrant Shares may be sold under Rule 144 without the requirement for the Company to be in compliance with the current public information requirements of Rule 144(c) and without
    volume or manner of sale restrictions or if such legend is not otherwise required under applicable requirements of the Securities Act (including Sections 4(a)(1) or 4(a)(7), judicial interpretations and pronouncements issued by the staff of the SEC
    including what is known as Section 4(a)(11⁄2)) then such Shares or Warrant Shares shall be issued free of all legends. For avoidance of doubt, the Company agrees that after the requisite holding period to comply with Rule 144, the legend may be removed
    under Rule 144 of the Securities Act, assuming the holder satisfies the requirements of Rule 144. The Company agrees that at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) two Trading
    Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by any Purchaser to the Company or the Transfer Agent of a certificate (or medallion guaranteed stock power if issued in book
    entry form) representing Shares or Warrant Shares, as applicable, issued without a restrictive legend (such date, the “Legend Removal Date”), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from
    all restrictive and other legends (or provide evidence of issuance in book entry form). The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section
    4. Certificates for Shares and Warrant Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to such Purchaser by crediting the account of the Purchaser’s prime broker with the Depository Trust Company System as directed
    by the Purchaser. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company Principal Market with respect to the Common Stock as in effect on the date of delivery of a
    certificate representing Shares and Warrant Shares, as applicable, issued with a restrictive legend. Certificates for the Shares or Warrant Shares subject to legend removal hereunder shall be transmitted by the transfer agent to such Purchaser by
    crediting the account of the Purchaser’s prime broker with the Depository Trust Company System as directed by the Purchaser. 

  
    27 

    
      
 

  

  The Company acknowledges and agrees that any Purchaser may from time-to-time pledge pursuant to a bona fide margin agreement with a registered
    broker-dealer or grant a security interest in some or all of the Shares or Warrant Shares to a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and, if required under the terms of such
    arrangement, such Purchaser may transfer pledged or secured Shares or Warrant Shares to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee,
    secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At such Purchaser’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of
    Shares or Warrant Shares may reasonably request, including, if the Shares or Warrant Shares have been registered for resale pursuant to a Resale Registration Statement, the preparation and filing of any required prospectus supplement under Rule
    424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of selling stockholders thereunder.

   

  (d)       In addition to each Purchaser’s other available remedies, (i) the Company shall pay to such Purchaser, in cash, as partial liquidated
    damages and not as a penalty, for each $1,000 of the principal amount of the Note being converted or the value of the Warrant Shares for which a Warrant is being exercised (based on the Warrant Exercise Price), $10 per Trading Day for each Trading Day
    after the Legend Removal Date (increasing to $20 per Trading Day after the fifth Trading Day) until such certificate is delivered without a legend. Nothing herein shall limit any Purchaser’s right to pursue actual damages for the Company’s failure to
    deliver certificates representing any Shares or Warrant Shares as required by the Transaction Documents, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of
    specific performance and/or injunctive relief, and (ii) if after the Legend Removal Date any Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any
    portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive
    legend, then, the Company shall pay to such Purchaser, an amount of cash equal to the excess of such Purchaser’s total purchase price (including brokerage commissions mark-ups and other out-of-pocket expenses, if any) for the shares of Common Stock so
    purchased (including brokerage commissions mark-ups and other out-of-pocket expenses, if any) (the “Buy-In Price”) over the product of (A) such number of Shares or Warrant Shares that the Company was required to deliver to the Purchaser by the
    Legend Removal Date multiplied by (B) the highest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares (as the
    case may be) and ending on the date of such delivery and payment under this Section 4.1(d). 

  
    28 

    
      
 

  

  (e)       In the event any Purchaser shall request delivery of unlegended shares as described in this Section 4.1 and the Company is required to
    deliver such unlegended shares and such request is not in violation of United States securities laws, (i) such Purchaser shall pay all fees and expenses associated with or required by the legend removal and/or transfer including but not limited to
    legal fees, transfer agent fees and overnight delivery charges and taxes, if any, imposed by any applicable government upon the issuance of Common Stock; and (ii) the Company may not refuse to deliver unlegended shares based on any claim that such
    Purchaser or anyone associated or affiliated with such Purchaser has not complied with such Purchaser’s obligations under the Transaction Documents, or for any other reason, unless, an injunction or temporary restraining order from a court, on notice,
    restraining and or enjoining delivery of such unlegended shares shall have been sought and obtained by the Company and the Company has posted a surety bond for the benefit of such Purchaser in the amount of the greater of (i) 15% of the amount of the
    aggregate purchase price of the Shares and Warrant Shares which is subject to the injunction or temporary restraining order, or (ii) the VWAP of the Common Stock on the Trading Day before the issue date of the injunction multiplied by the number of
    unlegended shares to be subject to the injunction, which bond shall remain in effect until the completion of the litigation of the dispute and the proceeds of which shall be payable to such Purchaser to the extent such Purchaser obtains judgment in
    such Purchaser’s favor.

   

   4.2          Furnishing of Public Information.

   

  (a)       Until the earliest of the time that no Purchaser owns any Securities, Shares or Warrant Shares, the Company covenants to timely file (or
    obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act as if it were subject to Section 13(a), and provide notice to its
    stockholders required by applicable state law, even if the Company is not then subject to the reporting requirements of the Exchange Act.

   

  (b)       At any time during the period commencing on the six month anniversary of the First Tranche Closing Date hereof and ending upon the earlier
    to occur of: (i) the Warrants no longer being outstanding, or (ii) all of the Warrant Shares may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule
    144 or under an effective Resale Registration Statement, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c) for a period of more than 15 consecutive days or (ii) has ever been an issuer
    described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) for a period of more than 15 consecutive days (a “Public Information Failure”) then, in addition to
    the Purchaser’s other available remedies, the Company shall pay to each Purchaser in cash as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Warrant Shares, an amount in cash equal
    to two percent of the aggregate Warrant Exercise Price of such Purchaser’s Warrants on the day of a Public Information Failure and on every 30th day (pro-rated for periods
    totaling less than 30 days) thereafter until the earlier of (1) the date such Public Information Failure is cured and (2) such time that such public information is no longer required for such Purchaser to transfer the Warrant Shares pursuant to Rule
    144. The payments to which each Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as “Public Information Failure Payments.” Public Information Failure Payments shall be paid on the earlier of (y) the last day of the
    calendar month during which such Public Information Failure Payments are incurred and (z) the second Trading Day after the event or failure giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public
    Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 2% per month (prorated for partial months) until paid in full. Nothing herein shall limit each Purchaser’s right to pursue
    actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. 

  
    29 

    
      
 

  

  (c)       Following the Second Tranche Closing Date, the same procedures in Section 4.2(b) shall apply, except the phrase “Second Tranche Closing
    Date” shall be substituted for the phrase “First Tranche Closing Date” and “Warrants” shall include the Warrants issued on the Second Tranche Closing Date.

   

  4.3          Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any
    security (as defined in Section 2(a)(1) of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of the Principal Market such that it would require shareholder approval prior to
    the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.

   

  4.4          Securities Laws Disclosure; Publicity. The Company shall, by 9:00 a.m. (New York City time) on the first Trading Day following
    the date of execution of this Agreement issue a press release announcing the entry into the Agreement, which press release shall be subject to the prior review of the Lead Investor. The Company shall, by 5:30 p.m. (New York City time) on the second
    Trading Day following the date of execution hereof, file a Current Report on Form 8-K with the SEC disclosing the material terms of this Agreement, including the forms of Transaction Documents as exhibits thereto. From and after the filing of the Form
    8-K as provided in the preceding sentence, the Company represents to each Purchaser that it shall have publicly disclosed all material, non-public information delivered to such Purchaser by the Company or any of its Subsidiaries, or any of their
    respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such Form 8-K, the Company acknowledges and agrees that any and all
    confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and each Purchaser or any
    of its Affiliates on the other hand, shall terminate. The Company and the Lead Investor shall consult with each other in issuing any press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall
    issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of the Lead Investor, with respect to any press release
    of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or
    communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the SEC or any regulatory agency or Principal Market, without the prior written
    consent of such Purchaser, except (a) to the extent such disclosure is required by law or Principal Market regulations or (c) is required in a Resale Registration Statement covering the Shares and the Warrant Shares. Following the First Tranche Closing
    Date and the Second Tranche Closing Date, shall issue press releases and file Form 8-Ks disclosing the respective financings and issuance of the Securities. 

  
    30 

    
      
 

  

  4.5          Shareholder Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other
    Person, that any Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted
    by the Company , or that such Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and any Purchaser.

   

  4.6          Non-Public Information. Except with respect to the material terms and conditions of the transactions contemplated by the
    Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that
    constitutes, or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such information and agreed with the Company to keep such information
    confidential. The Company understands and confirms that the Purchasers shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that any notice provided pursuant to any Transaction Document or any
    other communications made by the Company, or information provided, to any Purchaser constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice or other
    material information with the SEC pursuant to a Form 8-K. The Company understands and confirm that Purchasers shall be relying on the foregoing covenant in effecting transactions in securities of the Company. In addition to any other remedies provided
    by this Agreement or other Transaction Documents, if the Company provides any material, non-public information to any Purchaser without its prior written consent, and it fails to immediately (no later than that Trading Day or by 9:00 am New York City
    time the next Trading Day) file a Form 8-K disclosing this material, non-public information, it shall pay such Purchaser as partial liquidated damages and not as a penalty a sum equal to $1,000 per day for each $100,000 principal of such Purchaser’s
    Note beginning with the day the information is disclosed to such Purchaser and ending and including the day the Form 8-K disclosing this information is filed. 

  
    31 

    
      
 

  

  4.7          Use of Proceeds. The Company shall use the net proceeds from the sale of the Securities hereunder to repay all outstanding
    Indebtedness as reflected on Schedule 4.7 and then for working capital, and/or general corporate purposes, and shall not use such proceeds: (a) for the redemption of any Common Stock or other securities as opposed to prepayments which are
    required, (b) for the settlement of any outstanding litigation, (c) in violation of FCPA or OFAC regulations, or to lend money, give credit, or make advances to any officers, directors, employees or affiliates of the Company, except for routine travel
    advances or (d) for the purchase of real estate.

   

  4.8          Indemnification of Each Purchaser. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each
    Purchaser and its directors, officers, shareholders, members, managers, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title),
    each Person who controls the Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, members, managers, partners, employees and agents (and any other Persons with
    a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless from any and all losses, liabilities, obligations, claims,
    contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation (including local counsel, if retained) that the Purchaser Party may suffer or incur
    as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents, (b) any action instituted against the Purchaser Party in any
    capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of the Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is based
    upon a breach of the Purchaser Party’s representations, warranties or covenants under the Transaction Documents or any agreements or understandings the Purchaser Party may have with any such stockholder or any violations by the Purchaser Party of state
    or federal securities laws or any conduct by the Purchaser Party which constitutes gross negligence or wilfull misconduct) or (c) any untrue or alleged untrue statement of a material fact contained in any registration statement, any prospectus or any
    form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
    therein (in the case of any prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading. If any action shall be brought against any Purchaser Party in respect of which indemnity sought pursuant to this
    Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. The Purchaser Party shall
    have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of the Purchaser Party except to the extent that (i) the employment thereof has been
    specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of the Purchaser Party, a material
    conflict on any material issue between the position of the Company and the position of the Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel (in addition to
    local counsel, if retained). The Company will not be liable to the Purchaser Party under this Agreement (y) for any settlement by any Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or
    delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to such Purchaser Party’s breach of any of the representations, warranties, covenants or agreements made by the Purchaser Party in this
    Agreement or in the other Transaction Documents. Any Purchaser Party shall have the right to settle any action against it by the payment of money by the Company provided that it cannot agree to any equitable relief and the Company, its officers,
    directors and Affiliates receive unconditional releases in customary form. The indemnification required by this Section 4.8 shall be made by periodic payments of the attorney’s fees and costs in addition to a reasonable initial retainer during the
    course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any
    liabilities the Company may be subject to pursuant to law. 

  
    32 

    
      
 

  

   

   4.9          Reservation and Listing of Common Stock.

   

  (a)       Prior to each Closing, as applicable, the Company shall reserve and keep available at all times in favor of each Purchaser a number of
    shares of Common Stock equal to three times the number of Shares issuable upon conversion of the Notes and when issued the Additional Notes, and Warrant Shares issuable upon exercise of the Warrants issued at each Closing (the “Required Minimum”).

   

  (b)       If, on any date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the Required Minimum
    on such date, then the Board of Directors shall use its best efforts to amend the Company’s Certificate of Incorporation to increase the number of authorized but unissued shares of Common Stock to at least the Required Minimum at such time, as soon as
    possible and in any event not later than the 60th day after such date. If the Company fails to comply with the Required Minimum, the Company shall continue to hold a special or annual meeting of its stockholders every 60 days until it amends to
    Certificate of Incorporation and as a result is able to meet the Required Minimum or otherwise meets the Required Minimum.

   

  (c)       The Company shall, if applicable: (i) in the time and manner required by the Principal Market, prepare and file with such Principal Market
    an additional shares listing application covering a number of shares of Common Stock at least equal to the Required Minimum on the date of such application, (ii) take all steps necessary to cause such shares of Common Stock to be approved for listing
    or quotation on such Principal Market as soon as possible thereafter, (iii) provide to the Purchasers evidence of such listing and (iv) maintain the listing of such Common Stock on any date at least equal to the Required Minimum on such date on such
    Principal Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to
    the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer. 

  
    33 

    
      
 

  

  

  (d)       Subsequent to the consummation of the Merger, the Company shall
      not enter into any agreement or file any amendment to its Certificate of Incorporation (including the filing of a Certificate of Designation) which conflicts with this Section 4.9 while the Notes, Additional Notes or Warrants remain outstanding.

   

    

  (e)       Upon the making of any amortization payment in shares of
    Common Stock where the Amortization Conversion Price is lower than the Conversion Price, the Company shall promptly increase the Requirement Minimum.

    

   

  4.10       Participation in Future Financing.

   

  (a)       From the date after the First Tranche Closing until 18 months
      following the First Tranche Closing, upon any issuance by the Company or any of its Subsidiaries of (i) Common Stock or Common Stock Equivalents for cash consideration, (ii) Indebtedness or (iii) a combination of the foregoing in a transaction exempt
      from registration under the Securities Act (a “Subsequent Financing”), the Purchasers shall have the right to purchase of the securities offered in the Subsequent Financing in an amount equal to 30% of the Subsequent Financing (the “Participation
      Maximum”) on the same terms, conditions and price provided for in the Subsequent Financing. For avoidance of doubt, this Section 4.10 shall not apply to an Equity Line with CF Principal Investments LLC or any of its Affiliates as permitted by the
      Notes and the Additional Notes. Between five and 10 Trading Days prior to the closing of the Subsequent Financing, the Company shall deliver to each Purchaser a written notice of its intention to effect a Subsequent Financing (“Pre-Notice”), which
      Pre-Notice shall ask such Purchasers if they want to review the details of such financing (such additional notice, a “Subsequent Financing Notice”). Upon the request of any Purchaser, and only upon a request by such Purchaser, for a Subsequent
      Financing Notice, the Company shall promptly, but no later than one Trading Day after such request, deliver a Subsequent Financing Notice to each Purchaser. The Subsequent Financing Notice shall describe in reasonable detail the proposed terms of
      such Subsequent Financing, the amount of proceeds intended to be raised thereunder and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected and shall include a term sheet or similar document relating thereto
      as an attachment. If the Company delivers any notice to any Purchaser which may be reasonably be deemed to contain material non-public information as such term has been construed under the Exchange Act, the notice shall generically refer to a second
      notice which may possibly include material non-public information and such first notice shall not refer to any future financing.

   

  (b)       Any Purchaser desiring to participate in such Subsequent
      Financing must provide written notice to the Company by not later than 5:30 p.m. (New York City time) on the fifth Trading Day after such Purchaser has received the Pre-Notice (the “Notice Termination Time”) that such Purchaser is willing to
      participate in the Subsequent Financing, the amount of such Purchaser’s participation, and representing and warranting that such Purchaser has such funds ready, willing, and available for investment on the terms set forth in the Subsequent Financing
      Notice. If the Company receives no such notice from any Purchaser as of such fifth Trading Day, each Purchaser shall be deemed to have notified the Company that it does not elect to participate.

   

  (c)       If by the Notice Termination Time, notifications by each
      Purchaser of its willingness to participate in the Subsequent Financing is, in the aggregate, less than the total amount of the Participation Maximum, then the Company may effect the remaining portion of such Subsequent Financing on the terms and
      with the Persons set forth in the Subsequent Financing Notice.

  

  
    34 

    
      
 

  

  

  (d)       If, by the Notice Termination Time, the Company receives
      responses to a Subsequent Financing Notice from Purchasers seeking to purchase more than the aggregate amount of the Participation Maximum, each such Purchaser shall have the right to purchase its Pro Rata Portion (as defined below) of the
      Participation Maximum. “Pro Rata Portion” means the ratio of (x) the Subscription Amount of Securities purchased by a Purchaser participating under this Section 4.10 and (y) the sum of the aggregate Subscription Amounts of Securities purchased
      by all Purchasers participating under this Section 4.10.

   

  (e)       The Company must provide each Purchaser with a second Subsequent
      Financing Notice, and each Purchaser will again have the right of participation set forth above in this Section 4.10, if the Subsequent Financing subject to the initial Subsequent Financing Notice is not consummated for any reason on the terms set
      forth in such Subsequent Financing Notice within 10 Trading Days after the date of the initial Subsequent Financing Notice.

   

  (f)       The Company and each Purchaser agrees that if such Purchaser
      elects to participate in the Subsequent Financing, the transaction documents related to the Subsequent Financing shall not include any term or provision whereby such Purchaser shall be required to agree to any restrictions on trading as to any of the
      Securities purchased hereunder (or the Shares or Warrant Shares) or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or in connection with, this Agreement, without the prior written consent
      of such Purchaser. In addition, the Company and each Purchaser agree that, in connection with a Subsequent Financing, the transaction documents related to the Subsequent Financing shall include a requirement for the Company to issue a widely
      disseminated press release by 9:30 am (New York City time) on the Trading Day of execution of the transaction documents in such Subsequent Financing (or, if the date of execution is not a Trading Day, on the immediately following Trading Day) that
      discloses the material terms of the transactions contemplated by the transaction documents in such Subsequent Financing.

   

  (g)       Notwithstanding anything to the contrary in this Section 4.10
      and unless otherwise agreed to in writing by such Purchaser, the Company shall either confirm in writing to such Purchaser that the transaction with respect to the Subsequent Financing has been abandoned or shall publicly disclose its intention to
      issue the securities in the Subsequent Financing, in either case in such a manner such that such Purchaser will not be in possession of any material, non-public information, by 9:30 a.m. (New York City time) or the second Trading Day following
      delivery of the Subsequent Financing Notice. If by such second Trading Day, no public disclosure regarding a transaction with respect to the Subsequent Financing has been made, and no notice regarding the abandonment of such transaction has been
      received by such Purchaser, such transaction shall be deemed to have been abandoned and such Purchaser shall not be deemed to be in possession of any material, non-public information with respect to the Company or any of its Subsidiaries.

   

  (h)       The Company shall provide the Purchasers with notice of any such
      issuance or sale in the manner for disclosure of Subsequent Financings set forth in this Section 4.10.

  
    35 

    
      
 

  

  

  4.11       Subsequent Equity Sales.

   

  (a)       From the date hereof until the effective date of a Resale
      Registration Statement registering all of the Shares and the Warrant Shares, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Capital Stock or Capital
      Stock Equivalents, except for Exempt Issuances.

   

  (b)       From the date hereof until repayment of the Notes, the Company,
      shall not (i) enter into any Equity Line, an at-the-market or similar agreement for an at-the-market offering, or similar agreement, nor (ii) issue nor agree to issue any Capital Stock, floating or variable priced equity linked instruments or any
      other Indebtedness or equity security, in any case with price reset rights including protection against lower priced issuances or adjustments in the event of such issuances (not including adjustments for stock splits, distributions, dividends,
      recapitalizations and the like) (collectively, “Variable Rate Transactions”) except for an Equity Line with CF Principal Investments LLC or any of its Affiliates as permitted by the Notes and the Additional Notes. For purposes hereof, “Equity Line”
      shall include any transaction involving a written agreement between the Company and counterparty whereby the Company has the right to “put” its securities to the counterparty over an agreed period of time and at an agreed price or price formula, and
      “variable priced equity linked instruments” shall include: (A) any debt or equity securities which are convertible into, exercisable or exchangeable for, or carry the right to receive additional shares of Capital Stock either (1) at any conversion,
      exercise or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for Capital Stock at any time after the initial issuance of such debt or equity security, or (2) with a fixed conversion, exercise or
      exchange price that is subject to being reset at some future date at any time after the initial issuance of such debt or equity security due to a change in the market price of the Company’s Capital Stock since the date of initial issuance, and (B)
      any amortizing convertible security which amortizes prior to its maturity date, where the Company is required or has the option to (or any investor in such transaction has the option to require the Company to) make such amortization payments in
      shares of Capital Stock which are valued at a price that is based upon and/or varies with the trading prices of or quotations for Capital Stock at any time after the initial issuance of such debt or equity security (whether or not such payments in
      stock are subject to certain equity conditions). The Company agrees that it shall compensate the Lead Investor $20,000 payable in cash as liquidated damages for any breach of this Section 4.11(b).

   

  4.12       Equal Treatment of Purchasers. Except as otherwise
      provided for in this Agreement, no consideration (including any modification of any Transaction Document) shall be offered or paid to any Purchaser to amend or consent to a waiver or modification of any provision of the Transaction Documents unless
      the same consideration is also offered to all of the Purchasers. Further, the Company shall not make any payment of principal or interest on the Notes (or Additional Notes) in amounts which are disproportionate to the respective principal amounts
      outstanding on the Notes (or Additional Notes) at any applicable time. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for
      the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.

  
    36 

    
      
 

  

  

  4.13       Certain Transactions and Confidentiality. Each
      Purchaser covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company as provided in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this
      transaction. If the Transfer Agent shall failure to issue any Shares or Warrant Shares upon the terms and conditions and during the periods provided for in the Transaction Documents (each, a “Transfer Agent Issuance Failure”)each Purchaser shall not be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the occurrence of a Transfer Agent Issuance
      Failure, and (iii) such Purchaser shall not have any duty of confidentiality to the Company or duty not to trade in the securities of the Company from and after the occurrence of a Transfer Agent Issuance
      Failure. Notwithstanding the foregoing, in the case of any Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the
      portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by
      the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.

   

  4.14       Reserved.

   

  4.15       Form D; Blue Sky Filings.
        The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D under the Securities Act and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the
        Company either shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under applicable securities or “Blue Sky” laws of the states of the United States,
        and shall provide evidence of such actions promptly upon request of any Purchaser.

   

  4.16       Conversion and Exercise
          Procedures. The forms of Conversion Notice and Notice of Exercise included in the Notes, Additional Notes and Warrants set forth the totality of the procedures required of each Purchaser in order to convert the Note or Additional Note or to
        exercise the Warrants. No additional legal opinion, other information or instructions shall be required of each Purchaser to convert its Notes or exercise its Warrants. Without limiting the preceding sentences, no ink-original Conversion Notice or
        Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Conversion Notice or Notice of Exercise form be required in order to convert the Notes or exercise the Warrants. The Company
        shall honor conversions of the Notes or Additional Notes and exercises of the Warrants and shall deliver Shares and Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.

   

  4.17       DTC Program. For so long as any Warrants are
      outstanding, the Company will employ as the Transfer Agent for the Common Stock and Warrant Shares a participant in the Depository Trust Company Automated Securities Transfer Program and cause the Common Stock to be transferable pursuant to such
      program.

   

  4.18       Maintenance of Property. The Company shall keep all of
      its property, which is necessary or useful to the conduct of its business, in good working order and condition, ordinary wear and tear excepted.

  
    37 

    
      
 

  

  

  4.19       Preservation of Corporate Existence. Following the
      date of this Agreement, the Company shall preserve and maintain its corporate existence, rights, privileges and franchises in the jurisdiction of its incorporation, and qualify and remain qualified, as a foreign corporation in each jurisdiction in
      which such qualification is necessary in view of its business or operations and where the failure to qualify or remain qualified might reasonably have a Material Adverse Effect upon the Company taken as a whole.

   

  4.20       Operation of Business. As long as any Securities are
      outstanding the Company shall operate its business in the ordinary course consistent with past practices.

   

  4.21       Acknowledgment of Dilution. This Agreement and the
      Transaction Documents have been negotiated on an arms-length basis, and each party has retained counsel selected by it. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common Stock,
      which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under the Transaction Documents, including, without limitation, its obligations to issue the Shares and Warrant Shares pursuant
      to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and
      regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of the Company.

   

  4.22       Subsequent Registrations. If as result of an SEC Staff
      policy, rule or regulation the Company is unable to register all of a Purchaser’s Registrable Securities (as defined in the Registration Rights Agreement), then not later than 30 days (or such later time as is required by the Staff of the SEC or any
      rule of the SEC) after any Resale Registration Statement filed pursuant to the Registration Rights Agreement is declared effective by the SEC, the Company shall file another Resale Registration Statement including all or a portion of the Purchaser’s
      Registrable Securities and comply with the terms and conditions set forth in the Registration Rights Agreement. This covenant shall remain in effect, and the Company shall continue to file subsequent Resale Registration Statements and comply with the
      terms and conditions set forth in the Registration Rights Agreement in connection with each such filing until all of each Purchaser’s Registrable Securities shall have be registered.

   

  4.23       Amendment of the Merger Agreement or Sponsor Lockup.
      The Company shall not amend the Merger Agreement or the Sponsor Lockup, solely as it relates to the lockup provision in Section 7 thereof and its application to the Sponsor, from the date of this Agreement without the consent of the Lead Investor
      (with such consent not to be unreasonably withheld), in each case only if such amendment would result in a change to the capitalization or valuation of the Company that is materially adverse to the Purchasers.

  
    38 

    
      
 

  

  

  ARTICLE V.

      MISCELLANEOUS

   

  5.1       Termination. This Agreement may be terminated by the
      Purchasers or the Company, by written notice to the Company or the Purchasers, as applicable, if the Closing has not been consummated on or before three months from the date of this Agreement; provided, however, that no such
      termination will affect the right of any party to sue for any breach by any other party (or parties).

   

  5.2       Fees and Expenses. Except as expressly set forth below
      and in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
      execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered to the Company and any exercise notice
      delivered by any Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers. Upon the First Tranche Closing, the Company agrees to pay counsel for the Lead Investor’s legal fees, not
      to exceed $65,000 less the $25,000 initial deposit provided by the Company to such counsel, together with reasonable costs including those necessary to provide the Purchaser with a lien on all of the assets of the Company.

   

  5.3       Entire Agreement. The Transaction Documents, together
      with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which
      the parties acknowledge have been merged into such documents, exhibits and schedules.

   

  5.4       Notices. Any and all notices or other communications or
      deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via email at the email address as set
      forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via email at the email address as set
      forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second Trading Day following the date of transmission, if sent by U.S. nationally recognized
      overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto unless changed by a party. To
      the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company, or any Subsidiaries, the Company shall simultaneously file such notice with the SEC pursuant to
      a Form 8-K.

   

  5.5       Amendments; Waivers. No provision of this Agreement may
      be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and each Purchaser or, in the case of a waiver, by the party against whom enforcement of any such waived provision is
      sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or
      requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. A Purchaser may join this Agreement and be subject to its terms after the date hereof by executing a
      Joinder to this Agreement in the form attached hereto as Exhibit J.

  
    39 

    
      
 

  

  

  5.6       Headings. The headings herein are for convenience only,
      do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.

   

  5.7       Successors and Assigns. This Agreement shall be binding
      upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Purchaser (other than by merger,
      including the Merger). Each Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect
      to the transferred Securities, by the provisions of the Transaction Documents that apply to such Purchaser.

   

  5.8       No Third-Party Beneficiaries. The Placement Agent shall
      be the third-party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their
      respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in this Section 5.8.

   

  5.9       Governing Law; Exclusive Jurisdiction; Attorneys’ Fees.
      All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of Florida, without regard to the
      principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought
      against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in Miami-Dade County, Florida. Each party hereby
      irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in Miami-Dade County, Florida , for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
      herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
      court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a
      copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of
      process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
      Documents, then, in addition to the obligations of the Company elsewhere in this Agreement, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and
      expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.

  
    40 

    
      
 

  

  

  5.10       Survival. The representations and warranties contained
      herein shall survive the Closing and the delivery of the Securities.

   

  5.11       Execution. This Agreement may be executed in two or
      more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties
      need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on
      whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof.

   

  5.12       Severability. If any term, provision, covenant or
      restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and
      shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such
      term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
      hereafter declared invalid, illegal, void or unenforceable.

   

  5.13       Rescission and Withdrawal Right. Notwithstanding
      anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not
      timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company , any relevant notice, demand or election in whole or
      in part without prejudice to its future actions and rights; provided, however, that in the case of a rescission of an exercise of a Warrant, such Purchaser shall be required to return any Warrant Shares subject to any such rescinded exercise notice
      concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser’s right to acquire such shares pursuant to the Purchaser’s Warrant (including, issuance of a
      replacement warrant certificate evidencing such restored right).

   

  5.14       Replacement of Securities. If any certificate or
      instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution
      therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction without requiring the posting of any bond.

   

  5.15       Remedies. In addition to being entitled to exercise
      all rights provided herein or granted by law, including recovery of damages, each Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate
      compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at
      law would be adequate.

  
    41 

    
      
 

  

  

  5.16       Payment Set Aside. To the extent the Company makes a
      payment or payments to any Purchaser pursuant to any Transaction Document or such Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently
      invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without
      limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force
      and effect as if such payment had not been made or such enforcement or setoff had not occurred.

   

  5.17       Independent Nature of Purchasers’ Obligations and Rights.
      The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any
      other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an
      association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents.
      Except as provided in the Security Agreement, each Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it
      shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. The Collateral Agent, as defined in the Security Agreement, has been authorized to take actions under the Security Agreement solely
      because the Company wants enforcement of the Security Agreement to be consistent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience the Company and not because it was required or
      requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and
      the Purchasers collectively and not between and among the Purchasers.

   

  5.18       Liquidated Damages. The Company’s obligations
      to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding
      the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.

  
    42 

    
      
 

  

  

  5.19       Saturdays, Sundays, Holidays, etc. If the last or
      appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then such action may be taken, or such right may be exercised on the next succeeding Trading Day.

   

  5.20       Construction. The parties agree that each of them
      and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be
      employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Capital Stock in any Transaction Document shall be subject to adjustment for reverse and
      forward stock splits, stock dividends, stock combinations and other similar transactions of the Capital Stock that occur after the date of this Agreement.

   

  5.21       WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR
        PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVE
        FOREVER TRIAL BY JURY. 

   

  5.22       Non-Circumvention. The Company hereby covenant and
      agree that they will not, by amendment of its charters, including any Certificates of Designation or Bylaws (or similar documents), or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or
      sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Agreement, and will at all times in good faith carry out all of the provision of this Agreement and take all action as
      may be required to protect the rights of all holders of the Securities. Without limiting the generality of the foregoing or any other provision of this Agreement or the other Transaction Documents, the Company (a) shall not increase the par value of
      any shares of Common Stock receivable upon conversion of the Notes or Additional Notes or exercise of the Warrants above the Note Conversion Price, or Warrant Exercise Price, as applicable, then in effect and (b) shall take all such action as may be
      necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Shares upon the conversion of the Notes or Additional Notes and Warrant Shares upon exercise of the Warrants. Notwithstanding anything
      herein to the contrary, if after six months from the Original Issuance Date as such term is defined in the Notes and Additional Notes, a Purchaser is not permitted to convert the Note or Additional Note or exercise the Warrants, in full, for any
      reason, the Company shall use its best efforts to promptly remedy such failure, including, without limitation, obtaining such consent or approvals as necessary to permit such conversion or exercise.

   

  5.23       Usury. the Company hereby agrees not to insist upon or
      plead or in any manner whatsoever claim that the loans evidenced by the Notes or Additional Notes are usurious, and it will resist any and all efforts to be compelled to take the benefit or advantage of usury laws wherever enacted, now or at any time
      hereafter in force, in connection with any Action or Proceeding that may be brought by any Purchaser in order to enforce any right or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction
      Document, it is expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the nature of interest shall not exceed the maximum lawful rate authorized under applicable law (the “Maximum
      Rate”), and, without limiting the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums in the nature of interest that the Company may be obligated to pay under the Transaction
      Documents exceed such Maximum Rate. It is agreed that if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents is increased or decreased by statute or any official governmental action subsequent to the date
      hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable to the Transaction Documents from the effective date thereof forward, unless such application is precluded by applicable law. If under any
      circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to any Purchaser with respect to indebtedness evidenced by the Transaction Documents, such excess shall be applied by such Purchaser to the unpaid principal
      balance of any such indebtedness or be refunded to the Company, with the manner of handling such excess to be at such Purchaser’s election.

   

  
    43 

    
      
 

  

  

  5.24       Prohibition on Financing with Third Parties. Upon the
      execution of this Agreement in no event shall the Company directly or indirectly enter into any debt or equity financing arrangement with any third party other than with the Purchasers until the time and as provided in Section 4.11 unless waived by
      the Lead Investor. In the event of a breach by the Company of this Section 5.24, in addition to all remedies that the Purchasers may have at law or in equity, each Purchaser shall be entitled to Damages from the Company. For purposes of this Section
      5.24, “Damages” means any losses, damages, costs or expenses for any special, indirect, incidental, consequential, or punitive damages, including but not limited to a loss of potential profit, whether based in whole or in part in contract, in tort,
      including negligence, strict liability, or any other theory of liability.

   

  (Signature Pages Follow)

  

  
    44 

    
      
 

  

  IN WITNESS WHEREOF, the parties hereto have caused this Securities
      Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

   

  	 	COMPANY:	 
	 	 	 	 
	 	Tuatara Capital Acquisition Corporation	 
	 	 	 	 
	 	By:	/s/ Albert Foreman	 
	 	Name:	Albert Foreman	 
	 	Title:	Chief Executive Officer	 
	 	 	 	 
	 	Address for Notice:	 
	 	655 Third Avenue. 8th Floor	 
	 	New York, NY 10017	 
	 	 	 
	 	With a copy to	 
	 	(which shall not constitute notice):	 
	 	Davis Polk & Wardwell LLP	 
	 	450 Lexington Avenue	 
	 	New York, NY 10017	 
	 	Attn: Derek Dostal	 

   

  

  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

  

  SIGNATURE PAGE FOR PURCHASER FOLLOWS]

   

  Signature Page to Securities Purchase Agreement 

   

   

  
     

    
      
 

  

  PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT

   

  IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase
      Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. 

   

  	Name of Purchaser: 

        	L1 Capital Global Opportunities Master Fund

        

   

  	Signature of Authorized Signatory of Purchaser:  	/s/ David Feldman

        

   

  

  	Name of Authorized Signatory:  

        	David Feldman

   

  

  	Title of Authorized Signatory:  

        	Portfolio Manager

        

   

  

  	Email Address of Authorized Signatory:  

        	[***]

        

  

  

  

   

  

  Address for Notice to Purchaser:

  [***] 

    

   

    

  Address for Delivery of Securities to Purchaser (if not same as address for notice):

   

  With a copy to

  (which shall not constitute notice):

  Michael D. Harris, Esq.

  Nason, Yeager, Gerson, Harris & Fumero, P.A.

  3001 PGA Boulevard

  Palm beach Gardens, FL 33410

  mharris@nasonyeager.com

   

  Subscription Amount: $10,000,000

   

  Warrant Shares: [to be determined as of first tranche closing]

    

   

  Additional Subscription Amount: $[to be determined on second tranche closing]

    

   

  Additional Warrant Shares: [to be determined on second tranche closing]

   

  EIN Number: [***]

   

  Purchaser’s Signature Page to Securities Purchase Agreement 

  
     

    
      
 

  

   
  EXHIBIT A

      FORM OF GUARANTY AGREEMENT 

  

   

  
     

    
      
 

  

  
   

   

  EXHIBIT B 

  Form of Note

  
    
      
 

  

  
  THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
        SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
        STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
        OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
        ACCOUNT SECURED BY SUCH SECURITIES. ANY TRANSFEREE OF THIS SECURED CONVERTIBLE PROMISSORY NOTE SHOULD CAREFULLY REVIEW THE TERMS OF THIS SECURED ORIGINAL ISSUE DISCOUNT CONVERTIBLE PROMISSORY NOTE. THE PRINCIPAL AMOUNT REPRESENTED BY THIS SECURED
        ORIGINAL ISSUE DISCOUNT CONVERTIBLE PROMISSORY NOTE AND, ACCORDINGLY, THE SECURITIES ISSUABLE UPON CONVERSION HEREOF MAY BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF.

   

  SpringBig Holdings, Inc. 

  Senior Secured Original Issue Discount Convertible Promissory Note

   

  	Original Issuance Date: [_______________], 2022 	Principal: $[_____]

  

  	Maturity Date: [______________], 2024	Loan Amount: $[_____]

   

  FOR VALUE RECEIVED, SpringBig Holdings, Inc., a Delaware
      corporation (the “Maker” or the “Company”), hereby promises to pay to the order of [_____], or registered assigns (the “Holder”) the principal sum of $[_____] (the “Principal”) pursuant to the terms of this Senior Secured
      Original Issue Discount Convertible Promissory Note (this “Note”). In exchange for delivery of the Note on the Original Issuance Date referred to above, the Holder shall lend the Maker $[_____] in United States dollars net of original issuance
      discount of $[_____]. The Holder shall pay the Maker $[_____] on the Original Issuance Date.

   

  The Maturity Date of this Note shall be 24 months from the Original
      Issuance Date of this Note which is specified above, unless the Holder has given notice to the Maker that it elects to accelerate the Maturity Date to the extent explicitly permitted by this Note (the “Maturity Date”). The Maturity Date is the
      date upon which the Principal, accrued Interest and other amounts shall be due and payable unless prepaid earlier or converted. This Note may not be repaid in whole or in part except as otherwise explicitly set forth herein.

   

  This Note is secured by a first lien security interest as evidenced by
      and to the extent set forth in that certain Security Agreement by and among the Maker, its subsidiary, SpringBig, Inc. a Delaware corporation (the “Guarantor”) and the Holder dated as of the Original Issuance Date (the “Security Agreement”).

  
    Exhibit B-1

    
      
 

  

  
   

  All payments under or pursuant to this Note shall be made in United
      States dollars in immediately available funds to the Holder at the address of the Holder set forth in the Purchase Agreement (as hereinafter defined) or at such other place as the Holder may designate from time- to-time in writing to the Maker or by
      wire transfer of funds to the Holder’s account designated in writing by the Holder to the Maker.

   

  1.1          Purchase Agreement; Subsidiary Guarantee. This Note
      has been executed and delivered pursuant to, and is one of the Notes issued pursuant to, the Securities Purchase Agreement, dated as of the Original issuance Date (as the same may be amended from time to time, the “Purchase Agreement”), by and
      among the Maker, the other “Investors” (as such term is defined in the Purchase Agreement) and the Holder. Capitalized words and terms used and not otherwise defined herein shall have the meanings set forth for such terms in the Purchase Agreement.
      The full amount of this Note and all the cash payment obligations of the Company under the Transaction Documents shall be guaranteed in full by the Guarantor pursuant to a Guarantee in the form attached as an exhibit to the Purchase Agreement.

   

  1.2          Interest.

   

  (a)          Interest on this Note shall commence accruing on the Original
      Issuance Date at 6% per annum (the “Interest”) calculated based on the outstanding Principal amount of this Note, shall be computed on the basis of a 360-day year assuming a 30-day month (i.e. 30/360 basis) and shall be payable by the Company
      to the Holder in cash except as specifically provided in this Note. Interest shall be payable quarterly in arrears (each such date the interest payment is due, an “Interest Payment Date”).

   

  (b)          Beginning upon the occurrence of an Event of Default which
      has not been cured within the time specified in Section 2.2(a), and which occurs following the earlier of (i) the effective date of the Resale Registration Statement or (ii) twelve months after the Original Issuance Date, the Holder may elect to
      receive payments of Interest in shares of Common Stock determined by dividing the Interest due by the lower of (x) the Conversion Price or (y) a 7% discount to the lowest Selected VWAP over the 10 Trading Days immediately preceding the applicable
      Payment Date. The Holder shall deliver notice to the Maker of its election to receive Interest in Common Stock at any time prior to the Interest Payment Date.

   

  (c)          From and after the occurrence and during the continuance of
      any Event of Default, the Interest rate shall automatically be increased to 14% per annum or the highest amount permitted by law, shall compound monthly, and shall be due and payable on the first Trading Day of each calendar month during the
      continuance of such Event of Default (a “Default Interest Payment Date”). In the event that such Event of Default is subsequently cured (and no other Event of Default then exists (including, without limitation, for the Company’s failure to pay
      such Interest at the Default rate on the applicable Default Interest Payment Date), the adjustment referred to in the preceding sentence shall cease to be effective as of the day immediately following the date of such cure; provided that the Interest
      as calculated and unpaid at such increased rate during the continuance of such Event of Default shall continue to apply to the extent relating to the days after the occurrence of such Event of Default through and including the date of such cure of
      such Event of Default.

  
    Exhibit B-2

    
      
 

  

   

  1.3          Principal Amortization Payments.

   

  (a)          Commencing on the first business day of the month that begins
      six months after the Original Issuance Date or earlier with mutual written consent of the Maker and the Holder, the Maker shall pay to the Holder the Principal amount hereunder in equal monthly installments (each a “Monthly Payment”) on such
      date and on the same day each month thereafter (each, a “Payment Date”) until the Principal has been paid in full prior to or on the Maturity Date or, if earlier, upon acceleration, conversion or prepayment of this Note in accordance with its terms.

   

  (b)          The Maker and the Holder agree that all payments made under
      this Note, including the provisions of this Section 1.3, shall be subject in all cases to the terms of the Purchase Agreement, including, without limitation, Section 2.4 thereof.

   

  (c)          At the option of the Maker, the Monthly Payments shall be
      made in cash or in shares of Common Stock of the Maker. The Maker may only elect to make a Monthly Payment in Common Stock if the Holder either receives free trading shares or shares that can be immediately resold pursuant to Rule 144(i) under the
      Securities Act and all Equity Conditions have been satisfied, unless the Holder in its sole discretion elects to waive this requirement for a specific Monthly Payment. In connection with any Monthly Payment made in shares of Common Stock, the number
      of shares to be delivered shall be determined by dividing the Monthly Payment Amount by the lower of (i) the Conversion Price or (ii) the Amortization Conversion Price (“Monthly Conversion Price”).

   

  In order to elect to pay a Monthly Payment in Common Stock, the Maker
      must give the Holder written notice no later than seven Trading Days before the applicable Payment Date, which notice shall be irrevocable (the “Monthly Payment Notice”). The Holder may convert pursuant to Section 3 any Principal amount of
      this Note subject to a Monthly Payment at any time prior to the date that the Monthly Payment, plus accrued but unpaid Interest, and any other amounts then owing to the Holder are due and paid in full. Unless otherwise indicated by the Holder in the
      applicable Conversion Notice, any Principal of this Note converted during the applicable Monthly Conversion Period until the date the Monthly Payment is paid in full shall be first applied to the Principal subject to the Monthly Payment payable in
      cash and then to the Monthly Payment payable in Conversion Shares. The Maker covenants and agrees that it will honor all Conversion Notices tendered up until the amounts due hereunder are paid in full. The Maker’s determination to pay a Monthly
      Payment in cash, Conversion Shares or a combination thereof shall be applied ratably to all of the holders of the then outstanding Notes based on their (or their predecessors) initial purchases of Notes pursuant to the Purchase Agreement.

   

  Notwithstanding anything to the contrary contained herein, upon three
      Trading Days’ notice to the Maker (the date of such notice, the “Monthly Payment Adjustment Notice Date”), and with the prior consent of the Maker the Holder may elect at its sole option, to defer or accelerate up to four Monthly Payments or
      any portion of a Monthly Payment, to any future Trading Day In the event that the Holder elects to defer or accelerate any such Monthly Payments, to the extent applicable, the procedures set forth in this Section 1.3 shall continue to apply to the
      Maker. The Holder’s right to accelerate under this Section 1.3(c) shall be subject to the prior written consent of the Maker in its sole discretion.

  
    Exhibit B-3

    
      
 

  

   

  1.4          Prepayment. (a) Except for Monthly Payments as
      required by this Note, as otherwise provided elsewhere in this Note or as provided in Section 1.4(a) or (b), the Maker may not prepay any portion of the Principal.

   

  (a)          If following the Original Issuance Date while this Note is
      outstanding the Maker directly or indirectly receives proceeds from and closes any kind of financing including though the issuance of any equity or Indebtedness or the exercise of Common Stock Equivalents (any, a “Security”), the Maker shall give
      written notice to the Holder within one Trading Day, and the Holder within five Trading Days may request a prepayment of Principal in an amount up to 25% of the Gross Proceeds received by the Maker; provided that this will not apply to proceeds of
      the Equity Line with CF Principal Investments LLC or its Affiliates.

   

  (b)          Beginning five months after the Original Issuance Date, the
      Holder may give notice of prepayment to the Maker from proceeds received from Equity Line puts or the sale of Common Stock or other Securities issued by the Maker to CF Principal Investments LLC or its Affiliates, or another broker-dealer who is a
      party to an Equity Line (provided that the Holder consents to such other broker-dealer, which consent may be withheld in its sole discretion), net of any discount and other fees and expenses related to such Equity Line (such proceeds, “Gross
      Proceeds”) with the Maker as follows:

   

  (1)        60% of the Gross Proceeds when the Principal of this
      Note is at least $[__] million;

   

  (2)        50% of the Gross Proceeds when the Principal of this
      Note is at least $[__] million; and

   

  (3)        25% of the Gross Proceeds when the Principal of this
      Note is less than $[__] million.

   

  Within two Trading Days after the completion of a calendar month in
      which the Maker received Gross Proceeds from an Equity Line transaction including sales of Securities referred to in this Section 1.4(b), the Maker shall give notice to the Holder of the amount of Gross Proceeds. Within seven Trading Days after the
      Holder receives such notice, it may give notice of its prepayment election to the Maker which shall then make the applicable prepayment within two Trading Days after receipt of notice from the Holder.

   

  1.5          Delisting from a Trading Market. If at any time the
      Common Stock ceases to be traded or cease to be listed on a Trading Market, (i) the Holder may deliver a demand for payment to the Company and if such a demand is delivered, the Company shall, within 30 Trading Days following receipt of the demand
      for payment from the Holder, pay all of the outstanding Principal together with Interest and other amounts due Notwithstanding anything to the contrary contained herein, any payments made under this Note, including the provisions of this Section 1.5,
      shall be subject in all cases to the terms of the Purchase Agreement.

  
    Exhibit B-4

    
      
 

  

   

  1.6          Payment on Non-Trading Days. Whenever any payment to
      be made shall be due on a day which is not a Trading Day, such payment may be due on the next succeeding Trading Day.

   

  1.7          Transfer. Except to an Affiliate (as defined in the
      Purchase Agreement) of the Holder, this Note may not be transferred or sold, or pledged, hypothecated or otherwise granted as security by the Holder, without the prior written consent of the Company (not to be unreasonably withheld).

   

  1.8          Replacement. Upon receipt of a duly executed
      Affidavit of Loss and Indemnity Agreement in customary form from the Holder with respect to the loss, theft or destruction of this Note (or any replacement hereof), or, in the case of a mutilation of this Note, upon surrender and cancellation of such
      Note, the Maker shall issue a new Note, of like tenor and amount, in lieu of such lost, stolen, destroyed or mutilated Note.

   

  1.9          [Intentionally omitted]

   

  1.10        Status of Note. The obligations of the Maker under
      this Note shall rank senior to all other existing Indebtedness and equity of the Company, other than the amounts owing to the other Investors under the other Notes in (the “Other Notes”), and the Additional Notes when issued, to the extent of
      the first lien security interest in the collateral per the Security Agreement. The obligations of the Maker under this Note shall rank pari passu with the amounts owing to the other Investors under the Other Notes and to the Holder and the
      Other Investors under the Additional Notes. Upon any Liquidation Event (as hereinafter defined), but subject in all cases to the Purchase Agreement, the Holder will be entitled to receive, before any distribution or payment is made upon, or set apart
      with respect to, any Indebtedness of the Maker (other than the Other Notes) or any class of capital stock of the Maker, an amount equal to the outstanding Principal, Interest and any other sums due. For purposes of this Note, “Liquidation Event”
      means a liquidation pursuant to a filing of a petition for bankruptcy under applicable law or any other insolvency or debtor’s relief, an assignment for the benefit of creditors, or a voluntary or involuntary liquidation, dissolution or winding up of
      the affairs of the Maker.

   

  ARTICLE 2 

   

  2.1          Events of Default. An “Event of Default”
      under this Note shall mean the following (unless the Event of Default is waived in writing by the Holder):

   

  (a)          Following a three Trading Day opportunity to
      cure, any default in the payment of the Principal, Interest or other sums due under this Note or the Additional Note when due (whether on the Maturity Date or by acceleration or otherwise);

   

  (b)          Except as otherwise permitted in this Note, the
      Maker shall fail to observe or perform any other material covenant, condition or agreement contained in this Note or any Transaction Document, including, for the avoidance of doubt, the Maker issuing any Indebtedness or the imposition of a Lien upon
      any of the assets of the Maker or any subsidiary, except for Permitted Indebtedness or Permitted Liens or as otherwise expressly permitted under Article 4, the entry into an Variable Rate Transaction except as otherwise expressly permitted under
      Article 4, or otherwise breaching its material obligations under the Registration Rights Agreement entered into by and among the Maker, the Holder and the other Investor(s) dated the Original Issuance Date including the required effective date of the
      Resale Registration Statements; provided that if the Resale Registration Statement is not declared effective by the required effective date due to factors outside the Maker’s control, including due to SEC delays, such failure to meet the
      required effective date shall not be considered an Event of Default under this Section 2.1;

  
    Exhibit B-5

    
      
 

  

   

  (c)          the Maker or any of its Subsidiaries shall (A)
      default in any payment of any amount or amounts of principal of or interest (if any) on any Indebtedness (other than this Note), the aggregate principal amount of which Indebtedness is in excess of $600,000 or (B) default in the observance or
      performance of any other agreement or condition relating to any such Indebtedness or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event shall occur or condition exist, the effect of which default or
      other event or condition is to cause, or to permit the holder or holders or beneficiary or beneficiaries of such Indebtedness to cause with the giving of notice if required, such Indebtedness to become due prior to its stated maturity;

   

  (d)          the Maker’s notice to the Holder, including by
      way of public announcement at any time of its inability to comply (including for any of the reasons described in Section 3.6(a) hereof) or its intention not to comply with proper requests for conversion of this Note into Common Stock;

   

  (e)          at any time after the Resale Registration
      Statement is effective and subject to compliance with applicable law or if the Holder has sold shares of Common Stock pursuant to Rule 144, when available, but only to the extent of the number of shares sold, the failure of the Maker to instruct its
      transfer agent to remove any legends from the Common Stock and issue such unlegended certificates to the Holder within the Standard Settlement Period. As used herein, “Standard Settlement Period” means the standard settlement period, expressed
      in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a Conversion Notice so long as the Holder has provided reasonable assurances to the Maker that such Common
      Stock will be sold pursuant to Rule 144, once it is available, or any other applicable exemption from registration under the Securities Act or if there is an effective Resale Registration Statement that may be used. For avoidance of doubt, as of the
      Original Issuance Date the Standard Settlement Period is two Trading Days;

   

  (f)           the Maker shall fail to timely deliver the
      Common Stock as and when required in Section 3.2;

   

  (g)          at any time the Maker shall fail to have the
      Required Minimum of Common Stock authorized, reserved and available for issuance to satisfy the potential conversion in full (disregarding for this purpose any and all limitations of any kind on such conversion) of this Note or upon exercise of the
      Warrants;

  
    Exhibit B-6

    
      
 

  

   

  (h)          any representation or warranty made by the Maker
      or any of its Subsidiaries herein or in the Purchase Agreement, this Note, the Warrant or any other Transaction Document shall prove to have been false or incorrect or breached in a material respect on the date as of which made;

   

  (i)           the Maker or any of its Subsidiaries shall: (i)
      apply for or consent to the appointment of, or the taking of possession by, a receiver, custodian, trustee or liquidator of itself or of all or a substantial part of its property or assets; (ii) make a general assignment for the benefit of its
      creditors; (iii) commence a voluntary case under the United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic); (iv) file a petition seeking to take advantage of any
      bankruptcy, insolvency, moratorium, reorganization or other similar law affecting the enforcement of creditors’ rights generally; (v) acquiesce in writing to any petition filed against it in an involuntary case under United States Bankruptcy Code (as
      now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic); (vi) issue a notice of bankruptcy or winding down of its operations or issue a press release regarding same; or (vii) take any action under the laws
      of any jurisdiction (foreign or domestic) analogous to any of the foregoing;

   

  (j)           a proceeding or case shall be commenced in
      respect of the Maker or any of its Subsidiaries, without its application or consent, in any court of competent jurisdiction, seeking: (i) the liquidation, reorganization, moratorium, dissolution, winding up, or composition or readjustment of its
      debts; (ii) the appointment of a trustee, receiver, custodian, liquidator or the like of it or of all or any substantial part of its assets in connection with the liquidation or dissolution of the Maker or any of its Subsidiaries; or (iii) similar
      relief in respect of it under any law providing for the relief of debtors, and such proceeding or case described in clause (i), (ii) or (iii) shall continue undismissed, or unstayed and in effect, for a period of 30 days or any order for relief shall
      be entered in an involuntary case under United States Bankruptcy Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic) against the Maker or any of its Subsidiaries or action under the laws of any
      jurisdiction (foreign or domestic) analogous to any of the foregoing shall be taken with respect to the Maker or any of its Subsidiaries and shall continue undismissed, or unstayed and in effect for a period of 30 days;

   

  (k)          one or more final judgments or orders for the
      payment of money aggregating in excess of $600,000 (or its equivalent in the relevant currency of payment) are rendered against one or more of the Company and/or any of its Subsidiaries, that is not dismissed or stayed within 10 days;

   

  (l)           the Maker’s Common Stock ceases to be listed on
      the Trading Market or, after the 12 month anniversary of the Original Issuance Date, any Common Stock including Conversion Shares may not be immediately resold under Rule 144 without restriction on the number of shares to be sold or manner of sale,
      unless such Common Stock has been registered for resale under the Securities Act and may be sold without restriction;

  
    Exhibit B-7

    
      
 

  

   

  (m)         the Maker consummates a “going private”
      transaction and as a result its Common Stock is no longer registered under Sections 12(b) of the Exchange Act;

   

  (n)          there shall be any SEC stop order with respect
      to the Resale Registration Statement, trading suspension by the SEC or the Trading Market of the Common Stock, or any restriction in place with the transfer agent for the Common Stock restricting the trading of such Common Stock;

   

  (o)          the Company replaces its transfer agent, and the
      Company fails to provide prior to the effective date of such replacement, a fully executed irrevocable transfer agent instructions (including but not limited to the provision to irrevocably reserve the Required Minimum) signed by the successor
      transfer agent and the Company;

   

  (p)          the Company or a Subsidiary enters into a
      Variable Rate Transaction or a similar transaction without the prior written consent of the Holder except as permitted by this Note; or

   

  (q)          the Company organizes a new Subsidiary and the
      Company fails to pledge the equity interests within 10 Trading Days of such organization or fails to cause the new Subsidiary to guarantee the Note and become a party to the Security Agreement and the Pledge Agreement (including the delivery of the
      pledged securities) within such period.

   

  2.2         Remedies Upon an Event of Default.

   

  (a)          Upon the occurrence of any Event of Default that
      has not been remedied or waived within (i) two Trading Days for an Event of Default occurring by the Company’s failure to comply with Section 3.2 of this Note, or (ii) 15 Trading Days for all other Events of Default; provided, however,
      that there shall be no cure period for an Event of Default described in Section 2.1(i) or 2.1(j), the Maker shall be obligated to pay to the Holder the Mandatory Default Amount, which Mandatory Default Amount shall be payable to the Holder on the
      date the Event of Default giving rise thereto occurs and shall be due and payable on the Maturity Date subject to prior conversion using the Mandatory Default Amount and the Default Conversion Price, (provided all payments shall be subject to the
      provisions of the Purchase Agreement with respect to the holders of the Other Notes). For this purpose, the Holder shall have the option to have the Default Conversion Price determined as of the date the Conversion Notice was given to the Maker, and
      it may use the Default Conversion Price during the Pricing Period.

   

  (b)          Upon the occurrence of any Event of Default, the
      Maker shall, as promptly as possible but in any event within three Trading Days of the occurrence of such Event of Default, notify the Holder of the occurrence of such Event of Default, describing the event or factual situation giving rise to the
      Event of Default and specifying the relevant subsection or subsections of Section 2.1 hereof under which such Event of Default has occurred.

  
    Exhibit B-8

    
      
 

  

   

  (c)          Subject to Section 2.2(a), the Holder may at any
      time at its option declare, by written notice to the Maker, the Mandatory Default Amount due and payable, and thereupon, the same shall be accelerated and so due and payable within two Trading Days of receipt of such notice; provided however
      that, within two Trading Days of receipt of such notice, the Maker shall be permitted to provide the Holder with evidence that the Default was cured within the required periods set forth in Section 2.2(a).

   

  (d)          The provisions of Section 3.2(b) and (c) shall
      also apply upon any Events of Default relating to Conversion Shares in addition to the remedies under this Section 2.2.

   

  ARTICLE 3 

   

  3.1         Conversion.

   

  (a)          Conversion. At any time following the earlier of (i)
      the date of effectiveness of the first Resale Registration Statement covering the applicable Conversion Shares or (ii) 12 months after the Original Issuance Date, this Note shall be convertible (in whole or in part) at the option of the Holder into
      such number of fully paid and non-assessable shares of Common Stock as is determined by dividing (x) that portion of the outstanding Principal that the Holder elects to convert (the “Conversion Amount”) by (y) the Conversion Price then in
      effect on the date on which the Holder delivers to the Maker a notice of conversion in substantially the form attached hereto as Exhibit A (the “Conversion Notice”) in accordance with Section 5.1. The Holder shall deliver this Note to
      the Maker at the address designated in the Purchase Agreement at such time that this Note is fully converted. With respect to partial conversions of this Note, the Maker shall keep written records of the amount of this Note converted as of the date
      of such conversion (each, a “Conversion Date”).

   

  (b)          Conversion Price. The “Conversion Price” means
      $12.00 and shall be subject to adjustment as provided herein.

   

  3.2          Delivery of Conversion Shares.

   

  (a)          As soon as practicable after any conversion or payment of any
      amount due hereunder in the form of shares of Common Stock in accordance with this Note, and in any event within the Standard Settlement Period thereafter (such date, the “Share Delivery Date”), the Maker shall, at its expense, cause to be
      issued in the name of and delivered to the Holder, or as the Holder may direct, a certificate or certificates evidencing the number of shares of fully paid and non-assessable Common Stock to which the Holder shall be entitled on such conversion or
      payment (the “Conversion Shares”), in the applicable denominations based on the applicable conversion or payment, which certificate or certificates shall be free of restrictive and trading legends (except for any such legends as may be
      required under the Securities Act). In lieu of delivering physical certificates for the Common Stock issuable upon any conversion of this Note, provided the Company’s transfer agent is participating in the Depository Trust Company (“DTC”) Fast
      Automated Securities Transfer program or a similar program, upon request of the Holder, the Company shall cause its transfer agent to electronically transmit such Conversion Shares issuable upon conversion of this Note to the Holder (or its
      designee), by crediting the account of the Holder’s (or such designee’s) broker with DTC through its Deposit Withdrawal Agent Commission system (provided that the same time periods herein as for stock certificates shall apply) as instructed by the
      Holder (or its designee).

  
    Exhibit B-9

    
      
 

  

   

  (b)          Obligation Absolute. The Company’s obligations to
      issue and deliver the Conversion Shares upon conversion of this Note in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to
      any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any
      obligation to the Company or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection with the
      issuance of such Conversion Shares ; provided, however, that such delivery shall not operate as a waiver by the Company of any such action the Company may have against the Holder. In the event the Holder of this Note shall elect to
      convert any or all of the outstanding Principal amount hereof, the Company may not refuse conversion based on any claim that the Holder or anyone associated or affiliated with the Holder has been engaged in any violation of law, agreement or for any
      other reason, unless an injunction from a court, on notice to Holder, restraining and or enjoining conversion of all or part of this Note shall have been sought and obtained, and the Company posts a surety bond for the benefit of the Holder in the
      amount of 150% of the outstanding principal amount of this Note, which is subject to the injunction, which bond shall remain in effect until the completion of litigation of the underlying dispute and the proceeds of which shall be payable to the
      Holder to the extent it obtains judgment. In the absence of such injunction, the Company shall issue the Conversion Shares or, if applicable, cash, upon delivery of a Conversion Notice.

   

  (c)          The Company’s Failure to Timely Convert. If the
      Company shall fail for any reason or for no reason, on or prior to the applicable Share Delivery Date, if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program, to issue and deliver to the Holder (or its
      designee) a certificate for the number of Conversion Shares to which the Holder is entitled and register such Conversion Shares on the Company’s share register or, if the Transfer Agent is participating in the DTC Fast Automated Securities Transfer
      Program, to credit the balance account of the Holder or the Holder’s designee with DTC for such number of Conversion Shares to which the Holder is entitled upon the Holder’s conversion of this Note (as the case may be) (a “Conversion Failure”),

      then, in addition to all other remedies available to the Holder, the Holder may by notice to the Company elect to be paid in cash either (i) the amount of proceeds it would receive if it had been able to deliver the Conversion Shares on the Share
      Delivery Date or (ii) the Mandatory Default Amount. If the Holder elects to use Section 3.2(c)(i), the sum it shall be paid as a consequence of a Conversion Failure shall be the product of (x) the number of Conversion Shares subject to the Conversion
      Failure times (y) the VWAP for the date on the Holder delivers a Conversion Notice.

   

  (d)         Pro Rata Conversion; Disputes. In the event that the
      Company receives a Conversion Notice from the Holder and any holders of Options or other Convertible Securities for the same Conversion Date and the Company can convert some, but not all, of such portions of the Notes, Options or other Convertible
      Securities submitted for conversion, the Company, subject to Section 3(d), shall first convert the entire Conversion Amount submitted for conversion on such date by the Holder, and shall thereafter convert from each holder of Options or other
      Convertible Securities electing to have Options or other Convertible Securities converted on such date (other than the Notes) a pro rata amount of such holder’s portion of its Options or other Convertible Securities submitted for conversion based on
      the aggregate number of shares of Common Stock issuable upon exercise (or conversion) of all Options or other Convertible Securities submitted for conversion on such date (not including the Notes).

  
    Exhibit B-10

    
      
 

  

   

  3.3          Beneficial Ownership Limitation. The Company shall not effect the conversion of any portion of this Note, and the Holder shall not have the right to convert any portion of this Note pursuant to the terms and conditions of this Note and any such conversion shall
      be null and void and treated as if never made, to the extent that after giving effect to such conversion, the Holder together with the other Attribution Parties collectively would beneficially own in excess of 4.99% (the “Maximum Percentage”)
      of the shares of Common Stock outstanding immediately after giving effect to such conversion.  For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Holder and the other Attribution Parties
      shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon conversion of this Note with respect to which the determination of such sentence is being
      made, but shall exclude shares of Common Stock which would be issuable upon (A) conversion of the remaining, non-converted portion of this Note beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise or conversion of
      the unexercised or non-converted portion of any other securities of the Company (including, without limitation, any convertible notes or convertible preferred stock or warrants, including, without limitation, the Warrants) beneficially owned by the
      Holder or any other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 3(d)(i).  For purposes of this Section 3(d)(i), beneficial ownership shall be calculated in accordance with
      Section 13(d) of the Exchange Act.  For purposes of determining the number of outstanding shares of Common Stock the Holder may acquire upon the conversion of this Note without exceeding the Maximum Percentage, the Holder may rely on the number of
      outstanding shares of Common Stock as reflected in (x) the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the case may be, (y) a more recent public
      announcement by the Company or (z) any other written notice by the Company or the Transfer Agent, if any, setting forth the number of shares of Common Stock outstanding (the “Reported Outstanding Share Number”).  If the Company receives a
      Conversion Notice from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall notify the Holder in writing of the number of shares of Common Stock then
      outstanding and, to the extent that such Conversion Notice would otherwise cause the Holder’s beneficial ownership, as determined pursuant to this Section 3(d)(i), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced
      number of shares of Common Stock to be purchased pursuant to such Conversion Notice.  For any reason at any time, upon the written or oral request of the Holder, the Company shall within one (1) Business Day confirm orally and in writing or by
      electronic mail to the Holder the number of shares of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,
      including this Note, by the Holder and any other Attribution Party since the date as of which the Reported Outstanding Share Number was reported.  In the event that the issuance of shares of Common Stock to the Holder upon conversion of this Note
      results in the Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the Exchange Act),
      the number of shares so issued by which the Holder’s and the other Attribution Parties’ aggregate beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”) shall be deemed null and void and shall be cancelled ab initio, and the
      Holder shall not have the power to vote or to transfer the Excess Shares.  Upon delivery of a written notice to the Company, the Holder may from time to time increase (with such increase not effective until the sixty-first (61st) day after delivery of such notice) or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified in such notice; provided that (i) any
      such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such notice is delivered to the Company and (ii) any such increase
      or decrease will apply only to the Holder and the other Attribution Parties and not to any other holder of Notes that is not an Attribution Party of the Holder.  For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of
      this Note in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the Exchange Act.  No prior inability to convert this Note
      pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of convertibility.  The provisions of this paragraph shall be construed and implemented in a manner
      otherwise than in strict conformity with the terms of this Section 3(d)(i) to the extent necessary to correct this paragraph (or any portion of this paragraph) which may be defective or inconsistent with the intended beneficial ownership limitation
      contained in this Section 3(d)(i) or to make changes or supplements necessary or desirable to properly give effect to such limitation.  The limitation contained in this paragraph may not be waived and shall apply to a successor holder of this Note. 

  

  
    Exhibit B-11

    
      
 

  

   

  3.4          Adjustment of Conversion Price.

   

  (a)          Until the Note has been paid in full or converted in
    full, the Conversion Price shall be subject to adjustment from time to time as follows (but shall not be increased, other than pursuant to a combination:

   

  (i)            Adjustments for Stock Splits and
      Combinations. If the Maker shall at any time or from time-to-time after the Original Issuance Date effect a split of the outstanding Common Stock, the applicable Conversion Price in effect immediately prior to the stock split shall be
    proportionately decreased. If the Maker shall at any time or from time-to-time after the Original Issuance Date, combine the outstanding Common Stock into a lesser number of shares, the applicable Conversion Price in effect immediately prior to the
    combination shall be proportionately increased. Any adjustments under this Section 3.4(a)(i) shall be effective at the close of business on the date the stock split or combination occurs.

   

  (ii)           Adjustments for Certain Dividends and
      Distributions. If the Maker shall at any time or from time to time after the Closing Date (but whether before or after the Issuance Date) make or issue or set a record date for the determination of holders of Common Stock entitled to receive a
    dividend or other distribution payable in Common Stock, then, and in each event, the applicable Conversion Price in effect immediately prior to such event shall be decreased as of the time of such issuance or, in the event such record date shall have
    been fixed, as of the close of business on such record date, by multiplying the applicable Conversion Price then in effect by a fraction: 

  

  
    Exhibit B-12

    
      
 

  

   

  (1)           the numerator of which shall be the total
    number of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date; and

   

  (2)           the denominator of which shall be the total
    number of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of Common Stock issuable in payment of such dividend or distribution.

   

  (iii)          Adjustment for Other Dividends and
      Distributions. If the Maker shall at any time or from time to time after the Closing Date (but whether before or after the Issuance Date) make or issue or set a record date for the determination of holders of Common Stock entitled to receive a
    dividend or other distribution payable in other Common Stock, then, and in each event, an appropriate revision to the applicable Conversion Price shall be made and provision shall be made (by adjustments of the Conversion Price or otherwise) so that
    the Holder of this Note shall receive upon conversions thereof, in addition to the number of Common Stock receivable thereon, the number of securities of the Maker or other issuer (as applicable) or other property that it would have received had this
    Note been converted into Common Stock in full (without regard to any conversion limitations herein) on the date of such event and had thereafter, during the period from the date of such event to and including the Conversion Date, retained such
    securities (together with any distributions payable thereon during such period) or assets, giving application to all adjustments called for during such period under this Section 3.4(a)(iii) with respect to the rights of the holders of this Note; provided,
    however, that if such record date shall have been fixed and such dividend is not fully paid or if such distribution is not fully made on the date fixed therefor, the Conversion Price shall be adjusted pursuant to this paragraph as of the time of
    actual payment of such dividends or distributions.

   

  (iv)          Adjustments for Reclassification,
      Exchange or Substitution. If the Common Stock at any time or from time to time after the Closing Date (but whether before or after the Issuance Date) shall be changed to the same or different number of shares or other securities of any class or
    classes of stock or other property, whether by reclassification, exchange, substitution or otherwise (other than by way of a stock split or combination of shares or stock dividends provided for in Sections 3.4(a)(i), (ii) and (iii) hereof, or a
    reorganization, merger, consolidation, or sale of assets provided for in Section 3.4(a)(v) hereof), then, and in each event, an appropriate revision to the Conversion Price shall be made and provisions shall be made (by adjustments of the Conversion
    Price or otherwise) so that the Holder shall have the right thereafter to convert this Note into the kind and amount of shares of stock or other securities or other property receivable upon reclassification, exchange, substitution or other change, by
    holders of the number of Common Stock into which such Note might have been converted immediately prior to such reclassification, exchange, substitution or other change, all subject to further adjustment as provided herein. 

  

  
    Exhibit B-13

    
      
 

  

   

  (v)           Adjustment Due to Dilutive Issuance.
    If, at any time when any Notes are issued and outstanding, the Company issues or sells, or in accordance with this Section 3.4(a)(v) hereof is deemed to have issued or sold, except for Common Stock issued in an Exempt Issuance (as defined in the
    Purchase Agreement), any Common Stock for a consideration per share (before deduction of reasonable expenses or commissions or underwriting discounts or allowances in connection therewith) less than the Conversion Price in effect on the date of such
    issuance (or deemed issuance) of such Common Stock (a “Dilutive Issuance”), then immediately upon the Dilutive Issuance, the Conversion Price will be reduced to the amount of the consideration per share received by the Company in such Dilutive
    Issuance.

   

  Except for Exempt Issuances, the Company shall be deemed to have issued or sold Common Stock if the Company in any manner issues or grants any
    warrants, rights or options, whether or not immediately exercisable, to subscribe for or to purchase Common Stock or other securities convertible into or exchangeable for Common Stock (“Convertible Securities”) (such warrants, rights and options
    to Common Stock or Convertible Securities are hereinafter referred to as “Options”) and the price per share for which such Common Stock is issuable upon the exercise of such Options is less than the Conversion Price then in effect, then the
    Conversion Price shall be reduced to such price per share. For purposes of the preceding sentence, the “price per share for which such Common Stock are issuable upon the exercise of such Options” is determined by dividing (i) the total amount, if any,
    received or receivable by the Company as consideration for the issuance or granting of all such Options, plus the minimum aggregate amount of additional consideration, if any, payable to the Company upon the exercise of all such Options, plus, in the
    case of Convertible Securities issuable upon the exercise of such Options, the minimum aggregate amount of additional consideration payable upon the conversion or exchange thereof at the time such Convertible Securities first become convertible or
    exchangeable, by (ii) the maximum total number of Common Stock issuable upon the exercise of all such Options (assuming full conversion of Convertible Securities, if applicable). No further adjustment to the Conversion Price will be made upon the
    actual issuance of such Common Stock upon the exercise of such Options or upon the conversion or exchange of Convertible Securities issuable upon exercise of such Options.

   

  Additionally, the Company shall be deemed to have issued or sold Common Stock if the Company in any manner issues or sells any Convertible
    Securities, whether or not immediately convertible (other than in an issuance in an Exempt Issuance), and the price per share for which such Common Stock is issuable upon such conversion or exchange is less than the Conversion Price then in effect,
    then the Conversion Price shall be equal to such price per share. For the purposes of the preceding sentence, the “price per share for which such Common Stock are issuable upon such conversion or exchange” is determined by dividing (i) the total
    amount, if any, received or receivable by the Company as consideration for the issuance or sale of all such Convertible Securities, plus the minimum aggregate amount of additional consideration, if any, payable to the Company upon the conversion or
    exchange thereof at the time such Convertible Securities first become convertible or exchangeable, by (ii) the maximum total number of Common Stock issuable upon the conversion or exchange of all such Convertible Securities. No further adjustment to
    the Conversion Price will be made upon the actual issuance of such Common Stock upon conversion or exchange of such Convertible Securities. 

  

  
    Exhibit B-14

    
      
 

  

   

  (vi)          Fractional Shares. If any
    adjustments to the Conversion Price under this Section 3.4 result in a fractional amount, the fractional amount rounded down to the nearest whole cent.

   

  (vii)         Consideration for Stock. In case any
    Common Stock or any Common Stock Equivalents shall be issued or sold:

   

  (1)           in connection with any merger or
    consolidation in which the Maker is the surviving corporation (other than any consolidation or merger in which the previously outstanding Common Stock of the Maker shall be changed to or exchanged for the stock or other securities of another
    corporation), the amount of consideration therefor shall be, deemed to be the fair value, as determined reasonably and in good faith by the Board of Directors of the Maker and approved by the Holders, of such portion of the assets and business of the
    non-surviving corporation as such Board of Directors may determine to be attributable to such Common Stock, Convertible Securities, rights or warrants or options, as the case may be; or

   

  (2)           in the event of any consolidation or merger
    of the Maker in which the Maker is not the surviving corporation or in which the previously outstanding Common Stock of the Maker shall be changed into or exchanged for the stock or other securities of another corporation or other property, or in the
    event of any sale of all or substantially all of the assets of the Maker for stock or other securities or other property of any corporation, the Maker shall be deemed to have issued Common Stock, at a price per share equal to the valuation of the
    Maker’s Common Stock based on the actual exchange ratio on which the transaction was predicated, as applicable, and the fair market value on the date of such transaction of all such stock or securities or other property of the other corporation. If any
    such calculation results in adjustment of the applicable Conversion Price, or the number of Common Stock issuable upon conversion of the Note, the determination of the applicable Conversion Price or the number of Common Stock issuable upon conversion
    of the Note immediately prior to such merger, consolidation or sale, shall be made after giving effect to such adjustment of the number of Common Stock issuable upon conversion of the Note. In the event Common Stock are issued with other shares or
    securities or other assets of the Maker for consideration which covers both, the consideration computed as provided in this Section 3.4(a)(vii) shall be allocated among such securities and assets as determined in good faith by the Board of Directors of
    the Maker, and approved by the Holders. 

  

  
    Exhibit B-15

    
      
 

  

   

  (viii)        Record Date. In case the Maker shall
    take record of the holders of its Common Stock for the purpose of entitling them to subscribe for or purchase Common Stock or Convertible Securities, then the date of the issue or sale of the Common Stock shall be deemed to be such record date.

   

  (b)          No Impairment. The Maker shall not, by
    amendment of its Certificate of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any
    of the terms to be observed or performed hereunder by the Maker, but will at all times in good faith assist in the carrying out of all the provisions of this Section 3.4 and in the taking of all such action as may be necessary or appropriate in order
    to protect the conversion rights of the Holder against impairment. In the event the Holder shall elect to convert this Note as provided herein, the Maker cannot refuse conversion based on any claim that the Holder or anyone associated or affiliated
    with the Holder has been engaged in any violation of law, violation of an agreement to which the Holder is a party or for any reason whatsoever, unless, an injunction from a court, or notice, restraining and or adjoining conversion of this Note shall
    have issued and the Maker posts a surety bond for the benefit of the Holder in an amount equal to 150% of the Principal of the Note which the Holder has elected to convert, which bond shall remain in effect until the completion of
    arbitration/litigation of the dispute and the proceeds of which shall be payable to the Holder (as liquidated damages) in the event it obtains judgment.

   

  (c)          Certificates as to Adjustments. Upon occurrence
    of each adjustment or readjustment of the Conversion Price or number of Common Stock issuable upon conversion of this Note pursuant to this Section 3.4, the Maker at its expense shall promptly compute such adjustment or readjustment in accordance with
    the terms hereof and furnish to the Holder a certificate setting forth such adjustment and readjustment, showing in detail the facts upon which such adjustment or readjustment is based. The Maker shall, upon written request of the Holder, at any time,
    furnish or cause to be furnished to the Holder a like certificate setting forth such adjustments and readjustments, the applicable Conversion Price in effect at the time, and the number of Common Stock and the amount, if any, of other securities or
    property which at the time would be received upon the conversion of this Note. Notwithstanding the foregoing, the Maker shall not be obligated to deliver a certificate unless such certificate would reflect an increase or decrease of at least one
    percent of such adjusted amount.

   

  (d)          Issue Taxes. The Maker shall pay any and all
    issue and other taxes, excluding federal, state or local income taxes, that may be payable in respect of any issue or delivery of Common Stock on conversion of this Note pursuant thereto; provided, however, that the Maker shall not be obligated
    to pay any transfer taxes resulting from any transfer requested by the Holder in connection with any such conversion.

   

  (e)          Fractional Shares. No fractional Common Stock
    shall be issued upon conversion of this Note. In lieu of any fractional shares to which the Holder would otherwise be entitled, the Maker shall pay cash equal such fractional shares multiplied by the Conversion Price then in effect. 

  

  
    Exhibit B-16

    
      
 

  

   

  (f)           Reservation of Common Stock. The Maker shall
    at all while this Note shall be outstanding, reserve and keep available out of its authorized but unissued Common Stock the Required Minimum of Common Stock (disregarding for this purpose any and all limitations of any kind on such conversion). The
    Maker shall, from time-to-time, increase the authorized number of Common Stock or take other effective action if at any time the unissued number of authorized shares shall not be sufficient to satisfy the Maker’s obligations under this Section 3.4(f).

   

  (g)          Regulatory Compliance. If any Common Stock to
    be reserved for the purpose of conversion of this Note requires registration or listing with or approval of any governmental authority, national securities exchange or other regulatory body under any federal or state law or regulation or otherwise
    before such shares may be validly issued or delivered upon conversion, the Maker shall, at its sole cost and expense, in good faith and as expeditiously as possible, secure such registration, listing or approval, as the case may be.

   

  3.5          Prepayment Following a Change of Control.

   

  (a)           Mechanics of Prepayment at Option of
      Holder in Connection with a Change of Control. No later than 15 days following the entry by the Company into an agreement for a Change of Control but in no event prior to the public announcement of such Change of Control, the Maker shall deliver
    written notice describing the entry into such agreement (“Notice of Change of Control”) to the Holder. Within 15 days after receipt of a Notice of Change of Control, the Holder may require the Maker to prepay, effective immediately prior to the
    consummation of such Change of Control, an amount equal to 102% of the outstanding principal amount of this Note (the “COC Repayment Price”), by delivering written notice thereof (“Notice of Prepayment at Option of Holder Upon Change of
      Control”) to the Maker, with such prepayment due in connection with but in no event prior to the closing of the Change of Control transaction.

   

  (b)          Payment of COC Repayment Price. Upon the
    Maker’s receipt of a Notice(s) of Prepayment at Option of Holder Upon Change of Control from the Holders, the Maker shall deliver the COC Repayment Price to the Holder immediately prior to the consummation of the Change of Control; provided, that
    the Holder’s original Note shall have been so delivered to the Maker, and, provided, further that all payments shall be subject to the provisions of the Purchase Agreement with respect to the holders of the Other Notes.]

   

  3.6          Inability to Fully Convert.

   

  (a)          Holder’s Option if Maker Cannot Fully Convert.
    If, upon the Maker’s receipt of a Conversion Notice or as otherwise required under this Note, including with respect to repayment of Principal in Common Stock as permitted under this Note, the Maker cannot issue Common Stock for any reason, including,
    without limitation, because the Maker (x) does not have a sufficient number of shares of Common Stock authorized and available or (y) is otherwise prohibited by applicable law or by the rules or regulations of any national securities exchange,
    interdealer quotation system or other self-regulatory organization with jurisdiction over the Maker or any of its securities from issuing all of the shares of Common Stock which are to be issued to the Holder pursuant to this Note, then the Maker shall
    issue as many shares of Common Stock as it is able to issue and, with respect to the unconverted portion of this Note or with respect to any Common Stock not timely issued in accordance with this Note, the Holder, solely at Holder’s option, can elect
    to: 

  

  
    Exhibit B-17

    
      
 

  

   

  (i)            require the Maker to prepay that portion
    of this Note for which the Maker is unable to issue Common Stock or for which Common Stock were not timely issued (the “Mandatory Prepayment”) at a price equal to the number of shares of Common Stock that the Maker is unable to issue multiplied
    by the VWAP on the date of the Conversion Notice (the “Mandatory Prepayment Price”) (provided all payments shall be subject to the provisions of the Purchase Agreement with respect to the holders of the Other Notes);

   

  (ii)           void its Conversion Notice and retain or
    have returned, as the case may be, this Note that was to be converted pursuant to the Conversion Notice (provided that the Holder’s voiding its Conversion Notice shall not affect the Maker’s obligations to make any payments which have accrued
    prior to the date of such notice); or

   

  (iii)          defer issuance of the applicable
    Conversion Shares until such time as the Maker can legally issue such shares; provided that the Principal Amount underlying such Conversion Shares shall remain outstanding until the delivery of such Conversion Shares; and provided, further,
    that if the Holder elects to defer the issuance of the Conversion Shares, it may exercise its rights under either clause (i) or (ii) above at any time prior to the issuance of the Conversion Shares upon two Trading Days’ notice to the Maker.

   

  (b)          Mechanics of Fulfilling Holder’s Election. The
    Maker shall immediately send to the Holder, upon receipt of a Conversion Notice from the Holder, which cannot be fully satisfied as described in Section 3.6(a) above, a notice of the Maker’s inability to fully satisfy the Conversion Notice (the “Inability

      to Fully Convert Notice”). Such Inability to Fully Convert Notice shall indicate (i) the reason why the Maker is unable to fully satisfy the Holder’s Conversion Notice; and (ii) the amount of this Note which cannot be converted. The Holder shall
    notify the Maker of its election pursuant to Section 3.6(a) above by delivering written notice to the Maker (“Notice in Response to Inability to Convert”).

   

  (c)          Payment of Mandatory Prepayment Price. If the
    Holder shall elect to have its Note prepaid pursuant to Section 3.6(a)(i) above, the Maker shall pay the Mandatory Prepayment Price to the Holder within five Trading Days of the Maker’s receipt of the Holder’s Notice in Response to Inability to
    Convert; provided that prior to the Maker’s receipt of the Holder’s Notice in Response to Inability to Convert the Maker has not delivered a notice to the Holder stating, to the satisfaction of the Holder, that the event or condition resulting
    in the Mandatory Prepayment has been cured and all Conversion Shares issuable to the Holder can and will be delivered to the Holder in accordance with the terms of this Note. If the Maker shall fail to pay the applicable Mandatory Prepayment Price to
    the Holder on the date that is two Trading Days following the Maker’s receipt of the Holder’s Notice in Response to Inability to Convert, in addition to any remedy the Holder may have under this Note and the Purchase Agreement, such unpaid amount shall
    bear interest at the rate of two percent per month (prorated for partial months) until paid in full. Until the full Mandatory Prepayment Price is paid in full to the Holder, the Holder may (i) void the Mandatory Prepayment with respect to that portion
    of the Note for which the full Mandatory Prepayment Price has not been paid and (ii) receive back such Note. 

  

  
    Exhibit B-18

    
      
 

  

   

  (d)          No Rights as Shareholder. Nothing contained in
    this Note shall be construed as conferring upon the Holder, prior to the conversion of this Note, the right to vote or to receive dividends or to consent or to receive notice as a shareholder of the Company in respect of any meeting of shareholders for
    the election of directors of the Maker or of any other matter, or any other rights as a shareholder of the Maker.

   

  ARTICLE 4 

   

  4.1          Covenants. For so long as the Note is
    outstanding, without the prior written consent of the Holder:

   

  (a)          Rank. All payments due under this Note shall
    rank senior to all other Indebtedness of the Company and its Subsidiaries, except for the Other Notes and the Additional Notes upon issuance.

   

  (b)          Incurrence of Indebtedness. The Company shall
    not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, incur or guarantee or assume any Indebtedness (other than (i) this Note, the Other Notes, and the Additional Notes upon issuance, and (ii) Permitted
    Indebtedness).

   

  (c)          Existence of Liens. The Company shall not, and
    the Company shall cause each of its Subsidiaries to not, directly or indirectly, allow or suffer to exist any mortgage, lien, pledge, charge, security interest, deed of trust, or other encumbrance upon or in any property or assets (including accounts
    and contract rights) owned by the Company or any of its Subsidiaries (collectively, “Liens”) other than Permitted Liens.

   

  (d)          Restricted Payments. Except as otherwise
    provided for in this Note, the Other Notes or the other Transaction Documents, the Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, prepay, defease, repurchase, repay or make any payments in
    respect of, by the payment of cash or cash equivalents (in whole or in part, whether by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any Indebtedness (other than the Note, Other Notes, and
    Additional Notes) whether by way of payment in respect of principal of (or premium, if any) or interest on, such Indebtedness if at the time such payment is due or is otherwise made or, after giving effect to such payment, (i) an event constituting an
    Event of Default has occurred and is continuing or (ii) an event that with the passage of time and without being cured would constitute an Event of Default has occurred and is continuing. 

  

  
    Exhibit B-19

    
      
 

  

   

  (e)          Restriction on Prepayment and Cash Dividends.
    The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, prepay, repurchase or declare or pay any cash dividend or distribution on any of its capital stock.

   

  (f)           Restriction on Transfer of Assets.
    The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, sell, lease, license, assign, transfer, spin-off, split-off, close, convey or otherwise dispose of any assets or rights of the Company or any
    Subsidiary owned or hereafter acquired whether in a single transaction or a series of related transactions, other than (i) sales, leases, licenses, assignments, transfers, conveyances and other dispositions of such assets or rights by the Company and
    its Subsidiaries in the ordinary course of business consistent with its past practice, (ii) sales of inventory and products in the ordinary course of business, and (iii) sales of unwanted or obsolete assets.

   

  (g)          Preservation of Existence, Etc. The Company
    shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, its existence, rights and privileges, and become or remain, and cause each of its material Subsidiaries to become or remain, duly qualified and in good standing
    in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its business makes such qualification necessary.

   

  (h)          Maintenance of Properties, Etc. The Company
    shall maintain and preserve, and cause each of its material Subsidiaries to maintain and preserve, all of its properties which are necessary or useful in the proper conduct of its business in good working order and condition, ordinary wear and tear
    excepted, and comply, and cause each of its material Subsidiaries to comply, at all times with the provisions of all leases to which it is a party as lessee or under which it occupies property, so as to prevent any loss or forfeiture thereof or
    thereunder.

   

  (i)           Maintenance of Intellectual Property. The
    Company will, and will cause each of its material Subsidiaries to, take all action necessary or advisable to maintain all of the rights or licenses to use all trademarks, trade names, service marks, service mark registrations, service names, original
    works of authorship, patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications and registrations therefor of the Company and/or any of its
    Subsidiaries, in each case that are necessary or material to the conduct of its business in full force and effect, except those that the loss of which, individually or in the aggregate, have not had and would not reasonably be expected to have a
    Material Adverse Effect.

   

  (j)           Maintenance of Insurance. The Company shall
    maintain, and cause each of its Subsidiaries to maintain, insurance with responsible and reputable insurance companies or associations (including, without limitation, comprehensive general liability, hazard, rent and business interruption insurance)
    with respect to its properties (including all real properties leased or owned by it) and business, in such amounts and covering such risks as is required by any governmental authority having jurisdiction with respect thereto or as is carried generally
    in accordance with sound business practice by companies in similar businesses similarly situated. 

  

  
    Exhibit B-20

    
      
 

  

   

  (k)          Transactions with Affiliates. The Company shall
    not, nor shall it permit any of its Subsidiaries to, enter into, renew, extend or be a party to, any transaction or series of related transactions (including, without limitation, the purchase, sale, lease, transfer or exchange of property or assets of
    any kind or the rendering of services of any kind) with any Affiliate, except in the ordinary course of business in a manner and to an extent consistent with past practice and necessary or desirable for the prudent operation of its business, for fair
    consideration and on terms no less favorable to it or its Subsidiaries than would be obtainable in a comparable arm’s length transaction with a Person that is not an Affiliate thereof.

   

  (l)           Use of Proceeds. The Maker shall use the
    proceeds of this Note as set forth in the Purchase Agreement.

   

  (m)         Operation of Business. The Company shall operate
    its business in the ordinary course consistent with past practices.

   

  (n)          Compliance with Transaction Documents. The
    Maker shall, and shall cause its Subsidiaries to, comply with its obligations under this Note and the other Transaction Documents.

   

  (o)          Payment of Taxes, Etc. The Maker shall, and
    shall cause each of its Subsidiaries to, promptly pay and discharge, or cause to be paid and discharged, when due and payable, all lawful taxes, assessments and governmental charges or levies imposed upon the income, profits, property or business of
    the Maker and the Subsidiaries, except for such failures to pay that, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect; provided, however, that any such tax,
    assessment, charge or levy need not be paid if the validity thereof shall currently be contested in good faith by appropriate proceedings and if the Maker or such Subsidiaries shall have set aside on its books adequate reserves with respect thereto,
    and provided, further, that the Maker and such Subsidiaries will pay all such taxes, assessments, charges or levies forthwith upon the commencement of proceedings to foreclose any lien which may have attached as security therefor.

   

  (p)          Variable Rate Transactions. The Company shall
    not enter into any Variable Rate Transactions except for an Equity Line Agreement with CF Principal Investments LLC or its Affiliates.

   

  ARTICLE 5

   

  5.1          Notices. Any and all notices or other
    communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via email at the email
    address specified in this Section 5.1 prior to 5:00 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via email at the email address specified in this
    Section 5.1 on a day that is not a Trading Day or later than 5:00 p.m. (New York City time) on any date and earlier than 11:59 p.m. (New York City time) on such date, (c) the Trading Day following the date of delivery to a carrier , if sent by U.S.
    nationally recognized overnight courier service next Trading Day delivery, or (d) upon actual receipt by the party to whom such notice is required to be given. The addresses for notice shall be as set forth in the Purchase Agreement. 

  

  
    Exhibit B-21

    
      
 

  

   

  5.2

  Governing Law. This Note
    shall be governed by and construed in accordance with the Purchase Agreements. This Note shall not be interpreted or construed with any presumption against the party causing this Note to be drafted.

   

  5.3

  Headings. Article and
    section headings in this Note are included herein for purposes of convenience of reference only and shall not constitute a part of this Note for any other purpose.

   

  5.4

  Remedies, Characterizations,
      Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note, at law or in equity (including, without limitation, a decree of specific
    performance and/or other injunctive relief), no remedy contained herein shall be deemed a waiver of compliance with the provisions giving rise to such remedy and nothing herein shall limit the Holder’s right to pursue actual damages for any failure by
    the Maker to comply with the terms of this Note. Amounts set forth or provided for herein with respect to payments, conversion and the like (and the computation thereof) shall be the amounts to be received by the Holder thereof and shall not, except as
    expressly provided herein, be subject to any other obligation of the Maker (or the performance thereof). The Maker acknowledges that a breach by it of its obligations hereunder will cause irreparable and material harm to the Holder and that the remedy
    at law for any such breach would be inadequate. Therefore, the Maker agrees that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available rights and remedies, at law or in equity, to seek
    equitable relief, including but not limited to an injunction restraining any such breach or threatened breach, without the necessity of pleading and proving irreparable harm or lack of an adequate remedy at law and without any bond or other security
    being required.

   

  5.5

  Enforcement Expenses. The
    Maker agrees to pay all costs and expenses of enforcement by the Holder of this Note, including, without limitation, reasonable attorneys’ fees and expenses.

   

  5.6

  Binding Effect. The
    obligations of the Maker set forth herein shall be binding upon its successors and assigns, whether or not such successors or assigns are permitted by the terms herein.

   

  5.7

  Amendments; Waivers. No
    provision of this Note may be waived or amended except in a written instrument signed by the Company and the Holder. No waiver of any default with respect to any provision, condition or requirement of this Note shall be deemed to be a continuing waiver
    in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of the Holder to exercise any right hereunder in any manner impair the exercise of any such right. 

  

  
    Exhibit B-22

    
      
 

  

   

  5.8          Compliance with Securities Laws. The Holder
    of this Note acknowledges that this Note is being acquired solely for the Holder’s own account and not as a nominee for any other party, and for investment, and that the Holder shall not offer, sell or otherwise dispose of this Note in violation of
    applicable securities laws. This Note and any Note issued in substitution or replacement therefor shall be stamped or imprinted with a legend in substantially the following form:

   

  “THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
    REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM,
    OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR OR THE MAKER TO SUCH EFFECT, THE SUBSTANCE OF
    WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.”

   

  5.9          Exclusive Jurisdiction; Venue. Any action,
    proceeding or claim arising out of, or relating in any way to, this Agreement shall be brought and enforced only as provided in the Purchase Agreement.

   

  5.10        Failure or Indulgence Not Waiver. No failure
    or delay on the part of the Holder in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof
    or of any other right, power or privilege.

   

  5.11        Maker Waivers. Except as otherwise specifically
      provided herein, the Maker and all others that may become liable for all or any part of the obligations evidenced by this Note, hereby waive presentment, demand, notice of nonpayment, protest and all other demands’ and notices in connection with
    the delivery, acceptance, performance and enforcement of this Note, and do hereby consent to any number of renewals of extensions of the time or payment hereof and agree that any such renewals or extensions may be made without notice to any such
    persons and without affecting their liability herein and do further consent to the release of any person liable hereon, all without affecting the liability of the other persons, firms or Maker liable for the payment of this Note, and do hereby
      waive the right to a trial by jury.

   

  5.12        Definitions. Capitalized terms used herein and
    not defined shall have the meanings set forth in the Purchase Agreement. For the purposes hereof, the following terms shall have the following meanings.

   

  (a)          “Additional Note” means the $[ ] Note the Maker is required to issue the Holder upon the Holder lending the Maker an additional $[ ] as required by Section 2.1(c ) of the Purchase Agreement and
    in an amount reflected on the Holder’s signature page to the Purchase Agreement and subject to its conditions. 

  

  
    Exhibit B-23

    
      
 

  

   

  (b)          “Affiliate” means,

      with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control with, such Person, it being understood for purposes of this definition that “control” of a Person means the power directly
      or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.

   

  (c)          “Attribution Parties” means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder funds or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly managed or advised
      by the Holder’s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder
      or any of the foregoing and (iv) any other Persons whose beneficial ownership of the Company’s Common Stock would or could be aggregated with the Holder’s and the other Attribution Parties for purposes of Section 13(d) of the Exchange Act.  For
      clarity, the purpose of the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.

   

  (d)          “Amortization Conversion Price” means a 7%
    discount to the lowest Selected VWAP over the 10 Trading Days immediately preceding the applicable Payment Date or other date of determinization.

   

  (e)          “Change of Control” means any Fundamental
    Transaction other than (i) any merger of the Company or any of its, direct or indirect, wholly-owned Subsidiaries with or into any of the foregoing Persons, (ii) any reorganization, recapitalization or reclassification of the shares of Common Stock in
    which holders of the Company’s voting power immediately prior to such reorganization, recapitalization or reclassification continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly or
    indirectly, are, in all material respects, the holders of the voting power of the surviving entity (or entities with the authority or voting power to elect the members of the board of directors (or their equivalent if other than a corporation) of such
    entity or entities) after such reorganization, recapitalization or reclassification, or (iii) pursuant to a migratory merger effected solely for the purpose of changing the jurisdiction of incorporation of the Company or any of its Subsidiaries.

   

  (f)           “COC Repayment Price” has the meaning
    contained in Section 3.6(a).

   

  (g)          “Conversion Amount” has the meaning contained
    in Section 3.1(a).

   

  (h)          “Conversion Date” has the meaning contained in
    Section 3.1(a).

   

  (i)           “Conversion Failure” has the meaning contained in
    Section 3.2(c).

   

  (j)           “Conversion Notice” has the meaning contained
    in Section 3.1(a).

   

  (k)          “Conversion Price” has the meaning contained in
    Section 3.1(b). 

  

  
    Exhibit B-24

    
      
 

  

   

  (l)           “Conversion Shares” has the meaning contained
    in Section 3.2(a). In this Note, the use of Common Stock shall also refer to Conversion shares unless otherwise apparent form the context.

   

  (m)         “Convertible Securities” has the meaning
    contained in Section 3.4(v).

   

  (n)          “Default Conversion Price” means the lower of
    (i) the Conversion Price, as adjusted, or (ii) 0.80 times the Market Price.

   

  (o)          “Default Interest Payment Date” has the meaning
    contained in Section 1.2(c).

   

  (p)          “DTC” has the meaning contained in Section
    3.2(a).

   

  (q)          “Equity Conditions” shall having the meaning as
    defined by the Purchase Agreement.

   

  (r)           “Equity Interests” means any security other
    than Common Stock which is registered under Section 12(b) or 12(g) under the Exchange Act.

   

  (s)          “Exchange Act” means the Securities and
    Exchange Act of 1934, as amended, and the rules and regulations thereunder.

   

  (t)           “Final Monthly Payment Provisional Conversion
      Price” has the meaning contained in Section 1.3(e).

   

  (u)          “Fundamental Transaction” means (A) that the
    Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the surviving corporation) another Subject Entity,
    or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of the Company or any of its “significant subsidiaries” (as defined in Rule 1-02 of Regulation S-X) to one or more Subject Entities, or
    (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the
    holders of at least either (x) 50% of the outstanding shares of Common Stock, (y) 50% of the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all Subject Entities making or party to, or Affiliated with any Subject
    Entities making or party to, such purchase, tender or exchange offer were not outstanding; or (z) such number of shares of Common Stock such that all Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such
    purchase, tender or exchange offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the Exchange Act) of at least 50% of the outstanding shares of Common Stock, or (iv) consummate a stock or share purchase agreement or other
    business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire, either (x) at
    least 50% of the outstanding shares of Common Stock, (y) at least 50% of the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all the Subject Entities making or party to, or Affiliated with any Subject Entity
    making or party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number of shares of Common Stock such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under
    the Exchange Act) of at least 50% of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in
    one or more related transactions, allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, whether through
    acquisition, purchase, assignment, conveyance, tender, tender offer, exchange, reduction in outstanding shares of Common Stock, merger, consolidation, business combination, reorganization, recapitalization, spin-off, scheme of arrangement,
    reorganization, recapitalization or reclassification or otherwise in any manner whatsoever, of either (x) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock, (y) at least 50% of the aggregate ordinary
    voting power represented by issued and outstanding Common Stock not held by all such Subject Entities as of the date of this Note calculated as if any shares of Common Stock held by all such Subject Entities were not outstanding, or (z) a percentage of
    the aggregate ordinary voting power represented by issued and outstanding shares of Common Stock or other equity securities of the Company sufficient to allow such Subject Entities to effect a statutory short form merger or other transaction requiring
    other shareholders of the Company to surrender their shares of Common Stock without approval of the shareholders of the Company or (C) directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions,
    the issuance of or the entering into any other instrument or transaction structured in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition shall be construed and implemented in a manner otherwise
    than in strict conformity with the terms of this definition to the extent necessary to correct this definition or any portion of this definition which may be defective or inconsistent with the intended treatment of such instrument or transaction. 

  

  
    Exhibit B-25

    
      
 

  

   

  (v)          “Group” means a
      “group” as that term is used in Section 13(d) of the Exchange Act and as defined in Rule 13d-5 thereunder.

   

  (w)          “Guarantor” refers to each Subsidiary of the
    Company including SpringBig, Inc.

   

  (x)           “Inability to Fully Convert Notice” has the
    meaning contained in Section 3.6(b).

   

  (y)          “Indebtedness” means: (a) all obligations for
    borrowed money; (b) all obligations evidenced by bonds, debentures, notes, or other similar instruments and all reimbursement or other obligations in respect of letters of credit, bankers acceptances, current swap agreements, interest rate hedging
    agreements, interest rate swaps, or other financial products; (c) all obligations or liabilities secured by a lien or encumbrance on any asset of the Maker, irrespective of whether such obligation or liability is assumed; and (d) any obligation
    guaranteeing or intended to guarantee (whether directly or indirectly guaranteed, endorsed, co-made, discounted or sold with recourse) any of the foregoing obligations of any other person. 

  

  
    Exhibit B-26

    
      
 

  

   

  (z)           “Interest” has the meaning contained in
    Section 1.2(a).

   

  (aa)         “Liens” has the meaning contained in Section
    4.1(c).

   

  (bb)        “Mandatory Default Amount” means an amount equal
    to 115% of the outstanding Principal Amount of this Note on the date on which the first Event of Default has occurred hereunder.

   

  (cc)         “Mandatory Prepayment” and “Mandatory
      Prepayment Price” have the meaning contained in Section 3.6(a)(ii).

   

  (dd)        “Market Price” means the Selected VWAP of the
    Common Stock on the principal Trading Market for the 10 consecutive Trading Days ending on the Trading Day that is immediately prior to the applicable date of determination.

   

  (ee)         “Maturity Date” has the meaning contained on
    page 1 of this Note and is 24 months after the Original Issuance Date.

   

  (ff)          “Maximum Percentage” has the meaning contained
    in Section 3.3.

   

  (gg)        “Monthly Conversion Period” refers to the 10-day
    period used in the definition of Amortization Conversion Price. .

   

  (hh)        “Monthly Conversion Price” has the meaning
    contained in Section 1.3(d).

   

  (ii)           “Monthly Payment” has the meaning contained
    in Section 1.3(a).

   

  (jj)           “Monthly Payment Adjustment Notice” has the
    meaning contained in Section 1.3.

   

  (kk)         “Monthly Payment Notice” has the meaning
    contained in Section 1.3(d).

   

  (ll)           “Note” means this Senior Secured Original
    Issue Discount Convertible Promissory Note;

   

  (mm)       “Notice in Response to Inability to Convert” has
    the meaning contained in Section 3.6(b).

   

  (nn)        “Notice of Change of Control” has the meaning
    contained in Section 3.6(a).

   

  (oo)        “Notice of Prepayment at Option of Holder Upon
      Change of Control” has the meaning contained in Section 3.6(a).

   

  (pp)        “Other Notes” has the meaning contained in
    Section 1.10. 

  

  
    Exhibit B-27

    
      
 

  

   

  (qq)        “Payment Date” has the meaning contained in
    Section 1.3(a).

   

  (rr)          “Permitted Indebtedness” means (i)
    Indebtedness evidenced by this Note, the Other Notes, the Additional Notes when issued, (ii) capitalized leases and purchase money security interests for purchases of equipment and assets used in the business in the ordinary course of business, and
    (iii) working capital credit line in an amount not to exceed $1,000,000 outstanding at any time.

   

  (ss)         “Permitted Liens” means (i) any lien for taxes
    not yet due or delinquent or being contested in good faith by appropriate proceedings for which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary course of business by operation of law with
    respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation of law, such as materialmen’s Liens, mechanics’ Liens and other similar Liens, arising in the ordinary course of business with respect to a liability that is
    not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv) Liens securing Permitted Indebtedness, and (v) incurred in connection with the extension, renewal or refinancing of the Indebtedness secured by Liens
    of the type described in clause (iv) above, provided that any extension, renewal or replacement Lien shall be limited to the property encumbered by the existing Lien and the principal amount of the Indebtedness being extended, renewed or refinanced
    does not increase, (vi) Liens in favor of customs and revenue authorities arising as a matter of law to secure payments of custom duties in connection with the importation of goods, and (vii) Liens arising from judgments, decrees or attachments in
    circumstances not constituting an Event of Default under this Note.

   

  (tt)          “Pricing Period” means the 10 Trading Days
    following the cure of an Event of Default as permitted by this Note.

   

  (uu)        “Purchase Agreement” has the meaning contained
    in Section 1.1

   

  (vv)        “Principal” means $[_____].

   

  (ww)       “SEC” means the United States Securities and
    Exchange Commission or the successor thereto.

   

  (xx)          “Securities Act” means the Securities Act of
    1933, as amended, and the rules and regulations thereunder.

   

  (yy)         “Selected VWAP” means an actual daily VWAP
    selected by the Holder during any period of ten consecutive trading days.

   

  (zz)          “Share Delivery Date” has the meaning
    contained in Section 3.2(a).

   

  (aaa)       “Standard Settlement Period” has the meaning
    contained in Section 2.1(e).

   

  (bbb)      “Succeeding Measurement Period” has the meaning
    contained in Section 1.3(e). 

  

  
    Exhibit B-28

    
      
 

  

   

  (ccc)       “Trading Day” means a day on which the Common
    Stock are traded on a Trading Market for at least 4.5 hours.

   

  (ddd)      Trading Market” means any of the New York Stock
    Exchange, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Select Market, or the Nasdaq Global Market, or any successors of any of these exchanges on which the Common Stock is listed.

   

  (eee)       “Variable Rate Transactions” has the meaning
    contained in the Purchase Agreement.

   

  (fff)         “VWAP” means, for any date, the price
    determined by the first of the following clauses that applies: (a) if the Common Stock are then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such
    date (or the nearest preceding date) on the Trading Market on which the Common Stock are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the
    Common Stock are traded on OTCQB or OTCQX , the volume weighted average sales price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock are not then listed or quoted for trading on
    OTCQB or OTCQX and if prices for the Common Stock are then reported in the “Pink Open Market” or successor operated by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid
    price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent broker-dealer selected in good faith by the Holder and reasonably acceptable to the Company,
    the fees and expenses of which shall be paid by the Company.

   

  [Signature Page Follows] 

  
    Exhibit B-29

    
      
 

  

   

  IN WITNESS WHEREOF, the Maker has caused this Note to be duly executed by its duly authorized officer as of the date first above indicated.

   

  

  	 	SpringBig Holdings, inc. 
	 	 	 
	 	By: 	                                      
	 	Name:
	 	Title:

  

   

  Signature Page to Note

  
    
      
 

  

  
  EXHIBIT C

      FORM OF PLEDGE AGREEMENT 

  

  
     

    
      
 

  

  
   

  EXHIBIT D 

  Form of Registration Rights Agreement 

  
     

    
      
 

  

  
   

  REGISTRATION RIGHTS AGREEMENT

   

  THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is dated as of ________ ___, 2022, by and among SpringBig Holdings Inc. (the “Company”), and
    each Person defined on the signature pages hereto (together with their respective successors and assigns, each an “Investor”).

   

  WHEREAS, the Company has agreed to provide certain registration rights to the Investors in order to induce each Investor to enter into that
    certain Securities Purchase Agreement by and among the Company and each Investor dated as of April ___, 2022 (the “Purchase Agreement”).

   

  Now, therefore, in consideration of the mutual promises and the covenants as set forth herein, the parties hereto hereby agree as follows:

   

  1.            Definitions. Unless the context otherwise requires, capitalized words and terms used herein without definition and
    defined in the Purchase Agreement are used herein as defined therein. Notwithstanding the foregoing, as used herein the capitalized words and terms defined in this Section 1 shall have the meanings herein specified for all purposes of this Agreement,
    applicable to both the singular and plural forms of any of the terms herein defined:

   

  “Agreement” means this Registration Rights Agreement, as the same may be amended, modified or supplemented in accordance with the terms hereof.

   

  “Board” means the Board of Directors of the Company.

   

  “Common Stock” means the Company’s authorized common stock, as constituted on the date of this Agreement, any stock into which such Common Stock may thereafter be
    changed and any stock of the Company of any other class, which is not preferred as to dividends or assets over any other class of stock of the Company and which is not subject to redemption, issued to the holders of shares of such Common Stock upon any
    re-classification thereof.

   

  “Company” has the meaning assigned to it in the introductory paragraph of this Agreement.

   

  “Company Securities” means any securities proposed to be sold by the Company for its own account in a registered public offering.

   

  “Exchange Act” means the Securities Exchange Act of 1934 (or successor statute).

   

  “Excluded Forms” means Registration Statements under the Securities Act on Forms S-4 and S-8 or any successors.

   

  “Investors” has the meaning assigned to it in the introductory paragraph of this Agreement.

   

  “Person” includes any natural person, corporation, trust, association, company, partnership, joint venture, limited liability company and other
    entity and any government, governmental agency, instrumentality or political subdivision. 

  
    Exhibit D-1 

    
      
 

  

  
   

  “Proposed Registration” means any proposed Registration Statement to be filed pursuant to this Agreement.

   

  “Purchase Agreement” has the meaning assigned to it in the Recitals of this Agreement.

   

  The terms “register” “registered” and “registration” refer to a registration effected by preparing and filing a Registration Statement on other
    than any of the Excluded Forms in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such Registration Statement.

   

  “Registration Statement” means any registration statement filed by the Company on behalf of any Investors.

   

  “Registrable Securities” means the greater of (a) (i) the Common Stock to be acquired by each Investor pursuant to the conversion of the Notes and exercise of the
    Warrants and any other shares of Common Stock subsequently acquired by any Investor under any Transaction Documents, and (ii) any securities of the Company issued with respect to such Common Stock by way of any stock dividend or stock split or in
    connection with any merger, combination, recapitalization, share exchange, consolidation, reorganization or other similar transaction, or (b) the Required Minimum as defined by the Purchase Agreement.

   

  “Representatives” means all shareholders, officers, directors, members, managers, partners, employees and agents.

   

  “Rule 144” has the meaning assigned to it in Section 8 of this Agreement.

   

  “SEC” means the Securities and Exchange Commission or any other governmental body at the time administering the Securities Act.

   

  “Securities Act” means the Securities Act of 1933 (or successor statute).

   

  “Selling Expenses” means all selling commissions, underwriting discounts, other fees paid by an Investor to a broker-dealer, finder’s fees and
    stock transfer taxes applicable to the Registrable Securities contained in a Registration Statement for the benefit of each Investor.

   

  2.            Required Registration. Within 20 days after each of the First Tranche Closing and the Second Tranche Closing, the
    Company shall file with the SEC a Registration Statement on Form S-1 or S-3, or any successor form covering the sale of all of the Registrable Securities. The Company shall also fully comply with Section 4.23 of the Purchase Agreement.

   

  3.            Obligations of the Company. If and whenever the Company is required by the provisions hereof to effect or cause the
    registration of any Registrable Securities under the Securities Act as provided herein, the Company shall: 

  
    Exhibit D-2 

    
      
 

  

  
   

  (a)           prepare and file with the SEC within 20 days after
    the First Tranche Closing and the Second Tranche Closing, as applicable, a Registration Statement with respect to such Registrable Securities and cause any such Registration Statement to become effective within 75 days from the First Tranche Closing
    and the Second Tranche Closing, as applicable (and to remain effective (provided that before filing a Registration Statement or any amendment or supplement thereto, the Company will at least three Trading Days prior to making any such filing it shall
    furnish to each Investor copies of the Registration Statement, as amended if applicable and any response letter to the Staff of the SEC proposed to be filed));

   

  (b)         subject to complying with Section 3(a), prepare and
    file with the SEC such amendments to any such Registration Statement (including post-effective amendments) and supplements to the prospectus included therein as may be necessary to keep such Registration Statement effective and to comply with the
    provisions of the Securities Act with respect to the sale or other disposition of all Registrable Securities covered by such Registration Statement during such period in accordance with the intended methods of disposition by the Investors set forth in
    such Registration Statement;

   

  (c)          furnish to each Investor such number of copies of
    such Registration Statement and of each such amendment and supplement thereto (in each case including all exhibits), such number of copies of the prospectus included in such Registration Statement (including each preliminary prospectus), in conformity
    with the requirements of the Securities Act, and such other documents, as each Investor may reasonably request, in order to facilitate the public sale or other disposition of the Registrable Securities owned by the Investors;

   

  (d)          use all commercially reasonable efforts to make such
    filings under the securities or blue sky laws of such states or commonwealths as any Investor may reasonably request to enable each Investor to consummate the sale;

   

  (e)           promptly notify the Investors at any time when a
    prospectus relating to their Registrable Securities is required to be delivered under the Securities Act, of the Company’s becoming aware that the prospectus included in the related Registration Statement, as then in effect, includes an untrue
    statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing, and promptly prepare and furnish to the Investors a
    reasonable number of copies of a prospectus supplemented or amended so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus shall not include an untrue statement of a material fact or omit to state a material
    fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing. In such event, the Company shall file a Form 8-K or amended prospectus or prospectus supplement within four
    Trading Days in order to permit the Holder to be able to sell Warrant Shares;

   

  (f)           otherwise comply with all applicable rules and
    regulations of the SEC and to perform its obligations hereunder;

   

  (g)          use commercially reasonable efforts to cause the
    Registrable Securities to be quoted on the Principal Market; 

  
    Exhibit D-3 

    
      
 

  

  
   

  (h)          provide a transfer agent for all Registrable
    Securities and promptly pay all fees and costs of the transfer agent;

   

  (i)           provide a CUSIP number for all Registrable
    Securities, in each case not later than the effective date of the applicable Registration Statement;

   

  (j)           notify the Investors of any stop order threatened or
    issued by the SEC and take all actions reasonably necessary to prevent the entry of such stop order or to remove it if entered;

   

  (k)          the Company shall promptly email each Investor copies
    of all comment letters and other communications from and with the Staff of the SEC, file an amendment to a Registration Statement within ten Trading Days after receipt of a comment letter or oral comments, and request acceleration of the effectiveness
    of the Registration Statement within three Trading Days after the Company or its counsel has been advised that the Staff has no further comments; and

   

  (l)            if a Registration Statement is not declared
    effective by the required effective date due to factors outside its control as permitted by Section 2.1(b) of the Note, the Company shall promptly email the Company and disclose the underlying facts and further if requested promply answer any questions
    by email.

   

  A failure to comply with Section 3 of this Agreement and Section 4.23 of the Purchase Agreement shall be deemed to be an Event of Default under the Notes.

   

  4.            Other Procedures.

   

  (a)           Subject to the remaining provisions of this Section 4 and the Company’s general obligations under Section 3, the Company shall be
    required to maintain the effectiveness of a Registration Statement until the earlier of (i) the sale of all Registrable Securities, or (ii) two years unless the SEC eliminates the requirement in Rule 144(i) and permits a former shell issuer to use Rule
    144 after one year without complying with Rule 144(c) in which case the two years shall be reduced to one year.

   

  (b)           In consideration of the Company’s obligations under this Agreement, the Investors agree that, upon receipt of any notice from the Company of the happening
    of any event of the kind described in Section 3(e) herein, each Investor shall forthwith discontinue its sale of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities until the Investor’s receipt of the
    copies of the supplemented or amended prospectus contemplated by said Section 3(e).

   

  (c)           The Company’s obligation to file any Registration Statement or amendment including a post-effective amendment, shall be subject to each Investor, as
    applicable, furnishing to the Company in writing such information and documents regarding such Investor and the distribution of such Investor’s Registrable Securities as may reasonably be required to be disclosed in the Registration Statement in
    question by the rules and regulations under the Securities Act or under any other applicable securities or blue sky laws of the jurisdiction referred to in Section 3(d) herein. The Company’s obligations are also subject to each Investor promptly
    executing any representation letter concerning compliance with Regulation M under the Exchange Act (or any successor rule or regulation). If any Investor fails to provide all of the information required by this Section 4(c), the Company shall have no
    obligation to include its Registrable Securities in a Registration Statement or it may withdraw such Investor’s Registrable Securities from the Registration Statement without incurring any penalty or otherwise incurring liability to such Investor. 

  
    Exhibit D-4 

    
      
 

  

  
   

  (d)           If any such registration or comparable statement refers to an Investor by name or otherwise as a stockholder of the Company, but such reference to such
    Investor by name or otherwise is not required by the Securities Act or the rules thereunder, then each Investor shall have the right to require the deletion of the reference to such Investor, as may be applicable.

   

  (e)           If the Company is unable to register all Registrable Securities in one Registration Statement due to an SEC Rule or Staff policy, the
    Company shall continue to file new Registration Statements for the remaining Registrable Securities every 30 days after the effectiveness of the last Registration Statement, in which event the conditions of this Agreement including the 75 day
    effectiveness shall apply; provided, however, in no event shall the Company delay the effective date of any Registration Statement for more than five Trading Days after receipt of notice from the SEC Staff that it will either not review
    a Registration Statement or it has no further comments with respect to a Registration Statement.

   

  (f)           The Company shall not include any securities for any other stockholder in any registration statement other than Registrable Securities
    for the Investors in any Registration Statement.

   

  5.            Registration Expenses. In connection with any registration of Registrable Securities pursuant to Sections 2, the
    Company shall, whether or not any such registration shall become effective, from time to time, pay all expenses (other than Selling Expenses) incident to its performance of or compliance, including, without limitation, all registration, and filing
    fees, fees and expenses of compliance with securities or blue sky laws, word processing, printing and copying expenses, messenger and delivery expenses, fees and disbursements of counsel for the Company and all independent public accountants and other
    Persons retained by the Company.

   

  6.            Indemnification.

   

  (a)           In the event of any registration of any shares of Common Stock under the Securities Act pursuant to this Agreement, the Company shall
    indemnify, defend and hold harmless each Investor, its Affiliates, and their respective Representatives, successors and assigns, from and against any losses, claims, damages or liabilities, joint or several, to which each Investor, its Affiliates, and
    its respective Representatives, successors and assigns may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement
    or alleged untrue statement of a material fact contained in any Registration Statement under which such Registrable Securities were registered under the Securities Act, any preliminary prospectus or final prospectus contained therein, or any amendment
    or supplement thereto, or any document incident to registration or qualification of any Registrable Securities pursuant to Section 3(d) herein, or arise out of or are based upon the omission or alleged omission to state therein a material fact required
    to be stated therein or necessary to make the statements therein not misleading or, with respect to any prospectus, necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, or any violation by
    the Company of the Securities Act, the Exchange Act, or state securities or blue sky laws or relating to action or inaction required of the Company in connection with such registration or qualification under the Securities Act or such state securities
    or blue sky laws. If the Company fails to defend the Investor, its Affiliates, and its respective Representatives, successors and assigns, as applicable, as required by Section 6(c) herein, it shall reimburse (after receipt of appropriate
    documentation) each Investor, its Affiliates, and its respective Representatives, successors and assigns for any legal or any other reasonable and documented out-of-pocket expenses incurred by any of them in connection with investigating or defending
    any such loss, claim, damage, liability or action; provided, however, that the Company shall not be liable to an Investor, its Affiliates, or its respective Representatives, successors or assigns in any such case to the extent that any
    such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in said Registration Statement, said preliminary prospectus, said prospectus, or said amendment or
    supplement or any document incident to registration or qualification of any Registrable Securities pursuant to Section 3(d) hereof in reliance upon and in conformity with written information furnished to the Company by such Investor, its Affiliates, or
    its respective Representatives, successors or assigns specifically for use in the preparation thereof. 

  
    Exhibit D-5 

    
      
 

  

  
   

  (b)           In the event of any registration of any Registrable Securities under the Securities Act pursuant to this Agreement, each Investor shall, severally and not
    jointly, indemnify and hold harmless (in the same manner and to the same extent as set forth in Section 6(a)) the Company, each director of the Company, each officer of the Company who signs such Registration Statement, the Company’s attorneys and
    auditors and any Person who controls the Company within the meaning of the Securities Act, from and against any loss, claim, damage or liability that arises out of or is based upon any untrue statement or omission from such Registration Statement, any
    preliminary prospectus or final prospectus contained therein, or any amendment or supplement thereto, if and to the extent that such untrue statement or omission was made in reliance upon and in conformity with written information furnished to the
    Company by such Investor specifically for use in the preparation of such Registration Statement, preliminary prospectus, final prospectus or amendment or supplement.

   

  (c)           Promptly after receipt by an indemnified party of notice of the commencement of any action involving a claim referred to in Section
    6(a) or (b), such indemnified party shall, if a claim in respect thereof is made against an indemnifying party, give written notice to such indemnifying party of the commencement of such action. The indemnifying party shall be relieved of its
    obligations under this Section 6(c) if and to the extent that the indemnified party delays in giving notice and the indemnifying party is damaged or prejudiced by the delay. In case any such action is brought against an indemnified party, the
    indemnifying party shall be entitled to participate in and to assume the defense thereof, jointly with any other indemnifying party similarly notified to the extent that it may wish, with counsel reasonably satisfactory to such indemnified party, and,
    after notice from the indemnifying party to such indemnified party of its election so as to assume the defense thereof, the indemnifying party shall be responsible for any legal or other expenses subsequently incurred by the indemnifying party in
    connection with the defense thereof, provided, however, that, if counsel for an indemnified party shall have reasonably concluded that there is an actual or potential conflict of interest between the indemnified party and the indemnifying
    party, the indemnifying party shall not have the right to assume the defense of such action on behalf of such indemnified party, and such indemnifying party shall reimburse such indemnified party for the reasonable and documented fees and expenses of
    counsel (including local counsel, if applicable) retained by the indemnified party which are reasonably related to the matters covered by the indemnity agreement provided in this Section 7. Provided, further, that in no event shall any
    indemnification by an Investor under this Section 7 exceed the net proceeds from the sale of Registrable Securities received by such Investor. No indemnified party shall make any settlement of any claims indemnified against hereunder without the
    written consent of the indemnifying party, which consent shall not be unreasonably withheld. In the event that any indemnifying party enters into any settlement without the written consent of the indemnified party, the indemnifying party shall not
    consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff of a release of such indemnified party from all liability in respect to such claim or
    litigation. 

  
    Exhibit D-6 

    
      
 

  

  
   

  (d)           In order to provide for just and equitable contribution to joint liability under the Securities Act in any case in which (i) any
    indemnified party makes a claim for indemnification pursuant to this Section 6, but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the
    last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this Section 6 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required in circumstances for
    which indemnification is provided under this Section 6; then, in each such case, the Company and each such Investor shall contribute to the aggregate losses, claims, damages or liabilities to which they may be subject as is appropriate to reflect the
    relative fault of the Company and such Investor in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities, it being understood that the parties acknowledge that the overriding equitable consideration
    to be given effect in connection with this provision is the ability of one party or the other to correct the statement or omission (or avoid the conduct or take an act) which resulted in such losses, claims, damages or liabilities, and that it would
    not be just and equitable if contribution pursuant hereto were to be determined by pro-rata allocation or by any other method of allocation which does not take into consideration the foregoing equitable considerations. Notwithstanding the foregoing,
    (i) no such Investor shall be required to contribute any amount in excess of the net proceeds to it of all Registrable Securities sold by it pursuant to such Registration Statement, and (ii) no Person who is guilty of fraudulent misrepresentation
    within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution from any Person who is not guilty of such fraudulent misrepresentation.

   

  7.            Rule 144. As long as an Investor holds restricted securities (as that term is used in Rule 144) or has the right to
    acquire restricted Shares or restricted Warrant Shares, the Company covenants that it will (i) make and keep public information available, as those terms are understood and defined in Rule 144, at all times, (ii) file in a timely manner the reports and
    other documents required to be filed under the Securities Act or the Exchange Act and the rules and regulations adopted by the SEC thereunder, (iii) furnish to each Investor promptly upon request (x) a written statement by the Company as to its
    compliance with the reporting requirements of Rule 144 and the Exchange Act, (y) a copy of the most recent annual or quarterly report of the Company, and (z) such other information as an Investor may reasonably request, and (iv) cooperate with each
    Investor and respond as promptly as possible to any requests from such Investor in connection with Rule 144 transfers of restricted securities, in each case to enable such Investor to sell its Registrable Securities without registration under the
    Securities Act within the limitation of the exemption provided by (a) Rule 144 under the Securities Act, as such Rule may be amended from time to time, or (b) any similar rule or regulation hereafter adopted by the SEC (collectively, “Rule 144”); provided,
    however, nothing contained in this Section 7 or elsewhere in this Agreement shall prevent the Company from consummating a transaction in which another entity acquires it through a merger or similar transaction. 

  
    Exhibit D-7 

    
      
 

  

  
   

  8.            Severability. In the event any parts of this Agreement are found to be illegal, unenforceable or void, the remaining
    provisions of this Agreement shall nevertheless be binding with the same effect as though the illegal, unenforceable or void parts were deleted.

   

  9.            Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original
    but all of which together shall constitute one and the same instrument. The execution of this Agreement may be by actual or facsimile signature.

   

  10.          Benefit. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their legal
    representatives, successors and assigns.

   

  11.          Notices and Addresses. All notices, approvals, requests, demands and other communications hereunder shall be delivered
    or made in the manner set forth in, and shall be effective in accordance with the terms of, the Purchase Agreement.

   

  12.          Attorneys’ Fees. In the event that there is any controversy or claim arising out of or relating to this Agreement, or
    to the interpretation, breach or enforcement thereof, and any action or proceeding relating to this Agreement is filed, the prevailing party shall be entitled to an award by the court of reasonable attorneys’ fees, costs and expenses.

   

  13.          Entire Agreement; Oral Evidence. This Agreement constitutes the entire Agreement between the parties and supersedes all
    prior oral and written agreements between the parties hereto with respect to the subject matter hereof. Neither this Agreement nor any provision hereof may be changed, waived, discharged or terminated orally, except by a statement in writing signed by
    the party or parties against which enforcement of the change, waiver discharge or termination is sought.

   

  14.          Additional Documents. The parties hereto shall execute such additional instruments as may be reasonably required by
    their counsel in order to carry out the purpose and intent of this Agreement and to fulfill the obligations of the parties hereunder.

   

  15.          Governing Law. This Agreement and any dispute, disagreement, or issue of construction or interpretation arising
    hereunder whether relating to its execution, its validity, the obligations provided herein or performance shall be governed or interpreted according to the internal laws of the State of Florida. 

  
    Exhibit D-8 

    
      
 

  

  
   

  17.          Section or Paragraph Headings. Section headings herein have been inserted for reference only and shall not be deemed to
    limit or otherwise affect, in any matter, or be deemed to interpret in whole or in part any of the terms or provisions of this Agreement.

   

  [Signature Page Follows] 

  
    Exhibit D-9 

    
      
 

  

  
   

  IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed personally or by a duly authorized representative thereof as of the day and year first
    above written.

   

  

  	 	Company:
	 	 	 	 
	 	SpringBig Holdings Inc.

   

  	 	By:	 	 
	 	Name:	 
	 	Title:	 
	 	 	 	 

  

  

  

  	 	Investors:

        
	 	 
	 	[                                        ] 
	 	 

  

  	 	By:	 	 
	 	Name:	 
	 	Title:	 

  

  
     

    
      
 

  

  
   

  

  

  EXHIBIT E

  FORM OF SECURITY AGREEMENT

   

      

   

      

  
    
      

  

  EXHIBIT F

  SPONSOR LOCKUP

   

   

    

   

    

  

  
    
      

  

  EXHIBIT G

  

  Form of Warrant

  
    
      

  

  
   

   

  NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE
        SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT
        PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
        SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE
        PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

   

  COMMON STOCK PURCHASE WARRANT 

  SPRINGBIG HOLDINGS INC. 

   

  

  	 	Initial Exercise Price: $12.00
	Warrant Shares: __________1	Initial Exercise Date: ____ __, 202_2

   

  

  THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received,
      ___________________________________, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, to subscribe for and purchase from SpringBig Holdings, Inc., a
      Delaware corporation (the “Company”), to ________ shares of Common Stock (subject to adjustment hereunder, (the “Warrant Shares”) at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the
      five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter.

   

  The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise
      Price, as defined in Section 2(b).

   

  Section 1.       Definitions. Capitalized terms used and not otherwise defined
      herein shall have the meanings set forth in that certain Securities Purchase Agreement (the “Agreement”), dated April ___, 2022, between the Company and the Holder.

   

  
  
     

  

  
  

  

  

  

  

  

  		1	Number of warrants to equal 50% of the Face value of the Note divided by the VWAP (as defined in the Note) prior to the applicable Closing
            Date.

  		2	The initial Exercise Date will be the applicable Closing Date

  

  
    Exhibit G-1

    
      

  

   

  Section 2.       Exercise.

   

  (a)          Exercise of the purchase rights represented by this Warrant
      may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to
      the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto. Within the earlier of (i) two Trading Days following the date of exercise as
      aforesaid or (ii) the Standard Settlement Period, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the
      cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. In the event that the Holder is required to make any payments to the Company’s stock transfer agent in connection with its exercise of this
      Warrant resulting from any failure of the Company to pay the transfer agent, the Holder may deduct such sums it pays the transfer agent from the total Exercise Price due. Notwithstanding anything herein to the contrary (although the Holder may
      surrender the Warrant to, and receive a replacement Warrant from, the Company), the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the
      Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within five Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this
      Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of
      Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise Form within one Trading Day
      of delivery of such notice. The Holder by acceptance of this Warrant, acknowledges and agrees that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares
      available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

   

  (b)          Exercise Price. The initial exercise price per share
      of the Common Stock under this Warrant shall be equal to $12.00 per share, subject to adjustment under Section 3 (the “Exercise Price”). 

  

  
    Exhibit G-2 

    
      
 

  

  

  (c)          Cashless Exercise. If at any time after the six
      months anniversary of the Initial Exercise Date, there is no effective Registration Statement covering the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised at the Holder’s election, in whole or in part and in lieu
      of making the cash payment otherwise contemplated to be made to the Company upon such exercise, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the number obtained by
      dividing [(A x B) – (A x C)] by (D), where:

   

  		(A)	= 	the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with
            the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise;

   

  		(B)	= 	the greater of (i) the arithmetic average of the VWAPs (as defined in the Notes or Additional Notes,
            as applicable) for the five consecutive Trading Days ending on the date immediately preceding the date on which the Holder elects to exercise this Warrant by means of a “cashless exercise,” as set forth in the applicable Notice of Exercise or
            (ii) the VWAP for the Trading Day immediately prior to the date on which the Holder makes such “cashless exercise” election;

   

  		(C)	= 	the Exercise Price of this Warrant, as adjusted hereunder, at the time of such exercise; and

   

  		(D)	= 	the lesser of (i) the arithmetic average of the VWAPs for the five consecutive Trading Days ending on the date
            immediately preceding the date on which the Holder elects to exercise this Warrant by means of a “cashless exercise,” as set forth in the applicable Notice of Exercise or (ii) the VWAP for the Trading Day immediately prior to the date on which
            the Holder makes such “cashless exercise” election.

   

  If Warrant Shares are issued in such a cashless exercise, the
      parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act of 1933, as amended (together with the rules and regulations promulgated thereunder, the “Securities Act”), the Warrant Shares shall take on the
      characteristics of the Warrants being exercised, and the holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to take any position contrary to this Section 2(c).

   

  For avoidance of doubt, the phrase “effective Registration Statement” means (i) a
      registration statement covering the sale of the Warrant Shares has been declared effective by the SEC, has not been withdrawn and is not subject to a stop order issued by the SEC, and (ii) the Prospectus contained in such registration statement
      complies with Sections 5(b) and 10 of the Securities Act.

   

  Notwithstanding anything herein to the contrary, if on the Termination Date (unless the
      Holder notifies the Company otherwise) if there is no effective Registration Statement covering the resale of the Warrant Shares by the Holder, then this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).

   

  (d)         Mechanics of Exercise.

   

  (i)         Delivery of Certificates Upon Exercise. Certificates
      for shares purchased hereunder shall be transmitted to the Holder by the Transfer Agent by crediting the account of the Holder’s prime broker with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the
      Company is then a participant in such system and (A) there is an effective Registration Statement covering the sale of the Warrant Shares by the Holder, or (B) or (B) this Warrant is being exercised via cashless exercise and Rule 144 under the
      Securities Act is available or otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise by the date that is two Trading Days after the latest of (A) the delivery to the Company of the Notice of Exercise and (B)
      payment of the aggregate Exercise Price as set forth above (unless by cashless exercise, if permitted) (such date, the “Warrant Share Delivery Date”). The Warrant Shares shall be deemed to have been issued, and Holder or any other person so
      designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price (unless by cashless exercise, if
      permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(vi) prior to the issuance of such shares, having been paid. The Company understands that a delay in the delivery of the Warrant Shares after the Warrant
      Share Delivery Date could result in economic loss to the Holder. As compensation to the Holder for such loss, the Company agrees to pay (as liquidated damages and not as a penalty) to the Holder for late issuance of Warrant Shares upon exercise of
      this Warrant the proportionate amount of $10 per Trading Day (increasing to $20 per Trading Day after the fifth Trading Day) after the Warrant Share Delivery Date for each $1,000 of the value of the Warrant Shares for which this Warrant is exercised
      (based on the Exercise Price) which are not timely delivered. The Company shall pay any payment incurred under this Section 2(d)(i) in immediately available funds upon demand. Furthermore, in addition to any other remedies which may be available to
      the Holder, in the event that the Company fails for any reason to effect delivery of the Warrant Shares by the Warrant Share Delivery Date, the Holder may revoke all or part of the relevant Warrant exercise by delivery of a notice to such effect to
      the Company, whereupon the Company and the Holder shall each be restored to their respective positions immediately prior to the exercise of the relevant portion of this Warrant except that the liquidated damages described above shall be payable
      through the date notice of revocation or rescission is given to the Company or the date the Warrant Shares are delivered to the Holder, whichever date is earlier. 

  
    Exhibit G-3

    
      

  

    

  (ii)         Delivery of New Warrants Upon Exercise. If this
      Warrant shall have been exercised in part, the Company shall not require the Holder to surrender this Warrant as a condition of exercise. If the Holder requests a new Warrant it shall surrender this Warrant, and the Company shall deliver to the
      Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical to this Warrant.

   

  (iii)       Rescission Rights. If the Company fails to deliver the
      Warrant Shares or cause the Transfer Agent to transmit to the Holder a certificate or the certificates representing the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right, at any time
      prior to issuance of such Warrant Shares, to rescind such exercise.

   

  (iv)       Compensation for Buy-In on Failure to Timely Deliver
        Certificates Upon Exercise. In addition to any other rights available to the Holder, if the Company fails to deliver the Warrant Shares, or cause the Transfer Agent to transmit to the Holder a certificate or the certificates representing the
      Warrant Shares pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise
      purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if
      any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to
      deliver to the Holder in connection with the exercise at issue by (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and
      equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
      complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an
      aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the
      amounts payable to the Holder in respect of the Buy-In and, upon written request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in
      equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver certificates representing shares of Common Stock upon exercise of the Warrant as required pursuant
      to the terms hereof. 

  
    Exhibit G-4

    
      

  

    

  (v)       No Fractional Shares or Scrip. No fractional shares or
      scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash
      adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

   

  (vi)       Charges, Taxes and Expenses. Issuance of certificates
      for Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate including any charges (limited to $100 per issuance) of any clearing firm, all of
      which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event certificates for
      Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a
      condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise. 

  
    Exhibit G-5

    
      

  

    

  (vii)      Closing of Books. The Company will not close its
      stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

   

  (e)          Holder’s Exercise Limitations. The Company shall not
      effect the exercise of any portion of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, pursuant to the terms and conditions of this Warrant and any such exercise shall be null and void and treated as if
      never made, to the extent that after giving effect to such exercise, the Holder together with the other Attribution Parties (as defined in the Note) collectively would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the shares of
      Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Holder and the other Attribution Parties shall include the
      number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall
      exclude shares of Common Stock which would be issuable upon (A) exercise of the remaining, unexercised portion of this Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise or conversion of the unexercised
      or unconverted portion of any other securities of the Company (including, without limitation, any convertible notes or convertible preferred stock or warrants, including other SPA Warrants) beneficially owned by the Holder or any other Attribution
      Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 1(f)(i). For purposes of this Section 1(f)(i), beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities
      and Exchange Act of 1934, as amended (together with the rules and regulations promulgated thereunder, the “Exchange Act”). For purposes of determining the number of outstanding shares of Common Stock the Holder may acquire upon the exercise of this
      Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form
      8-K or other public filing with the SEC, as the case may be, (y) a more recent public announcement by the Company or (z) any other written notice by the Company or the Transfer Agent, if any, setting forth the number of shares of Common Stock
      outstanding (the “Reported Outstanding Share Number”). If the Company receives an Exercise Notice from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company
      shall (i) notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the Holder’s beneficial ownership, as determined pursuant to this Section 1(f)(i), to
      exceed the Maximum Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to be acquired pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the “Reduction Shares”) and (ii) as soon
      as reasonably practicable, the Company shall return to the Holder any exercise price paid by the Holder for the Reduction Shares. For any reason at any time, upon the written or oral request of the Holder, the Company shall within one (1) Business
      Day confirm orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or
      exercise of securities of the Company, including this Warrant, by the Holder and any other Attribution Party since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of shares of Common Stock to
      the Holder upon exercise of this Warrant results in the Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined
      under Section 13(d) of the Exchange Act), the number of shares so issued by which the Holder’s and the other Attribution Parties’ aggregate beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”) shall be deemed null and void and
      shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to the
      Holder the exercise price paid by the Holder for the Excess Shares. Upon delivery of a written notice to the Company, the Holder may from time to time increase (with such increase not effective until the sixty-first (61st) day after delivery of such
      notice) or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such
      notice is delivered to the Company and (ii) any such increase or decrease will apply only to the Holder and the other Attribution Parties and not to any other holder of SPA Warrants that is not an Attribution Party of the Holder. For purposes of
      clarity, the shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section 13(d) or Rule
      16a-1(a)(1) of the Exchange Act. No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of exercisability. The
      provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(f)(i) to the extent necessary to correct this paragraph or any portion of this paragraph which may be
      defective or inconsistent with the intended beneficial ownership limitation contained in this Section 1(f)(i) or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this
      paragraph may not be waived and shall apply to a successor holder of this Warrant. 

  
    Exhibit G-6

    
      

  

    

  Section 3.          Certain Adjustments.

   

  (a)          Stock Dividends and Splits. If the Company, at any
      time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for
      avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant or pursuant to any of the other Transaction Documents), (ii) subdivides outstanding shares of Common Stock into a larger number of
      shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in
      each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be
      the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain
      unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
      the effective date in the case of a subdivision, combination or re-classification. 

  
    Exhibit G-7

    
      

  

    

  (b)       Adjustments for Issuance of Additional Securities. If
      the Company at any time while this Warrant is outstanding, issues or sells any additional shares of Common Stock or Common Stock Equivalents (hereafter defined) (“Additional Shares of Common Stock”) in a transaction other than in an Exempt Issuance
      (as defined in the Agreement), at a price per share less than the Exercise Price then in effect or without consideration (a “Dilutive Issuance” based on a “Dilutive Issuance Price”), then the Exercise Price upon each such issuance shall be reduced to
      an amount equal to the Dilutive Issuance Price.

   

  In case any Common Stock Equivalent is issued in connection with the issue or sale of other
      securities of the Company, together comprising one integrated transaction, (x) the Common Stock Equivalents (except for indebtedness) will be deemed to have been issued for the par value of the Common Stock and (y) the other securities issued or sold
      in such integrated transaction shall be deemed to have been issued or sold for the difference of (I) the aggregate consideration received by the Company less any consideration paid or payable by the Company pursuant to the terms of such other
      securities of the Company, less (II) the par value. Any indebtedness shall be valued at the principal less any original issue discount. If multiple shares of Common Stock are contained in a unit, the aggregate consideration shall be divided by the
      number of shares of Common Stock in a unit. If any shares of Common Stock or Common Stock Equivalents are issued or sold or deemed to have been issued or sold for cash, the amount of such consideration received by the Company will be deemed to be the
      net amount received by the Company therefor. If any shares of Common Stock or Common Stock Equivalents are issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of such
      consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration received by the Company will be the VWAP of such public traded securities on the date of receipt. If any shares of Common
      Stock or Common Stock Equivalents are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such
      portion of the net assets and business of the non-surviving entity as is attributable to such shares of Common Stock or Common Stock Equivalents, as the case may be.

   

  The provisions of this Section 3(b) shall apply each time the Company, at any time after the
      Initial Exercise Date and while this Warrant is outstanding, shall issue any securities with a Dilutive Issuance Price. Notwithstanding the foregoing, no adjustment shall be made pursuant to this Section 3(b) with respect to an Exempt Issuance (as
      defined in the Agreement). 

  
    Exhibit G-8

    
      

  

   

  (c)          Adjustment upon Event of Default. Upon the
      occurrence and during the continuance of an Event of Default (as defined in the Note), the Holder may, at the Holder’s option, elect to reduce the Exercise Price to the Default Conversion Price (as defined in the Note). Such election by the Holder
      shall not remain in effect upon the Company’s cure of such Event of Default provided, however, that any exercise of this Warrant at the Default Conversion Price during the continuance of such Event of Default shall continue to apply after the
      occurrence of such Event of Default through and including the date of such cure of such Event of Default. The Company shall give the Holder prompt written notice of the occurrence of an Event of Default.

   

  (d)         Subsequent Rights Offerings. In addition to any
      adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of
      Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of
      Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the
      grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however,
      to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or
      beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in
      the Holder exceeding the Beneficial Ownership Limitation). Notwithstanding the foregoing, no Purchase Rights will be made under this Section 3(d) in respect of an Exempt Issuance (as defined in the Agreement).

   

  (e)          Pro Rata Distributions. If the Company, at any time
      while this Warrant is outstanding, shall distribute to all holders of Common Stock (and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants to subscribe for or purchase any security
      other than the Common Stock (which shall be subject to Section 3(d)), then in each such case the Exercise Price shall be adjusted by multiplying the Exercise Price in effect immediately prior to the record date fixed for determination of stockholders
      entitled to receive such distribution by a fraction of which the denominator shall be the VWAP determined as of the record date mentioned above, and of which the numerator shall be such VWAP on such record date less the then per share fair market
      value at such record date of the portion of such assets or evidence of indebtedness so distributed applicable to one outstanding share of the Common Stock as determined by the Board of Directors in good faith. In either case the adjustments shall be
      described in a statement provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription rights applicable to one share of Common Stock. Such adjustment shall be made whenever any such distribution is
      made and shall become effective immediately after the record date mentioned above. 

  
    Exhibit G-9

    
      

  

    

  (f)          Fundamental Transaction.

   

  (i)          If, at any time while this Warrant is outstanding the Company enters into a
      Fundamental Transaction (as defined in the Note), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the
      occurrence of such Fundamental Transaction (without regard to any limitation on the exercise of this Warrant), at the option of the Holder the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the
      surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior
      to such Fundamental Transaction (without regard to any limitation on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
      based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting
      the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
      choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall not effect a Fundamental Transaction unless it gives the Holder at least 5 Trading Days’ prior notice
      together with sufficient details so the Holder can make an informed decision as to whether it elects to accept the Alternative Consideration and such Holder shall not share such non-public information nor trade on it until it is made public by the
      Company. Within two Trading Days after the Holder has been given such notice (or such later date as may be contemplated or required by the definitive agreements with respect to which such Fundamental Transaction will be consummated), the Company
      shall file a Form 8-K disclosing all material information about the Fundamental Transaction which has been given to the Holder.

   

  (ii)        Notwithstanding anything to the contrary, in the event of a Fundamental
      Transaction where the Company or its Successor does not remain a publicly-traded company, the Company or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the
      consummation of the Fundamental Transaction, purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the positive difference between the cash per share paid in such Fundamental Transaction minus the then in effect
      Exercise Price.

   

  (iii)        If Section 3(f)(i) is not applicable, the Company shall cause any successor entity
      in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this
      Section 3(f)(iii) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
      to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of
      such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant prior to such Fundamental Transaction (without regard to any limitation on the exercise of this Warrant),
      and with an exercise price which applies the then-current Exercise Price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of
      such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is
      reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the
      provisions of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under
      this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein. 

  
    Exhibit G-10

    
      

  

   

  Notwithstanding the foregoing, no adjustment shall be made pursuant to this Section
      3(f) with respect to an Exempt Issuance (as defined in the Agreement).

   

  (g)         Calculations. All calculations under this Section 3
      shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of
      shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

   

  (h)         Notice to Holder.

   

  (i)         Adjustment to Exercise Price. Whenever the Exercise
      Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly email to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting
      forth a brief statement of the facts requiring such adjustment. The Holder may supply an email address to the Company and change such address.

   

  (ii)        Notice to Allow Exercise by Holder. If (A) the Company
      shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all
      holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of
      the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other
      securities, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall deliver to the Holder at its last address as it shall appear upon
      the Warrant Register of the Company, at least 20 calendar days’ prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
      redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
      which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their
      shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to email such notice or any defect therein or in the
      emailing thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any
      of the Subsidiaries (as determined in good faith by the Company), the Company shall simultaneously file such notice with the United States Securities and Exchange Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
      to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein. 

  
    Exhibit G-11

    
      

  

    

  Section 4.         Transfer of Warrant.

   

  (a)          Transferability. Subject to compliance with any
      applicable securities laws and the provisions of the Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal
      office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable
      upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
      specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. The Warrant, if properly assigned in accordance herewith,
      may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

   

  (b)          New Warrants. This Warrant may be divided or
      combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.
      Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
      accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto. 

  
    Exhibit G-12

    
      

  

   

  (c)         Warrant Register. The Company shall register this
      Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner
      hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

   

  Section 5.      Miscellaneous.

   

  (a)          No Rights as Stockholder Until Exercise. This
      Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof other than as explicitly set forth in Section 3.

   

  (b)          Loss, Theft, Destruction or Mutilation of Warrant.
      The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and upon surrender and
      cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate. In no event shall the
      Holder be required to post a bond or other security.

   

  (c)          Saturdays, Sundays, Holidays, etc. If the last or
      appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.

   

  (d)          Authorized Shares.

   

  The Company covenants that during the period this Warrant is
      outstanding, it will comply with Section 4.9 of the Agreement with respect to reserving the Warrant Shares, subject to adjustment pursuant to Section 3.The Company further covenants that its issuance of this Warrant shall constitute full authority to
      its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable
      action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of any Principal Market upon which the Common Stock may be listed. The
      Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in
      accordance herewith, be duly authorized, validly issued, fully paid and non-assessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring
      contemporaneously with such issue). 

  
    Exhibit G-13

    
      

  

   

  In addition to any other remedies provided by this Warrant or the Agreement, if the Company
      at any time fails to meet this reservation of Common Stock requirement within 45 days after written notice from the Holder, it shall pay the Holder as partial liquidated damages and not as a penalty a sum equal to $250 per day for each $100,000 of
      such Holder’s Subscription Amount (or the Subscription Amount of the original Purchaser). The Company shall not enter into any agreement or file any amendment to its Articles of Incorporation (including the filing of a Certificate of Designation)
      which conflicts with this Section 5(d) while the Notes (as defined in the Agreement) and Warrants remain outstanding.

   

  Except and to the extent waived or consented to by the Holder, the Company shall not by any
      action, including, without limitation, amending its Certificate of Incorporation (or charter) or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or
      seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the
      rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately
      prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use best
      efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

   

  Before taking any action which would result in an adjustment in the number of Warrant Shares
      for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

   

  (e)          Jurisdiction. All questions concerning the
      construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Agreement.

   

  (f)          Restrictions. The Holder acknowledges that the
      Warrant Shares acquired upon the exercise of this Warrant, if not registered or if not exercised on a cashless basis when Rule 144 is available, will have restrictions upon resale imposed by state and federal securities laws. 

  
    Exhibit G-14

    
      

  

    

  (g)          Non-waiver and Expenses. No course of dealing or any
      delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant or the other
      Transaction Documents, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
      any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or
      remedies hereunder.

   

  (h)          Notices. Any notice, request or other document
      required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Agreement.

   

  (i)           Limitation of Liability. No provision hereof, in
      the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any
      Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

   

  (j)           Remedies. The Holder, in addition to being entitled
      to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by
      reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate or that there is no irreparable harm and not to require
      the posting of a bond or other security.

   

  (k)         Successors and Assigns. Subject to applicable
      securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of
      this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by any Holder from time to time of this Warrant or any Warrant Shares.

   

  (l)           Amendment. This Warrant may be modified or amended
      or the provisions hereof waived with the written consent of the Company and the Holder. 

  
    Exhibit G-15

    
      

  

    

  (m)         Severability. Wherever possible, each provision of
      this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such
      prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

   

  (n)          Headings. The headings used in this Warrant are for
      the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

   

  ********************

   

  (Signature Page Follows)

  
    Exhibit G-16

    
      

  

  
    

  IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer
      thereunto duly authorized as of the date first above indicated.

   

  

  	 	SPRINGBIG HOLDINGS INC.
	 	 	 
	 	By:	      
	 	Name:
	 	Title:

  

  
    
      

  

  
  EXHIBIT H

    FORM OF RESERVE LETTER

  
     

    
      
 

  

   EXHIBIT I

    FORM OF OPINION OF COUNSEL

   

  

   

  

  
     

    
      

  

   EXHIBIT J 

      FORM OF JOINDER

  

   

  

  
     

    
      

  

  Schedule 3.1(i)

  
     

    
      
 

  

   

  Schedule 3.1(l)

  
     

    
      
 

  

   

  Schedule 3.1(x)

  
     

    
      
 

  

   

  Schedule 3.1(rr)Exhibit 10.2

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  COMMON STOCK PURCHASE AGREEMENT

   

  This COMMON STOCK PURCHASE AGREEMENT is made and entered into as of April 29, 2022
      (this “Agreement”), by and between CF Principal Investments LLC, a Delaware limited liability company (the “Investor”), and Tuatara Capital Acquisition Corporation, a Cayman Islands corporation (the “Company”).

      For purposes of this Agreement, references to the “Company” shall also include any successor entity to the Company by any Fundamental Transaction (as defined below), but only from and after the closing of such Fundamental Transaction, including but
      not limited to, the resulting publicly listed company pursuant to the transactions contemplated by the Agreement and Plan of Merger (as may be amended from time to time, the “Merger Agreement”), dated as of November 8, 2021, by and
      among the Company, HighJump Merger Sub, Inc. and SpringBig, Inc., such transactions being referred to herein as the “Merger.”

   

  RECITALS 

   

  WHEREAS, following the consummation of the Merger (the “Merger

          Closing”), including the domestication of the Company as a Delaware corporation, the Company shall be the surviving entity, with shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”)
      registered under Section 12(b) of the Exchange Act;

   

  WHEREAS, the parties desire that, upon the terms and subject to
      the conditions and limitations set forth herein, the Company may issue and sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to the lesser of (i) $50,000,000 in aggregate gross purchase
      price of newly issued shares of Common Stock, and (ii) the Exchange Cap (to the extent applicable under Section 3.3);

   

  WHEREAS, such sales of Common Stock by the Company to the
      Investor will be made in reliance upon the provisions of Section 4(a)(2) of the Securities Act (“Section 4(a)(2)”) and/or Rule 506(b) of Regulation D promulgated by the Commission under the Securities Act (“Regulation D”),
      and upon such other exemption from the registration requirements of the Securities Act as may be available with respect to any or all of the issuances and sales of Common Stock by the Company to the Investor to be made hereunder;

   

  WHEREAS, the parties hereto are concurrently entering into a
      Registration Rights Agreement in the form attached as Exhibit A hereto (the “Registration Rights Agreement”), pursuant to which the Company shall register the resale of the Registrable Securities (as defined in the Registration
      Rights Agreement), upon the terms and subject to the conditions set forth therein;

   

  WHEREAS, in consideration for the Investor’s execution and
      delivery of this Agreement, the Company shall deliver the Upfront Commitment Fee to the Investor, on or prior to the Commencement Date, pursuant to and in accordance with Section 10.1(ii); and

   

  WHEREAS, the Company acknowledges that the Investor is an
      Affiliate of the Cantor Fitzgerald group of entities, and its Affiliate, Cantor Fitzgerald & Co. (“CF&CO”), is acting as Investor’s representative in connection with the transactions contemplated hereby.

   

  NOW, THEREFORE, the parties hereto, intending to be legally
      bound, hereby agree as follows:

  
    
      
 

  

  
   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  ARTICLE I

      DEFINITIONS

   

  Capitalized terms used in this Agreement shall have the meanings ascribed to such terms in Annex

        I hereto, and hereby made a part hereof, or as otherwise set forth in this Agreement.

   

  ARTICLE II

      PURCHASE AND SALE OF COMMON STOCK

   

  Section 2.1. Purchase and Sale of Stock. Upon the terms and
      subject to the conditions of this Agreement, during the Investment Period, the Company, in its sole discretion, shall have the right, but not the obligation, to issue and sell to the Investor, and the Investor shall purchase from the Company, up to
      the lesser of (i) $50,000,000 (the “Total Commitment”) in aggregate gross purchase price of duly authorized, validly issued, fully paid and non-assessable shares of Common Stock and (ii) the Exchange Cap, to the extent applicable under
      Section 3.3 (such lesser amount of shares of Common Stock, the “Aggregate Limit”), by the delivery to the Investor of VWAP Purchase Notices as provided in Article III.

   

  Section 2.2. Signing Date; Settlement Dates. This Agreement
      shall become effective and binding upon the delivery of counterpart signature pages of this Agreement and the Registration Rights Agreement executed by each of the parties hereto and thereto, to the offices of Covington & Burling LLP, Attn:
      Matthew T. Gehl and Charlotte May, The New York Times Building, 620 Eighth Avenue, New York, NY 10018, at 10:00 a.m., New York City time. In consideration of and in express reliance upon the representations, warranties and covenants contained in, and
      upon the terms and subject to the conditions of, this Agreement, during the Investment Period, the Company, at its sole option and discretion, may issue and sell to the Investor, and, if the Company elects to so issue and sell, the Investor shall
      purchase from the Company, the Shares in respect of each VWAP Purchase. The delivery of Shares in respect of each VWAP Purchase, and the payment for such Shares, shall occur in accordance with Section 3.2, provided that all of the conditions
      precedent in Article VII shall have been fulfilled at the applicable times set forth in Article VII.

   

  Section 2.3. Initial Public Announcements and Required Filings.
      The Company shall, not later than 9:00 a.m., New York City time, on the date of this Agreement, file with the Commission a Current Report on Form 8-K disclosing the execution of this Agreement and the Registration Rights Agreement by the Company and
      the Investor, and attaching as exhibits thereto copies of each of this Agreement and the Registration Rights Agreement (including all exhibits thereto, the “Current Report”). The Company shall provide the Investor and its legal counsel
      a reasonable opportunity to comment on a draft of the Current Report prior to filing the Current Report with the Commission and shall give due consideration to all such comments. From and after the filing of the Current Report with the Commission,
      the Company shall have publicly disclosed all material, nonpublic information delivered to the Investor (or the Investor’s representatives or agents) by the Company or any of its Subsidiaries, or any of their respective officers, directors,
      employees, agents or representatives (if any) in connection with the transactions contemplated by the Transaction Documents. The Company shall use its reasonable best efforts to prepare and, as soon as practicable following the Merger, file with the
      Commission the Initial Registration Statement and any New Registration Statement covering only the resale by the Investor of the Registrable Securities in accordance with the Securities Act and the Registration Rights Agreement. At or before 5:30
      p.m. (New York City time) on the second (2nd) Trading Day immediately following the Effective Date of the Initial Registration Statement and any New Registration Statement (or any post-effective amendment thereto), the Company shall use its
      reasonable best efforts to file with the Commission in accordance with Rule 424(b) under the Securities Act the final Prospectus to be used in connection with sales pursuant to such Registration Statement (or post-effective amendment thereto).

  
    2

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  ARTICLE III

      PURCHASE TERMS

   

  Subject to the satisfaction of the conditions set forth in Article VII, the parties agree as
      follows:

   

  Section 3.1. VWAP Purchases. Upon the initial satisfaction or waiver of all of
      the conditions set forth in Section 7.2 (the “Commencement” and the date of initial satisfaction of all of such conditions, the “Commencement Date”) and from time to time thereafter, subject to the satisfaction of all of
      the conditions set forth in Section 7.3, the Company shall have the right, but not the obligation, to direct the Investor, by its timely delivery to the Investor of a VWAP Purchase Notice, after 6:00 a.m., New York City time, but prior to 9:00 a.m.,
      New York City time, on a VWAP Purchase Date, to purchase a number of Shares equal to the applicable VWAP Purchase Share Amount, not to exceed the applicable VWAP Purchase Maximum Amount, at the applicable VWAP Purchase Price therefor on such VWAP
      Purchase Date in accordance with this Agreement (each such purchase, a “VWAP Purchase”). In addition, the Investor may, in its sole discretion, accept a VWAP Purchase Notice after 9:00 a.m., New York City time, on a VWAP Purchase Date,
      provided that such acceptance, once provided, shall be irrevocable and binding and the Company’s obligation to deliver the Shares that are the subject of such VWAP Purchase Notice shall be binding; provided that, if the Investor does not
      accept a VWAP Purchase Notice that is delivered after 9:00 a.m., New York City time, such VWAP Purchase Notice shall be deemed to be null and void. The Investor may also, in its sole discretion, accept additional VWAP Purchase Notices within a
      Trading Day, in which case any prior VWAP Purchase Notice accepted by the Investor in such Trading Day shall be null, void, superseded and replaced in its entirety by such subsequent VWAP Purchase Notice. The Company may timely deliver a VWAP
      Purchase Notice to the Investor as often as every Trading Day (and may deliver multiple VWAP Purchase Notices in any given day, it being understood that a subsequent VWAP Purchase Notice will supersede and replace all earlier VWAP Purchase Notices
      delivered within the same Trading Day in their entirety), so long as all Shares subject to all prior VWAP Purchases theretofore required to have been received by the Investor as DWAC Shares under this Agreement have been delivered to the Investor as
      DWAC Shares in accordance with this Agreement. The Investor is obligated to accept each VWAP Purchase Notice prepared and delivered by the Company in accordance with the terms of and subject to the satisfaction of the conditions contained in this
      Agreement. If the Company delivers any VWAP Purchase Notice directing the Investor to purchase a number of Shares that is in excess of the applicable VWAP Purchase Maximum Amount, such VWAP Purchase Notice shall be void ab initio, but solely
      to the extent of the amount by which the VWAP Purchase Share Amount set forth in such VWAP Purchase Notice exceeds such applicable VWAP Purchase Maximum Amount, and the Investor shall have no obligation to purchase such Excess Shares in respect of
      such VWAP Purchase Notice; provided, however, that the Investor shall remain obligated to purchase the applicable VWAP Purchase Maximum Amount in such VWAP Purchase. Notwithstanding anything in this paragraph to the contrary, in the
      case where the Sale Price falls below the Threshold Price during a Trading Day, the VWAP Purchase Amount shall be calculated using (i) the VWAP Purchase Share Percentage of the aggregate shares traded on the Principal Market for such portion of the
      VWAP Purchase Date the Sale Price is not below the Threshold Price and (ii) a VWAP Purchase Price calculated using the volume weighted average price of Common Stock sold during such portion of the VWAP Purchase Date the Sale Price is not below the
      Threshold Price. Each VWAP Purchase Notice must include a VWAP Purchase Share Estimate. Each VWAP Purchase Notice must be accompanied by irrevocable instructions to the Company’s Transfer Agent to immediately issue and deliver to the Investor a
      number of DWAC Shares equal to the VWAP Purchase Share Estimate. In no event shall the Investor purchase (or be deemed to have purchased), pursuant to any VWAP Purchase, a number of Shares constituting the applicable VWAP Purchase Share Amount that
      exceeds the VWAP Purchase Share Estimate issued on the VWAP Purchase Date in connection with such VWAP Purchase Notice; however, the Investor will promptly instruct the Transfer Agent to return to the Company any Shares issued pursuant to the VWAP
      Purchase Share Estimate that exceeds the number of Shares constituting the applicable VWAP Purchase Share Amount the Investor actually purchases in connection with such VWAP Purchase (such amount, the “Excess Shares”). Alternatively, if
      the Transfer Agent does not return the Excess Shares to the Company on the VWAP Purchase Date in accordance with the Investor’s instructions, or if otherwise instructed in writing by the Company, Investor may retain such Excess Shares (provided
      Investor will not be deemed to have purchased such Excess Shares), and such Excess Shares will be deemed pre-delivered Shares that will reduce the number of Shares required to be delivered by the Company in accordance with this section on the next
      VWAP Purchase Date in connection with the next VWAP Purchase Notice. At or prior to 5:30 p.m., New York City time, on the VWAP Purchase Date for each VWAP Purchase, the Investor shall provide to the Company a written confirmation for such VWAP
      Purchase setting forth the applicable VWAP Purchase Price per Share to be paid by the Investor in such VWAP Purchase, and the total aggregate VWAP Purchase Price to be paid by the Investor for the total VWAP Purchase Share Amount purchased by the
      Investor in such VWAP Purchase. Notwithstanding the foregoing, the Company shall not deliver any VWAP Purchase Notices to the Investor during the Post-Effective Amendment Period.

  
    3

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 3.2. Settlement. For each VWAP Purchase, the
      Investor shall pay to the Company an amount in cash equal to the product of (i) the total number of Shares purchased by the Investor in such VWAP Purchase and (ii) the applicable VWAP Purchase Price for such Shares (the “VWAP Purchase Amount”),

      as full payment for such Shares purchased by the Investor in such VWAP Purchase, via wire transfer of immediately available funds, not later than 5:00 p.m., New York City time, on the second (2nd) Trading Day following the applicable VWAP Purchase
      Share Delivery Date for such VWAP Purchase, provided the Investor shall have timely received, as DWAC Shares, all of such Shares purchased by the Investor in such VWAP Purchase on such VWAP Purchase Share Delivery Date in accordance with the first
      sentence of this Section 3.2. If the Investor fails to pay the VWAP Purchase Amount when due, the Investor will return the DWAC Shares to the Company. If the Company or the Transfer Agent shall fail for any reason to deliver to the Investor, as DWAC
      Shares, any Shares purchased by the Investor in a VWAP Purchase prior to 4:30 p.m., New York City time, on the Trading Day immediately following the date of the applicable VWAP Purchase Share Notice (the “Share Delivery Deadline”) for
      such VWAP Purchase, and if on or after such Trading Day the Investor purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Investor of such Shares that the Investor anticipated
      receiving from the Company on such VWAP Purchase Share Delivery Date in respect of such VWAP Purchase, then the Company shall, within one (1) Trading Day after the Investor’s request, either (i) pay cash to the Investor in an amount equal to the
      Investor’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased (the “Cover Price”), at which point the Company’s obligation to deliver such Shares as DWAC Shares (and the Investor’s
      obligation to purchase such Shares from the Company) shall terminate, or (ii) promptly honor its obligation to deliver to the Investor such Shares as DWAC Shares and pay cash to the Investor in an amount equal to the excess (if any) of the Cover
      Price over the total purchase price paid by the Investor pursuant to this Agreement for all of the Shares purchased by the Investor in such VWAP Purchase; provided, that Investor agrees to use its commercially reasonable efforts to purchase
      Common Shares in respect of the Cover Price only in normal brokerage transactions at the prevailing price per Common Share then available. The Company shall not issue any fraction of a share of Common Stock to the Investor in connection with any VWAP
      Purchase effected pursuant to this Agreement. If the issuance would result in the issuance of a fraction of a share of Common Stock, the Company shall round such fraction of a share of Common Stock up or down to the nearest whole share. All payments
      to be made by the Investor pursuant to this Agreement shall be made by wire transfer of immediately available funds to such account as the Company may from time to time designate by written notice to the Investor in accordance with the provisions of
      this Agreement.

   

  Section 3.3. Compliance with Rules of Principal Market.

   

  (i) Exchange Cap. The Company shall not issue or sell any
      shares of Common Stock pursuant to this Agreement, and the Investor shall not purchase or acquire any shares of Common Stock pursuant to this Agreement, to the extent that after giving effect thereto, the aggregate number of shares of Common Stock
      that would be issued pursuant to this Agreement and the transactions contemplated hereby would exceed such number of shares of Common Stock representing the lower of (i) 19.99% of the voting power of the Common Stock and (ii) 19.99% of the number of
      shares of issued and outstanding Common Stock, in each case, calculated immediately following the closing of the Merger in accordance with the applicable rules of the Principal Market, which number of shares shall be reduced, on a share-for-share
      basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction or series of transactions that may be aggregated with the transactions contemplated by this Agreement under applicable rules of the Principal Market
      (including, but not limited to, issuances of convertible notes and warrants to purchase shares of Common Stock that may be so aggregated) (such maximum number of shares, the “Exchange Cap”), unless the Company’s stockholders have
      approved the issuance of Common Stock pursuant to this Agreement in excess of the Exchange Cap in accordance with the applicable rules of the Principal Market. For the avoidance of doubt, the Company may, but shall be under no obligation to, request
      its stockholders to approve the issuance of Common Stock pursuant to this Agreement; provided, that if such stockholder approval is not obtained, the Exchange Cap shall be applicable for all purposes of this Agreement and the transactions
      contemplated hereby at all times during the term of this Agreement.

   

  (ii) General. The Company shall not issue or sell any
      shares of Common Stock pursuant to this Agreement if such issuance or sale would reasonably be expected to result in (a) a violation of the Securities Act or (b) a breach of the rules of the Principal Market.

   

  Section 3.4. Beneficial Ownership Limitation.
      Notwithstanding anything to the contrary contained in this Agreement, the Company shall not issue or sell, and the Investor shall not purchase or acquire, any shares of Common Stock under this Agreement which, when aggregated with all other shares of
      Common Stock then beneficially owned by the Investor and its Affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Investor and its Affiliates
      (on an aggregated basis) of more than 8% of the outstanding voting power or shares of Common Stock (the “Beneficial Ownership Limitation”). Upon the written or oral request of the Investor, the Company shall promptly (but not later than
      the next business day on which the Transfer Agent is open for business) confirm orally or in writing to the Investor the number of shares of Common Stock then outstanding. The Investor and the Company shall each cooperate in good faith in the
      determinations required under this Section 3.4 and the application of this Section 3.4. The Investor’s written certification to the Company of the applicability of the Beneficial Ownership Limitation, and the resulting effect thereof hereunder at any
      time, shall be conclusive with respect to the applicability thereof and such result absent manifest error.

  
    4

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  ARTICLE IV

      REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE INVESTOR

   

  The Investor hereby makes the following representations, warranties and covenants to the
      Company:

   

  Section 4.1. Organization and Standing of the Investor. The
      Investor is a limited liability company duly formed, validly existing and in good standing under the laws of the State of Delaware.

   

  Section 4.2. Authorization and Power. The Investor has the
      requisite corporate power and authority to enter into and perform its obligations under this Agreement and the Registration Rights Agreement and to purchase or acquire the Shares in accordance with the terms hereof. The execution, delivery and
      performance by the Investor of this Agreement and the Registration Rights Agreement and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action, and no further consent or
      authorization of the Investor or its sole member is required. Each of this Agreement and the Registration Rights Agreement has been duly executed and delivered by the Investor and constitutes a valid and binding obligation of the Investor enforceable
      against it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship, receivership, or similar laws relating to, or affecting generally
      the enforcement of, creditor’s rights and remedies or by other equitable principles of general application (including any limitation of equitable remedies).

   

  Section 4.3. No Conflicts. The execution, delivery and
      performance by the Investor of this Agreement and the Registration Rights Agreement and the consummation by the Investor of the transactions contemplated hereby and thereby do not and shall not (i) result in a violation of such Investor’s applicable
      organizational instruments, (ii) conflict with, constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give rise to any rights of termination, amendment, acceleration or cancellation of, any
      material agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Investor is a party or is bound, or (iii) result in a violation of any federal, state, local or foreign statute, rule,
      or regulation, or any order, judgment or decree of any court or governmental agency applicable to the Investor or by which any of its properties or assets are bound or affected, except, in the case of clauses (ii) and (iii), for such conflicts,
      defaults, terminations, amendments, acceleration, cancellations and violations as would not, individually or in the aggregate, prohibit or otherwise interfere with, in any material respect, the ability of the Investor to enter into and perform its
      obligations under this Agreement and the Registration Rights Agreement. The Investor is not required under any applicable federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or
      registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under this Agreement and the Registration Rights Agreement or to purchase or acquire the Shares in accordance with the terms
      hereof, other than as may be required by the Financial Industry Regulatory Authority Inc. (“FINRA”); provided, however, that for purposes of the representation made in this sentence, the Investor is assuming and relying
      upon the accuracy of the relevant representations and warranties and the compliance with the relevant covenants and agreements of the Company in the Transaction Documents to which it is a party.

   

  Section 4.4. Investment Purpose. The Investor is acquiring
      the Shares for its own account, for investment purposes and not with a view towards, or for resale in connection with, the public sale or distribution thereof, in violation of the Securities Act or any applicable state securities laws; provided,
      however, that by making the representations herein, the Investor does not agree, or make any representation or warranty, to hold any of the Shares for any minimum or other specific term and reserves the right to dispose of the Shares at any
      time in accordance with, or pursuant to, a registration statement filed pursuant to the Registration Rights Agreement or an applicable exemption under the Securities Act. The Investor is acquiring the Shares hereunder in the ordinary course of its
      business.

  
    5

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 4.5. Accredited Investor Status. The Investor is an
      “accredited investor” as that term is defined in Rule 501(a) of Regulation D.

   

  Section 4.6. Reliance on Exemptions. The Investor
      understands that the Shares are being offered and sold to it in reliance on specific exemptions from the registration requirements of U.S. federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and
      the Investor’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Investor set forth herein in order to determine the availability of such exemptions and the eligibility of the Investor to acquire
      the Shares.

   

  Section 4.7. Information. All materials relating to
      the business, financial condition, management and operations of the Company and materials relating to the offer and sale of the Shares which have been requested by the Investor have been furnished or otherwise made available (including through filing
      with or furnishing to the Commission) to the Investor or its advisors, including, without limitation, the Commission Documents. The Investor understands that its investment in the Shares involves a high degree of risk. The Investor is able to bear
      the economic risk of an investment in the Shares and has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of a proposed investment in the Shares. The Investor and its advisors have
      been afforded the opportunity to ask questions of and receive answers from representatives of the Company concerning the financial condition and business of the Company and other matters relating to an investment in the Shares. Neither such inquiries
      nor any other due diligence investigations conducted by the Investor or its advisors, if any, or its representatives shall modify, amend or affect the Investor’s right to rely on the Company’s representations and warranties contained in this
      Agreement or in any other Transaction Document to which the Company is a party or the Investor’s right to rely on any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transaction
      contemplated hereby. The Investor has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Shares. The Investor understands that it (and not the
      Company) shall be responsible for its own tax liabilities that may arise as a result of this investment or the transactions contemplated by this Agreement.

   

  Section 4.8. No Governmental Review. The Investor
      understands that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation or endorsement of the Shares or the fairness or suitability of the investment in the Shares nor have
      such authorities passed upon or endorsed the merits of the offering of the Shares.

   

  Section 4.9. No General Solicitation. The Investor is not
      purchasing or acquiring the Shares as a result of any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Shares.

   

  Section 4.10. Not an Affiliate. The Investor is not an
      officer, director or an Affiliate of the Company. During the Investment Period, the Investor will not acquire for its own account any shares of Common Stock or securities exercisable for or convertible into shares of Common Stock, other than pursuant
      to this Agreement; provided, however, that nothing in this Agreement shall prohibit or be deemed to prohibit the Investor from purchasing, in an open market transaction or otherwise, shares of Common Stock necessary to make delivery
      by the Investor in satisfaction of a sale by the Investor of Shares that the Investor anticipated receiving from the Company in connection with the settlement of a VWAP Purchase if the Company or its Transfer Agent shall have failed for any reason
      (other than a failure of Investor or its Broker-Dealer to set up a DWAC and required instructions) to electronically transfer all of the Shares subject to such VWAP Purchase to the Investor prior to the applicable Share Delivery Deadline by crediting
      the Investor’s or its designated Broker-Dealer’s account at DTC through its DWAC delivery system in compliance with Section 3.2 of this Agreement. For the avoidance of doubt, the foregoing restriction does not apply to any Affiliate of the Investor,
      provided that any such purchases do not cause the Investor to violate any applicable Exchange Act requirement, including Regulation M.

   

  Section 4.11. No Prior Short Sales. At no time prior to the
      date of this Agreement has the Investor or any entity managed or controlled by the Investor, engaged in or effected, in any manner whatsoever, directly or indirectly, for its own principal account, any (i) “short sale” (as such term is defined in
      Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock or (ii) hedging transaction, which establishes a net short position with respect to the Common Stock that remains in effect as of the date of this Agreement.

  
    6

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 4.12. Statutory Underwriter Status. The Investor
      acknowledges that it will be disclosed as an “underwriter” and a “selling stockholder” in each Registration Statement and in any Prospectus contained therein to the extent required by applicable law and to the extent the Prospectus is related to the
      resale of Registrable Securities.

   

  Section 4.13. Resales of Shares. The Investor will resell
      such Shares only pursuant to the Registration Statement in which the resale of such Shares is registered under the Securities Act, in a manner described under the caption “Plan of Distribution” in such Registration Statement, and in a manner in
      compliance with all applicable U.S. federal and state securities laws, rules and regulations.

   

  Section 4.14. Residency. The Investor is a resident of the
      State of Delaware.

   

  ARTICLE V

      REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY

   

  The Company hereby makes the following representations, warranties and covenants to the
      Investor:

   

  Section 5.1. Organization, Good Standing and Power. The
      Company and each of its Subsidiaries are duly organized, validly existing and in good standing under the laws of their respective jurisdictions of organization. The Company and each of its Subsidiaries are duly licensed or qualified as a foreign
      corporation (or other entity, if applicable) for transaction of business and in good standing under the laws of each other jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires
      such license or qualification, and have all entity power and authority necessary to own or hold their respective properties and to conduct their respective businesses as described in the Commission Documents, except where the failure to be so
      qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect or would reasonably be expected to have a material adverse effect on or affecting the assets, business,
      operations, earnings, properties, condition (financial or otherwise), prospects, stockholders’ equity or results of operations of the Company and the Subsidiaries taken as a whole, or prevent or materially interfere with consummation of the
      transactions contemplated hereby (a “Material Adverse Effect”).

   

  Section 5.2. Subsidiaries. The subsidiaries set forth on Schedule

        1 and the subsidiaries to be set forth in Exhibit 21 to the Registration Statement (collectively, the “Subsidiaries”) are, or will be, as the case may be, the Company’s only significant subsidiaries (as such term is defined in Rule 1-02
      of Regulation S-X promulgated by the Commission). Except as set forth in the Commission Documents, the Company owns, directly or indirectly, all of the equity interests of the Subsidiaries free and clear of any lien, charge, security interest,
      encumbrance, right of first refusal or other restriction, and all the equity interests of the Subsidiaries are validly issued and are fully paid, non-assessable and free of preemptive and similar rights. No Subsidiary is currently prohibited,
      directly or indirectly, from paying any dividends to the Company, from making any other distribution on such Subsidiary’s capital stock, from repaying to the Company any loans or advances to such Subsidiary from the Company or from transferring any
      of such Subsidiary’s property or assets to the Company or any other Subsidiary of the Company.

   

  Section 5.3. Authorization, Enforcement. The Company has
      the requisite corporate power and authority to enter into and perform its obligations under each of the Transaction Documents to which it is a party and to issue the Shares in accordance with the terms hereof and thereof. Except for approvals of the
      Company’s Board of Directors or a committee thereof as may be required in connection with any issuance and sale of Shares to the Investor hereunder (which approvals shall be obtained prior to the delivery of any VWAP Purchase Notice), the execution,
      delivery and performance by the Company of each of the Transaction Documents to which it is a party and the consummation by it of the transactions contemplated hereby and thereby have been duly and validly authorized by all necessary corporate
      action, and no further consent or authorization of the Company, its Board of Directors or its stockholders is required. Each of the Transaction Documents to which the Company is a party has been duly executed and delivered by the Company and
      constitutes a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation,
      conservatorship, receivership or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by other equitable principles of general application (including any limitation of equitable remedies).

  
    7

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 5.4. Capitalization. The authorized capital
      stock of the Company and the shares thereof issued and outstanding were as set forth in the Commission Documents as of the dates reflected therein. All of the outstanding shares of Common Stock have been duly authorized and validly issued and are
      fully paid and non-assessable. Except as set forth in the Commission Documents, this Agreement and the Registration Rights Agreement, there are no agreements or arrangements under which the Company is obligated to register the sale of any securities
      under the Securities Act. Except as set forth in the Commission Documents, no shares of Common Stock are entitled to preemptive rights and there are no outstanding debt securities and no contracts, commitments, understandings, or arrangements by
      which the Company is or may become bound to issue additional shares of the capital stock of the Company or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights
      convertible into or exchangeable for, any shares of capital stock of the Company other than those issued or granted in the ordinary course of business pursuant to the Company’s equity incentive and/or compensatory plans or arrangements. Except for
      customary transfer restrictions contained in agreements entered into by the Company to sell restricted securities or as set forth in the Commission Documents, the Company is not a party to, and it has no Knowledge of, any agreement restricting the
      voting or transfer of any shares of the capital stock of the Company. Except as set forth in the Commission Documents, there are no securities or instruments containing anti-dilution or similar provisions that will be triggered by this Agreement or
      any of the other Transaction Documents or the consummation of the transactions described herein or therein. The Company has filed with the Commission true and correct copies of the Company’s Amended and Restated Certificate of Incorporation as in
      effect on the Closing Date (the “Charter”), and the Company’s Amended and Restated Bylaws as in effect on the Closing Date (the “Bylaws”).

   

  Section 5.5. Issuance of Shares. The Commitment Shares and
      the Shares to be issued under this Agreement have been, or with respect to Shares to be purchased by the Investor pursuant to a particular VWAP Purchase Notice, will be, prior to the delivery to the Investor hereunder of such VWAP Purchase Notice,
      duly and validly authorized by all necessary corporate action on the part of the Company. The Commitment Shares, when issued to the Investor in accordance with this Agreement, and the Shares, if and when issued and sold against payment therefor in
      accordance with this Agreement, shall be validly issued and outstanding, fully paid and non-assessable and free from all liens, charges, taxes, security interests, encumbrances, rights of first refusal, preemptive or similar rights and other
      encumbrances with respect to the issue thereof, and the Investor shall be entitled to all rights accorded to a holder of Common Stock. At or prior to Commencement, the Company shall have duly authorized and reserved a number of shares of Common Stock
      equal to the Exchange Cap for issuance and sale as Shares to the Investor pursuant to VWAP Purchases that may be effected by the Company, in its sole discretion, from time to time from and after the Commencement Date, pursuant to this Agreement.

   

  Section 5.6. No Conflicts. The execution, delivery and
      performance by the Company of each of the Transaction Documents to which it is a party and the consummation by the Company of the transactions contemplated hereby and thereby do not and shall not (i) result in a violation of any provision of the
      Company’s Charter or Bylaws, (ii) conflict with or constitute a material default (or an event which, with notice or lapse of time or both, would become a material default) under, or give rise to any rights of termination, amendment, acceleration or
      cancellation of, any Material Contract to which the Company or any of its Subsidiaries is a party or is bound, (iii) result in a violation of any federal, state, local or foreign statute, rule, regulation, order, judgment or decree applicable to the
      Company or any of its Subsidiaries (including federal and state securities laws and regulations and the rules and regulations of the Principal Market), except, in the case of clauses (ii) and (iii), for such conflicts, defaults, terminations,
      amendments, acceleration, cancellations, liens, charges, encumbrances and violations as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect or that have been waived. Except as specifically
      contemplated by this Agreement or the Registration Rights Agreement and as required under the Securities Act, any applicable state securities laws and applicable rules of the Principal Market, the Company is not required under any federal, state or
      local rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under the Transaction Documents
      to which it is a party, or to issue the Shares to the Investor in accordance with the terms hereof and thereof (other than such consents, authorizations, orders, filings or registrations as have been obtained or made prior to the Closing Date); provided,
      however, that, for purposes of the representation made in this sentence, the Company is assuming and relying upon the accuracy of the representations and warranties of the Investor in this Agreement and the compliance by it with its covenants
      and agreements contained in this Agreement and the Registration Rights Agreement.

  
    8

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 5.7. Commission Documents, Financial Statements; Disclosure
          Controls and Procedures; Internal Controls Over Financial Reporting; Accountants.

   

  (i) Since February 11, 2021, the Company has timely filed (giving effect
      to permissible extensions in accordance with Rule 12b-25 under the Exchange Act) all filings required to be filed with or furnished to the Commission by the Company under the Securities Act or the Exchange Act, including those required to be filed
      with or furnished to the Commission under Section 13(a) or Section 15(d) of the Exchange Act. As of the date of this Agreement, no Subsidiary of the Company is required to file or furnish any report, schedule, registration, form, statement,
      information or other document with the Commission. As of its filing date, or in the case of the S-4 Registration Statement, as of its effective date, and in each case if amended or superseded by a filing prior to the Closing Date, on the date of such
      amended or superseded filing, each Commission Document filed with or furnished to the Commission prior to the Closing Date complied in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable, and in all
      material respects with other federal, state and local laws, rules and regulations applicable to it. Each Registration Statement, on the date it is filed with the Commission, on the date it is becomes effective and on each VWAP Purchase Date shall
      comply in all material respects with the requirements of the Securities Act (including, without limitation, Rule 415 under the Securities Act) and shall not contain any untrue statement of a material fact or omit to state a material fact required to
      be stated therein or necessary in order to make the statements therein not misleading, except that this representation and warranty shall not apply to statements in or omissions from such Registration Statement made in reliance upon and in conformity
      with information relating to the Investor furnished to the Company in writing by or on behalf of the Investor expressly for use therein. The Prospectus and each Prospectus Supplement required to be filed pursuant to this Agreement or the Registration
      Rights Agreement after the Closing Date, when taken together, on its date and on each VWAP Purchase Date shall comply in all material respects with the requirements of the Securities Act (including, without limitation, Rule 424(b) under the
      Securities Act) and shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were
      made, not misleading, except that this representation and warranty shall not apply to statements in or omissions from the Prospectus or any Prospectus Supplement made in reliance upon and in conformity with information relating to the Investor
      furnished to the Company in writing by or on behalf of the Investor expressly for use therein. The statistical, demographic and market-related data included in the Registration Statement and Prospectus are based on or derived from sources that the
      Company believes to be reliable and accurate in all material respects or represent the Company’s good faith estimates that are made on the basis of data derived from such sources. Each Commission Document (other than the Initial Registration
      Statement or any New Registration Statement, or the Prospectus included therein or any Prospectus Supplement thereto) to be filed with or furnished to the Commission after the Closing Date and incorporated by reference in the Initial Registration
      Statement or any New Registration Statement, or the Prospectus included therein or any Prospectus Supplement thereto required to be filed pursuant to this Agreement or the Registration Rights Agreement (including, without limitation, the Current
      Report), when such document is filed with or furnished to the Commission and, if applicable, when such document becomes effective, as the case may be, shall comply in all material respects with the requirements of the Securities Act or the Exchange
      Act, as applicable, and other federal, state and local laws, rules and regulations applicable to it. The Company has delivered or made available to the Investor via EDGAR or otherwise true and complete copies of all comment letters and substantive
      correspondence received by the Company from the Commission relating to the Commission Documents filed with or furnished to the Commission as of the Closing Date, together with all written responses of the Company thereto in the form such responses
      were filed via EDGAR. There are no outstanding or unresolved comments or undertakings in such comment letters received by the Company from the Commission. The Commission has not issued any stop order or other order suspending the effectiveness of any
      registration statement filed by the Company under the Securities Act or the Exchange Act.

   

  (ii) The consolidated financial statements of the Company included or
      incorporated by reference in the Commission Documents, together with the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and its then consolidated subsidiaries as of the dates
      indicated, and the consolidated results of operations, cash flows and changes in stockholders’ equity of the Company and its then consolidated subsidiaries for the periods specified and have been prepared, in all material respects, in compliance with
      the published requirements of the Securities Act and the Exchange Act, as applicable, and in conformity with generally accepted accounting principles in the United States (“GAAP”) applied on a consistent basis. The summary consolidated
      financial data included or incorporated by reference in the Commission Documents, if any, present fairly the information shown therein and have been compiled on a basis consistent with that of the financial statements included or incorporated by
      reference in the Commission Documents, as of and at the dates indicated. The pro forma condensed combined financial statements and the pro forma combined financial statements and any other pro forma financial statements or data included or
      incorporated by reference in the Commission Documents comply with the requirements of Regulation S-X of the Securities Act, including, without limitation, Article 11 thereof, and the assumptions used in the preparation of such pro forma financial
      statements and data are reasonable, the pro forma adjustments used therein are appropriate to give effect to the circumstances referred to therein and the pro forma adjustments have been properly applied to the historical amounts in the compilation
      of those statements and data. There are no financial statements (historical or pro forma) that are required to be included or incorporated by reference in the Commission Documents that are not included or incorporated by reference as required. The
      Company and the Subsidiaries do not have any material liabilities or obligations, direct or contingent (including any off-balance sheet obligations or any “variable interest entities” as that term is used in Accounting Standards Codification
      Paragraph 810-10-25-20), not described in Commission Documents which are required to be described in the Commission Documents. All disclosures contained or incorporated by reference in the Commission Documents, if any, regarding “non-GAAP financial
      measures” (as such term is defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent applicable. The interactive
      data in eXtensible Business Reporting Language included in the Commission Documents fairly presents the information called for in all material respects and has been prepared in accordance with the Commission’s rules and guidelines applicable thereto.

  
    9

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  (iii) (a) WithumSmith+Brown, PC, whose report on the consolidated
      financial statements of the Company are included in the Company’s S-4 Registration Statement and will be included in the Registration Statement, is and, during the periods covered by its report, was an independent public accounting firm within the
      meaning of the Securities Act and the rules and regulations of the Public Company Accounting Oversight Board (United States). To the Company’s Knowledge, WithumSmith+Brown, PC is not in violation of the auditor independence requirements of the
      Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) with respect to the Company. (b) From and after the Merger Closing, Marcum LLP (or any successor independent registered public accounting firm for the Company), whose report on the
      consolidated financial statements of SpringBig, Inc. and the Company are included in the S-4 Registration Statement and will be included in the Registration Statement, is and, during the periods covered by its report, was an independent public
      accounting firm within the meaning of the Securities Act and the rules and regulations of the Public Company Accounting Oversight Board (United States). To the Company’s Knowledge, Marcum LLP (or any successor independent registered public accounting
      firm for the Company) is not in violation of the auditor independence requirements of the Sarbanes-Oxley Act with respect to the Company.

   

  (iv) There is and has been no failure on the part of the Company or any of
      the Company’s directors or officers, in their capacities as such, to comply in all material respects with any applicable provisions of the Sarbanes-Oxley Act and the rules and regulations promulgated thereunder. Each of the principal executive
      officer and the principal financial officer of the Company (or each former principal executive officer of the Company and each former principal financial officer of the Company as applicable) has made all certifications required by Sections 302 and
      906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms, statements and other documents required to be filed by it or furnished by it to the Commission. For purposes of the preceding sentence, “principal executive officer” and
      “principal financial officer” shall have the meanings given to such terms in the Sarbanes-Oxley Act.

   

  Section 5.8. No Material Adverse Effect; Absence of Certain Changes.
      Subsequent to the respective dates as of which information is given in the Commission Documents (including any document deemed incorporated by reference therein), there has not been (i) any Material Adverse Effect or the occurrence of any development
      that the Company reasonably expects will result in a Material Adverse Effect, (ii) any transaction which is material to the Company and the Subsidiaries taken as a whole, (iii) any obligation or liability, direct or contingent (including any
      off-balance sheet obligations), incurred by the Company or any Subsidiary, which is material to the Company and the Subsidiaries taken as a whole, (iv) any material change in the capital stock or outstanding long-term indebtedness of the Company or
      any of its Subsidiaries, or (v) any dividend or distribution of any kind declared, paid or made on the capital stock of the Company or any Subsidiary, other than in each case above in the ordinary course of business or as otherwise disclosed in the
      Commission Documents (including any document deemed incorporated by reference therein). The Company and its Subsidiaries have conducted their respective businesses in the ordinary course of business consistent with past practice in all material
      respects, and there have not been any developments, including any new or amended Contracts between the Company or any of its Subsidiaries and its customers or any changes in applicable law, that would reasonably be expected to result in a material
      violation by the Company or any of its Subsidiaries of applicable law.

  
    10

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 5.9. No Material Defaults. Neither the Company nor
      any of its Subsidiaries has defaulted on any installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults would, individually or in the aggregate, have a Material Adverse Effect. The Company has not
      filed a report pursuant to Section 13(a) or 15(d) of the Exchange Act indicating that it (i) has failed to pay any dividend or sinking fund installment on preferred stock or (ii) has defaulted on any installment on indebtedness for borrowed money or
      on any rental on one or more long-term leases, which defaults would, individually or in the aggregate, have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is (i) in violation of its charter or by-laws or similar
      organizational documents; (ii) in default, and, to the Company’s Knowledge, no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition
      contained in any Contract to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound or to which any of the property or assets of the Company or any of its Subsidiaries are subject; or
      (iii) in violation of any law or statute or any judgment, order, rule or regulation of any Governmental Authority, except, in the case of each of clauses (ii) and (iii) above, for any such violation or default that would not, individually or in the
      aggregate, have a Material Adverse Effect.

   

  Section 5.10. No Preferential Rights. Except as set forth
      in the Commission Documents, (i) no Person, has the right, contractual or otherwise, to cause the Company to issue or sell to such Person any Common Stock or shares of any other capital stock or other securities of the Company, (ii) no Person has any
      preemptive rights, resale rights, rights of first refusal, rights of co-sale, or any other rights (whether pursuant to a “poison pill” provision or otherwise) to purchase any Common Stock or shares of any other capital stock or other securities of
      the Company, (iii) no Person has the right to act as an underwriter or as a financial advisor to the Company in connection with the offer and sale of the Common Stock, and (iv) no Person has the right, contractual or otherwise, to require the Company
      to register under the Securities Act any Common Stock or shares of any other capital stock or other securities of the Company, or to include any such shares or other securities in the Registration Statement or the offering contemplated thereby,
      whether as a result of the filing or effectiveness of the Registration Statement or the sale of the Shares as contemplated thereby or otherwise.

   

  Section 5.11. Material Contracts. Each Material Contract between the
      Company and a third party is in full force and effect and is a valid and binding obligation of the Company or the Subsidiary of the Company that is party thereto and, to the Knowledge of the Company, is a valid and binding obligation of each other
      party thereto. The Company has not received any written notice of the intention of any other party to a Material Contract to terminate for default, convenience or otherwise, or not renew, any Material Contract.

   

  Section 5.12. Solvency. The Company has not taken any
      steps, and does not currently expect to take any steps, to seek protection pursuant to Title 11 of the United States Code or any similar federal or state bankruptcy law or law for the relief of debtors, nor does the Company have any Knowledge that
      its creditors intend to initiate involuntary bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for relief under Title 11 of the United States Code or any other federal or state bankruptcy law or any law for the
      relief of debtors. The Company is financially solvent and is generally able to pay its debts as they become due.

   

  Section 5.13. Real Property; Intellectual Property.

   

  (i) Except as set forth in the Commission Documents, the Company and its
      Subsidiaries have good and marketable title in fee simple to all items of real property owned by them and good and valid title to all personal property described in the Commission Documents as being owned by them, in each case free and clear of all
      liens, encumbrances and claims, except those matters that (a) do not materially interfere with the use made and proposed to be made of such property by the Company and any of its Subsidiaries or (b) would not, individually or in the aggregate, have a
      Material Adverse Effect. Any real or personal property described in the Commission Documents as being leased by the Company and any of its Subsidiaries is held by them under valid, existing and enforceable leases, except those that (1) do not
      materially interfere with the use made or proposed to be made of such property by the Company or any of its Subsidiaries or (2) would not be reasonably expected, individually or in the aggregate, to have a Material Adverse Effect. Each of the
      properties of the Company and its Subsidiaries complies with all applicable codes, laws and regulations (including, without limitation, building and zoning codes, laws and regulations and laws relating to access to such properties), except if and to
      the extent disclosed in the Commission Documents or except for such failures to comply that would not, individually or in the aggregate, reasonably be expected to interfere in any material respect with the use made and proposed to be made of such
      property by the Company and its Subsidiaries or otherwise have a Material Adverse Effect. None of the Company or its Subsidiaries has received from any Governmental Authorities any notice of any condemnation of, or zoning change affecting, the
      properties of the Company and its Subsidiaries, and the Company knows of no such condemnation or zoning change which is threatened, except for such that would not reasonably be expected to interfere in any material respect with the use made and
      proposed to be made of such property by the Company and its Subsidiaries or otherwise have a Material Adverse Effect, individually or in the aggregate.

  
    11

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  (ii) Except as disclosed in the Commission Documents, the Company and its
      Subsidiaries own, possess, license or have other rights to use all foreign and domestic patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets,
      technology, Internet domain names, know-how and other intellectual property (collectively, the “Intellectual Property”), necessary for the conduct of their respective businesses as now conducted except to the extent that the failure to
      own, possess, license or otherwise hold adequate rights to use such Intellectual Property would not, individually or in the aggregate, have a Material Adverse Effect. Except as disclosed in the Commission Documents (a) there are no rights of third
      parties to any such Intellectual Property owned by the Company and its Subsidiaries; (b) to the Company’s Knowledge, there is no infringement by third parties of any such Intellectual Property; (c) there is no pending or, to the Company’s Knowledge,
      threatened action, suit, proceeding or claim by others challenging the Company’s and its Subsidiaries’ rights in or to any such Intellectual Property, and the Company is unaware of any facts which could form a reasonable basis for any such action,
      suit, proceeding or claim; (d) there is no pending or, to the Company’s Knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property; (e) there is no pending or, to the
      Company’s Knowledge, threatened action, suit, proceeding or claim by others that the Company and its Subsidiaries infringe or otherwise violate any patent, trademark, copyright, trade secret or other proprietary rights of others; (f) to the Company’s
      Knowledge, there is no third-party U.S. patent or published U.S. patent application which contains claims for which an Interference Proceeding (as defined in 35 U.S.C. § 135) has been commenced against any patent or patent application described in
      the Commission Documents as being owned by or licensed to the Company; and (g) the Company and its Subsidiaries have complied with the terms of each agreement pursuant to which Intellectual Property has been licensed to the Company or such
      Subsidiary, and all such agreements are in full force and effect, except, in the case of any of clauses (a)-(g) above, for any such infringement by third parties or any such pending or threatened suit, action, proceeding or claim as would not,
      individually or in the aggregate, result in a Material Adverse Effect. The Company and its Subsidiaries have taken reasonable best efforts to maintain the confidentiality of all material trade secrets and other material confidential information of
      the Company and its Subsidiaries and any confidential information owned by any Person to whom the Company or any of its Subsidiaries has a written confidentiality obligation.

   

  Section 5.14. Actions Pending. Except as set forth in the
      Commission Documents, there are no material actions, suits or proceedings by or before any Governmental Authority pending, nor, to the Company’s Knowledge, any audits or investigations by or before any Governmental Authority to which the Company or a
      Subsidiary is a party or to which any property of the Company or any of its Subsidiaries is the subject, and, to the Company’s Knowledge, no such actions, suits, proceedings, audits or investigations are threatened or contemplated by any Governmental
      Authority or threatened by others; and (i) there are no current or pending audits or investigations, actions, suits or proceedings by or before any Governmental Authority that are required under the Securities Act to be described in the Commission
      Documents that are not so described; and (ii) there are no contracts or other documents that are required under the Securities Act to be filed as exhibits to the Commission Documents that are not so filed.

   

  Section 5.15. Compliance with Law. The Company and each of
      its Subsidiaries are in material compliance with all applicable laws, regulations and statutes (including all Environmental Laws) in the jurisdictions in which it carries on business; the Company has not received a notice of non-compliance, and does
      not have any Knowledge of any facts that could give rise to a notice of non-compliance, with any such laws, regulations and statutes. The Company is not aware of any pending change or contemplated change to any applicable law or regulation or
      governmental position, in each case that would materially adversely affect the business of the Company or the business or legal environment under which the Company operates. Neither the Company nor any of the Subsidiaries has engaged in, or will
      engage in, (i) any direct or indirect dealings or transactions in violation of U.S. federal or state criminal laws, or (ii) any “aiding and abetting” in any violation of U.S. federal or state criminal laws.

   

  Section 5.16. Certain Fees. Neither the Company nor any of its Subsidiaries
      has incurred any liability for any finder’s fees, brokerage commissions or similar payments in connection with the transactions herein contemplated.

  
    12

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 5.17. Disclosure. The Company confirms that neither
      it nor any other Person acting on its behalf has provided the Investor or any of its agents, advisors or counsel with any information that constitutes or could reasonably be expected to constitute material, nonpublic information concerning the
      Company or any of its Subsidiaries, other than the existence of the transactions contemplated by the Transaction Documents. The Company understands and confirms that the Investor will rely on the foregoing representations in effecting resales of
      Shares under the Registration Statement.

   

  Section 5.18. Broker/Dealer Relationships. Neither the
      Company nor any of the Subsidiaries (i) is required to register as a “broker” or “dealer” in accordance with the provisions of the Exchange Act or (ii) directly or indirectly through one or more intermediaries, controls or is a “person associated
      with a member” or “associated person of a member” (within the meaning set forth in the FINRA Manual).

   

  Section 5.19. Controls. The Company maintains a system of
      “disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Exchange Act) that complies with the requirements of the Exchange Act and that has been designed to ensure that information required to be disclosed by the Company in reports
      that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is
      accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding required disclosure. The Company’s internal control over financial reporting is effective and the Company is not aware of any material
      weaknesses in its internal control over financial reporting (other than as set forth in the Commission Documents). Since the date of the latest audited financial statements of the Company included in the Commission Documents, there has been no change
      in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting (other than as set forth in the Commission Documents). The
      Company has carried out any evaluations of the effectiveness of its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act. Since the date of such evaluations, there have been no significant changes in the Company’s
      internal controls (as such term is defined in Item 307(b) of Regulation S-K under the Securities Act) or, to the Company’s Knowledge, in other factors that could significantly affect the Company’s internal controls.

   

  Section 5.20. Permits. Each of the Company and its
      Subsidiaries has made all material filings, applications and submissions, and holds all licenses, approvals, consents, registrations, franchises and permits (including, without limitation, any under Environmental Laws) necessary for the operation of
      the business of the Company and its Subsidiaries (the “Permits”). The Permits are valid and in full force and effect and the Company and its Subsidiaries are in compliance with and not in default under such Permits, have been conducting
      their business activities within their permitted scopes of business, and have been operating their businesses in compliance in all material respects with all relevant legal requirements. Neither the Company nor any Subsidiary has received, or has any
      reason to believe that it will receive, any notice of proceedings relating to the revocation or modification of, or non-compliance with, any Permit which, if the subject of an unfavorable decision, ruling or finding, would, individually or in the
      aggregate, have a Material Adverse Effect.

   

  Section 5.21. Environmental Compliance. Except as set forth
      in the Commission Documents, the Company and its Subsidiaries (i) are in compliance with any and all applicable federal, state, local and foreign laws, rules, regulations, decisions and orders relating to the protection of human health and safety,
      the environment or hazardous or toxic substances or wastes, pollutants or contaminants (collectively, “Environmental Laws”); (ii) have received and are in compliance with all permits, licenses or other approvals required of them under
      applicable Environmental Laws to conduct their respective businesses as described in the Commission Documents; and (iii) have not received notice of any actual or potential liability for the investigation or remediation of any disposal or release of
      hazardous or toxic substances or wastes, pollutants or contaminants, except, in the case of any of clauses (i), (ii) or (iii) above, for any such failure to comply or failure to receive required permits, licenses, other approvals or liability as
      would not, individually or in the aggregate, have a Material Adverse Effect.

   

  Section 5.22. No Improper Practices. (i) Neither the
      Company nor the Subsidiaries, nor any director, officer, or employee of the Company or any Subsidiary nor, to the Company’s Knowledge, any agent, Affiliate or other person acting on behalf of the Company or any Subsidiary has, in the past five years,
      made any unlawful contributions to any candidate for any political office (or failed fully to disclose any contribution in violation of applicable law) or made any contribution or other payment to any official of, or candidate for, any federal,
      state, municipal, or foreign office or other person charged with similar public or quasi-public duty in violation of any applicable law or of the character required to be disclosed in the Commission Documents; (ii) no relationship, direct or
      indirect, exists between or among the Company or any Subsidiary or any Affiliate of any of them, on the one hand, and the directors, officers and stockholders of the Company or any Subsidiary, on the other hand, that is required by the Securities Act
      to be described in the Commission Documents that is not so described; (iii) no relationship, direct or indirect, exists between or among the Company or any Subsidiary or any Affiliate of them, on the one hand, and the directors, officers, or
      stockholders of the Company or any Subsidiary, on the other hand, that is required by the rules of FINRA to be described in the Commission Documents that is not so described; (iv) except as described in the Commission Documents, there are no material
      outstanding loans or advances or material guarantees of indebtedness by the Company or any Subsidiary to or for the benefit of any of their respective officers or directors or any of the members of the families of any of them; (v) the Company has not
      offered, or caused any placement agent to offer, Common Stock to any person with the intent to influence unlawfully (a) a customer or supplier of the Company or any Subsidiary to alter the customer’s or supplier’s level or type of business with the
      Company or any Subsidiary or (b) a trade journalist or publication to write or publish favorable information about the Company or any Subsidiary or any of their respective products or services; and (vi) neither the Company nor any Subsidiary nor any
      director, officer or employee of the Company or any Subsidiary nor, to the Company’s Knowledge, any agent, Affiliate or other person acting on behalf of the Company or any Subsidiary has (a) violated or is in violation of any applicable provision of
      the U.S. Foreign Corrupt Practices Act of 1977, as amended, or any other applicable anti-bribery or anti-corruption law (collectively, “Anti-Corruption Laws”), (b) promised, offered, provided, attempted to provide or authorized the
      provision of anything of value, directly or indirectly, to any person for the purpose of obtaining or retaining business, influencing any act or decision of the recipient, or securing any improper advantage; or (c) made any payment of funds of the
      Company or any Subsidiary or received or retained any funds in violation of any Anti-Corruption Laws.

  
    13

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 5.23. Operations. The operations of the Company
      and its Subsidiaries are and have been conducted at all times in compliance with (i) applicable financial record keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering
      statutes of all jurisdictions to which the Company or its Subsidiaries are subject, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority
      (collectively, the “Money Laundering Laws”) and (ii) the Controlled Substances Act, all rules, regulations, and orders related thereto, and all other applicable laws, statutes, rules, and regulations concerning cannabis in all
      jurisdictions in which the Company and its Subsidiaries operate (collectively, the “Cannabis Laws”). No action, suit or proceeding by or before any Governmental Authority involving the Company or any of its Subsidiaries with respect to
      the Money Laundering Laws or the Cannabis Laws is pending or, to the Knowledge of the Company, threatened. The proceeds from the offering of the Shares will not be lent, used, or otherwise made available in any way that would cause a violation of
      Anti-Money Laundering Laws or Cannabis Laws by the Company or its subsidiaries.

   

  Section 5.24. Transactions With Affiliates. No
      relationship, direct or indirect, exists between or among the Company or any of its Subsidiaries on the one hand, and the directors, officers, trustees, managers, stockholders, partners, customers or suppliers of the Company or any of the
      Subsidiaries on the other hand, which would be required by the Securities Act or the Exchange Act to be disclosed in the Commission Documents, which is not so disclosed.

   

  Section 5.25. Labor Disputes. None of the Company nor any
      of its Subsidiaries is bound by or subject to any collective bargaining or similar agreement with any labor union, and, to the Knowledge of the Company, none of the employees, representatives or agents of the Company or any of its Subsidiaries is
      represented by any labor union. The Company and its Subsidiaries have complied with all employment laws applicable to employees of the Company and its Subsidiaries, except where non-compliance with any such employment laws would not have a Material
      Adverse Effect. No labor disturbance by or dispute with employees of the Company or any of its Subsidiaries exists or, to the Knowledge of the Company, is threatened that would result in a Material Adverse Effect.

   

  Section 5.26. Use of Proceeds. The proceeds from the sale
      of the Shares by the Company to the Investor shall be used by the Company in the manner as will be set forth in the Prospectus included in any Registration Statement (and any post-effective amendment thereto) and any Prospectus Supplement thereto
      filed pursuant to the Registration Rights Agreement.

   

  Section 5.27. Investment Company Act Status. The Company is
      not, and as a result of the consummation of the transactions contemplated by the Transaction Documents and the application of the proceeds from the sale of the Shares as will be set forth in the Prospectus included in any Registration Statement (and
      any post-effective amendment thereto) and any Prospectus Supplement thereto filed pursuant to the Registration Rights Agreement the Company will not be an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

  
    14

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 5.28. Taxes. The Company and each of its
      Subsidiaries have filed all federal, state, local and foreign tax returns which have been required to be filed and paid all taxes shown thereon, to the extent that such taxes have become due and are not being contested in good faith, except where the
      failure to so file or pay would not have a Material Adverse Effect. Except as otherwise disclosed in or contemplated by the Commission Documents, no tax deficiency has been determined adversely to the Company or any of its Subsidiaries which has had,
      or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. The Company has no Knowledge of any federal, state or other governmental tax deficiency, penalty or assessment which has been or might be asserted
      or threatened against it which would have a Material Adverse Effect.

   

  Section 5.29. ERISA. To the Knowledge of the Company, each material employee
      benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), that is maintained, administered or contributed to by the Company or any entity (“ERISA Affiliate”)

      that would be considered a single employer with the Company under Section 414 of the Internal Revenue Code of 1986, as amended (the “Code”) for employees or former employees of the Company and any of its ERISA Affiliates has been
      maintained in material compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Code; no prohibited transaction, within the meaning of Section 406 of ERISA or
      Section 4975 of the Code, has occurred which would result in a material liability to the Company with respect to any such plan excluding transactions effected pursuant to a statutory or administrative exemption; and for each such plan that is subject
      to the funding rules of Section 412 of the Code or Section 302 of ERISA, no “accumulated funding deficiency” as defined in Section 412 of the Code has been incurred, whether or not waived, and the fair market value of the assets of each such plan
      (excluding for these purposes accrued but unpaid contributions) exceeds the present value of all benefits accrued under such plan determined using reasonable actuarial assumptions.

   

  Section 5.30. Stock Transfer Taxes. All stock transfer or
      other taxes (other than income taxes) which are required to be paid in connection with the sale and transfer of the Shares to be sold hereunder will be, or will have been, fully paid or provided for by the Company and all laws imposing such taxes
      will be or will have been fully complied with.

   

  Section 5.31. Insurance. The Company and each of its
      Subsidiaries carry, or are covered by, insurance in such amounts and covering such risks as the Company and each of its Subsidiaries reasonably believe are adequate for the conduct of their business and as is customary for companies engaged in
      similar businesses in similar industries.

   

  Section 5.32. Exemption from Registration. Subject to, and
      in reliance on, the representations, warranties and covenants made herein by the Investor, the offer and sale of the Shares in accordance with the terms and conditions of this Agreement is exempt from the registration requirements of the Securities
      Act pursuant to Section 4(a)(2) and/or Rule 506(b) of Regulation D; provided, however, that at the request of and with the express agreements of the Investor (including, without limitation, the representations, warranties and
      covenants of Investor set forth in Section 4.9 through 4.13), the Shares to be issued from and after Commencement to or for the benefit of the Investor pursuant to this Agreement shall be issued to the Investor or its designee only as DWAC Shares and
      will not bear legends noting restrictions as to resale of such securities under federal or state securities laws, nor will any such securities be subject to stop transfer instructions.

   

  Section 5.33. No General Solicitation or Advertising.
      Neither the Company, nor any of its Subsidiaries or Affiliates, nor any Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or
      sale of the Shares.

   

  Section 5.34. No Integrated Offering. None of the Company,
      its Subsidiaries or any of their Affiliates, nor any Person acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would require registration
      of the issuance of any of the Shares under the Securities Act, whether through integration with prior offerings or otherwise, or cause this offering of the Shares to require approval of stockholders of the Company under any applicable stockholder
      approval provisions, including, without limitation, under the rules and regulations of the Principal Market. None of the Company, its Subsidiaries, their Affiliates nor any Person acting on their behalf will take any action or steps referred to in
      the preceding sentence that would require registration of the issuance of any of the Shares under the Securities Act or cause the offering of any of the Shares to be integrated with other offerings.

  
    15

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 5.35. Manipulation of Price. Neither the Company
      nor any of its officers, directors or Affiliates has, and, to the Knowledge of the Company, no Person acting on their behalf has, (i) taken, directly or indirectly, any action designed or intended to cause or to result in the stabilization or
      manipulation of the price of any security of the Company, or which caused or resulted in, or which would in the future reasonably be expected to cause or result in, the stabilization or manipulation of the price of any security of the Company, in
      each case to facilitate the sale or resale of any of the Shares, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Shares, or (iii) paid or agreed to pay to any Person any compensation for soliciting
      another to purchase any other securities of the Company. Neither the Company nor any of its officers, directors or Affiliates will during the term of this Agreement, and, to the Knowledge of the Company, no Person acting on their behalf will during
      the term of this Agreement, take any of the actions referred to in the immediately preceding sentence.

   

  Section 5.36. Listing and Maintenance Requirements; DTC Eligibility.
      The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the Company has taken no action designed to, or which to its Knowledge is likely to have the effect of, terminating the registration of the Common Stock under the
      Exchange Act, nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as disclosed in the Commission Documents, the Company has not received notice from the Principal Market to the
      effect that the Company is not in compliance with the listing or maintenance requirements of the Principal Market. The Common Stock is eligible for participation in the DTC book entry system and has shares on deposit at DTC for transfer
      electronically to third parties via DTC through its Deposit/Withdrawal at Custodian (“DWAC”) delivery system. The Company has not received notice from DTC to the effect that a suspension of, or restriction on, accepting additional
      deposits of the Common Stock, electronic trading or book-entry services by DTC with respect to the Common Stock is being imposed or is contemplated.

   

  Section 5.37. Application of Takeover Protections. The
      Company and its Board of Directors will, as of the Merger Closing, have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights
      agreement) or other similar anti-takeover provision under the Company’s Charter or the laws of its state of incorporation that is or could become applicable to the Investor as a result of the Investor and the Company fulfilling their respective
      obligations or exercising their respective rights under the Transaction Documents (as applicable), including, without limitation, as a result of the Company’s issuance of the Shares and the Investor’s ownership of the Shares.

   

  Section 5.38. OFAC. Neither the Company nor any of its
      Subsidiaries (collectively, the “Entity”), nor any director, officer, employee, agent, Affiliate or representative of the Company, is a Person that is, or is owned or controlled by a Person that is (i) the subject of any sanctions
      administered or enforced by the Office of Foreign Assets Control (“OFAC”), the United Nations Security Council, the European Union or any EU member state, Her Majesty’s Treasury of the United Kingdom, or other relevant sanctions authorities,
      including, without limitation, designation on OFAC’s Specially Designated Nationals and Blocked Persons List or OFAC’s Foreign Sanctions Evaders List or other relevant sanctions authority (collectively, “Sanctions”), (ii) located,
      organized or resident in a country or territory that is the subject of Sanctions that broadly prohibit dealings with that country or territory (including, without limitation, the Crimea, Donetsk People’s Republic, or Luhansk People’s Republic regions
      of Ukraine, Cuba, Iran, North Korea, and Syria (the “Sanctioned Countries”)), nor (iii) owned or controlled by any Person or Persons described in clause (i) or (ii). The Entity will not, directly or indirectly, use the proceeds from the
      sale of Shares, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person (a) to fund or facilitate any activities or business of or with any Person or in any country or territory that, at
      the time of such funding or facilitation, is the subject of Sanctions or is a Sanctioned Country, or (b) in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the transactions
      contemplated by this Agreement, whether as underwriter, advisor, investor or otherwise). For the past five years, the Entity has not engaged in, and is now not engaged in, any dealings or transactions with any Person, or in any country or territory,
      that at the time of the dealing or transaction is or was the subject of Sanctions or was a Sanctioned Country.

  
    16

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 5.39. Information Technology; Compliance with Data Privacy
          Laws.

   

  (i) The Company and its Subsidiaries’ information technology assets and
      equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, “IT Systems”) are adequate for, and operate and perform in all material respects as required in connection with the
      operation of the business of the Company as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its Subsidiaries have implemented and maintain reasonable
      physical, technical and administrative controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data,
      including all “Personal Data” (defined below) and all sensitive, confidential or regulated data (“Confidential Data”) used in connection with their businesses. “Personal Data” means (a) a natural person’s name, street
      address, telephone number, e-mail address, photograph, social security number or tax identification number, driver’s license number, passport number, credit card number, bank information, or customer or account number; (b) any information which would
      qualify as “personally identifying information” under the Federal Trade Commission Act, as amended; (c) any information which would qualify as “personal data” as defined by the European Union General Data Protection Regulation (“GDPR”)
      (EU 2016/679); (d) any information which would qualify as “protected health information” under the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act
      (collectively, “HIPAA”); (e) any “personal information” as defined by the California Consumer Privacy Act (“CCPA”); and (f) any other piece of information that allows the identification of such natural person, or his or
      her family, or permits the collection or analysis of any data related to an identified person’s health or sexual orientation. To the Company’s Knowledge, in the past twelve (12) months, there have been no breaches, violations, outages or unauthorized
      uses of or accesses to the IT Systems, except for those that have been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the same. The Company and
      its Subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual
      obligations relating to the privacy and security of IT Systems, Confidential Data, and Personal Data and to the protection of such IT Systems, Confidential Data, and Personal Data from unauthorized use, access, misappropriation or modification.

   

  (ii) The Company and its Subsidiaries are in material compliance with all
      applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, CCPA and the GDPR (collectively, the “Privacy Laws”). To ensure compliance with the Privacy Laws, the Company has in place,
      complies with, and takes appropriate steps to ensure compliance in all material respects with their policies and procedures relating to data privacy and security and the collection, storage, use, processing, disclosure, handling, and analysis of
      Personal Data and Confidential Data (the “Policies”). The Company further certifies that neither it nor any Subsidiary: (a) has received notice of any actual or potential liability under or relating to, or actual or potential violation
      of, any of the Privacy Laws, and has no Knowledge of any event or condition that would reasonably be expected to result in any such notice; (b) is currently conducting or paying for, in whole or in part, any investigation, remediation, or other
      corrective action pursuant to any Privacy Law; or (c) is a party to any governmental order, decree, or agreement that imposes any obligation or liability under any Privacy Law.

   

  Section 5.40. Acknowledgement Regarding Relationship with Investor
          and CF&CO. The Company acknowledges and agrees, to the fullest extent permitted by law, that the Investor is acting solely in the capacity of an arm’s-length purchaser with respect to this Agreement and the transactions contemplated
      by the Transaction Documents, and CF&CO is acting as a representative of the Investor in connection with the transactions contemplated by the Transaction Documents, and of no other party, including the Company. The Company further acknowledges
      that while the Investor will be deemed to be a statutory “underwriter” with respect to certain of the transactions contemplated by the Transaction Documents in accordance with interpretive positions of the Staff of the Commission, the Investor is a
      “trader” that is not required to register with the Commission as a broker-dealer under Section 15(a) of the Securities Exchange Act of 1934. The Company further acknowledges that the Investor and its representatives are not acting as a financial
      advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated by the Transaction Documents, and any advice given by the Investor or any of its representatives (including CF&CO)
      or agents in connection therewith is merely incidental to the Investor’s acquisition of the Shares. The Company and Investor understand and acknowledge that employees of CF&CO may discuss market color, VWAP Purchase Notice timing and parameter
      considerations and other related capital markets considerations with the Company in connection with the Transaction Documents and the transactions contemplated thereby, in all cases on behalf of the Investor. The Company acknowledges and agrees that
      the Investor has not made and does not make any representations or warranties with respect to the transactions contemplated by the Transaction Documents other than those specifically set forth in Article IV.

  
    17

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 5.41. Acknowledgement Regarding Investor’s Affiliate
          Relationships. Affiliates of the Investor, including CF&CO, engage in a wide range of activities for their own accounts and the accounts of customers, including corporate finance, mergers and acquisitions, merchant banking, equity and
      fixed income sales, trading and research, derivatives, foreign exchange, futures, asset management, custody, clearance and securities lending. In the course of their respective business, Affiliates of the Investor may, directly or indirectly, hold
      long or short positions, trade and otherwise conduct such activities in or with respect to debt or equity securities or bank debt of, or derivative products relating to, the Company. Any such position will be created, and maintained, independently of
      the position the Investor takes in the Company. In addition, at any given time Affiliates of the Investor, including CF&CO, may have been or in the future may be engaged by one or more entities that may be competitors with, or otherwise adverse
      to, the Company in matters unrelated to the transactions contemplated by the Transaction Documents, and Affiliates of the Investor, including CF&CO may have or may in the future provide investment banking or other services to the Company in
      matters unrelated to the transactions contemplated by the Transaction Documents. Activities of any of the Investor’s Affiliates performed on behalf of the Company may give rise to actual or apparent conflicts of interest given the Investor’s
      potentially competing interests with those of the Company. The Company expressly acknowledges the benefits it receives from the Investor’s participation in the transactions contemplated by the Transaction Documents, on the one hand, and the
      Investor’s Affiliates’ activities, if any, on behalf of the Company unrelated to the transactions contemplated by the Transaction Documents, on the other hand, and understands the conflict or potential conflict of interest that may arise in this
      regard, and has consulted with such independent advisors as it deems appropriate in order to understand and assess the risks associated with these potential conflicts of interest. Consistent with applicable legal and regulatory requirements,
      applicable Affiliates of the Investor have adopted policies and procedures to establish and maintain the independence of their research departments and personnel from their investment banking groups and the Investor. As a result, research analysts
      employed by Affiliates of the Investor may hold views, make statements or investment recommendations or publish research reports with respect to the Company or the transactions contemplated by the Transaction Documents that differ from the views of
      the Investor.

   

  Section 5.42. Emerging Growth Company Status. From the time
      of the initial filing of the Company’s first registration statement with the Commission, the Company has been and is an “emerging growth company,” as defined in Section 2(a) of the Securities Act.

   

  ARTICLE VI

      ADDITIONAL COVENANTS

   

  The Company covenants with the Investor, and the Investor covenants with the Company, as
      follows, which covenants of one party are for the benefit of the other party, during the Investment Period (and with respect to the Company, for the period following the termination of this Agreement specified in Section 8.3 pursuant to and in
      accordance with Section 8.3):

   

  Section 6.1. Securities Compliance. The Company shall
      notify the Commission and the Principal Market, if and as applicable, in accordance with their respective rules and regulations, of the transactions contemplated by the Transaction Documents, and shall take all necessary action, undertake all
      proceedings and obtain all registrations, permits, consents and approvals for the legal and valid issuance of the Shares to the Investor in accordance with the terms of the Transaction Documents, as applicable.

   

  Section 6.2. Reservation of Common Stock. The Company has
      available and the Company shall reserve and keep available at all times, free of preemptive and other similar rights of stockholders, the requisite aggregate number of authorized but unissued shares of Common Stock to enable the Company to timely
      effect the issuance, sale and delivery of all Shares to be issued, sold and delivered in respect of each VWAP Purchase effected under this Agreement, at least prior to the delivery by the Company to the Investor of the applicable VWAP Purchase Notice
      in connection with such VWAP Purchase.

  
    18

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 6.3. Registration and Listing. The Company shall
      use all commercially reasonable efforts to cause the Common Stock to continue to be registered as a class of securities under Section 12(b) of the Exchange Act, and to comply with its reporting and filing obligations under the Exchange Act, and shall
      not take any action or file any document (whether or not permitted by the Securities Act or the Exchange Act) to terminate or suspend such registration or to terminate or suspend its reporting and filing obligations under the Exchange Act or
      Securities Act, except as permitted herein. The Company shall use all commercially reasonable efforts to continue the listing and trading of its Common Stock and the listing of the Shares purchased by the Investor hereunder on the Principal Market
      and to comply with the Company’s reporting, filing and other obligations under the rules and regulations of the Principal Market. The Company shall not take any action which could be reasonably expected to result in the delisting or suspension of the
      Common Stock on the Principal Market. If the Company receives any final and non-appealable notice that the listing or quotation of the Common Stock on the Principal Market shall be terminated on a date certain, the Company shall promptly (and in any
      case within 24 hours) notify the Investor of such fact in writing and shall use all commercially reasonable efforts to cause the Common Stock to be listed or quoted on another Principal Market.

   

  Section 6.4. Compliance with Laws.

   

  (i) During the Investment Period, the Company shall comply with applicable
      provisions of the Securities Act and the Exchange Act, including Regulation M thereunder, applicable state securities or “Blue Sky” laws, and applicable listing rules of the Principal Market, in connection with the transactions contemplated by this
      Agreement and the Registration Rights Agreement, except as would not, individually or in the aggregate, prohibit or otherwise interfere with the ability of the Company to enter into and perform its obligations under this Agreement in any material
      respect or for the Investor to conduct resales of Shares under the Registration Statement in any material respect.

   

  (ii) The Investor shall comply with all laws, rules, regulations and
      orders applicable to the performance by it of its obligations under this Agreement and its investment in the Shares, except as would not, individually or in the aggregate, prohibit or otherwise interfere with the ability of the Investor to enter into
      and perform its obligations under this Agreement in any material respect. Without limiting the foregoing, the Investor shall comply with all applicable provisions of the Securities Act and the Exchange Act, including Regulation M thereunder, and all
      applicable state securities or “Blue Sky” laws, in connection with the transactions contemplated by this Agreement and the Registration Rights Agreement.

   

  Section 6.5. Keeping of Records and Books of Account; Due
          Diligence. 

   

  (i) The Investor and the Company shall each maintain records showing the
      remaining Total Commitment, the remaining Aggregate Limit and the dates and VWAP Purchase Share Amount for each VWAP Purchase.

   

  (ii) Subject to the requirements of Section 6.12, from time to time from
      and after the Closing Date, the Company shall make available for inspection and review by the Investor during normal business hours and after reasonable prior notice, customary documentation reasonably requested by the Investor and/or its appointed
      counsel or advisors to conduct due diligence related to this Agreement and the transactions contemplated hereby; provided, however, that after the Closing Date, the Investor’s satisfaction with the results of such due diligence shall
      not be a condition precedent to the Company’s right to deliver to the Investor any VWAP Purchase Notice or the settlement thereof except to the extent expressly contemplated by this Agreement.

   

  Section 6.6. No Frustration; No Variable Rate Transactions. 

   

  (i) No Frustration. The Company shall not enter into,
      announce or recommend to its stockholders any agreement, plan, arrangement or transaction in or of which the terms thereof would reasonably be expected to restrict, materially delay, conflict with or impair the ability or right of the Company to
      perform its obligations under the Transaction Documents to which it is a party, including, without limitation, the obligation of the Company to deliver the Shares to the Investor in respect of a VWAP Purchase not later than the Share Delivery
      Deadline. For the avoidance of doubt, nothing in this Section 6.6(i) shall in any way limit the Company’s right to terminate this Agreement in accordance with Section 8.2 (subject in all cases to Section 8.3).

  
    19

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  (ii) No Variable Rate Transactions. The Company shall not
      effect or enter into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction, other than in connection with an
      Exempt Issuance.

   

  Section 6.7. Fundamental Transaction. If a VWAP Purchase
      Notice has been delivered to the Investor and the transactions contemplated therein have not yet been fully settled in accordance with the terms and conditions of this Agreement, the Company shall not effect any Fundamental Transaction until the
      expiration of five (5) Trading Days following the date of full settlement thereof and the issuance to the Investor of all of the Shares issuable pursuant to the VWAP Purchase to which such VWAP Purchase Notice relates.

   

  Section 6.8. Selling Restrictions. 

   

  (i) Except as expressly set forth below, the Investor covenants that from
      and after the Closing Date through and including the Trading Day next following the expiration or termination of this Agreement as provided in Article VIII (the “Restricted Period”), none of the Investor or any entity managed or
      controlled by the Investor (collectively, the “Restricted Persons” and each of the foregoing is referred to herein as a “Restricted Person”) shall, directly or indirectly, (a) engage in any Short Sales of the Common Stock
      or (b) hedging transaction, which establishes a net short position with respect to the Common Stock, with respect to each of clauses (a) and (b) hereof, for the principal account of the Investor or any Restricted Person. Notwithstanding the
      foregoing, it is expressly understood and agreed that nothing contained herein shall (without implication that the contrary would otherwise be true) prohibit any Restricted Person during the Restricted Period from: (x) selling “long” (as defined
      under Rule 200 promulgated under Regulation SHO) the Shares; or (y) selling a number of shares of Common Stock equal to the number of Shares that such Restricted Person is unconditionally obligated to purchase under a pending VWAP Purchase Notice but
      has not yet received from the Company or the Transfer Agent pursuant to this Agreement, so long as (1) such Restricted Person (or the Broker-Dealer, as applicable) delivers the Shares purchased pursuant to such VWAP Purchase Notice to the purchaser
      thereof or the applicable Broker-Dealer promptly upon such Restricted Person’s receipt of such Shares from the Company in accordance with Section 3.2 of this Agreement and (2) neither the Company nor the Transfer Agent shall have failed for any
      reason to deliver such Shares to the Investor or its Broker-Dealer so that such Shares are received by the Investor as DWAC Shares prior to the applicable Share Delivery Deadline in accordance with Section 3.2 of this Agreement.

   

  (ii) In addition to the foregoing, in connection with any sale of Shares
      (including any sale permitted by paragraph (i) above), the Investor shall comply in all respects with all applicable laws, rules, regulations and orders, including, without limitation, the requirements of the Securities Act and the Exchange Act.

   

  Section 6.9. Effective Registration Statement. During the
      Investment Period, the Company shall use its reasonable best efforts to maintain the continuous effectiveness of the Initial Registration Statement and each New Registration Statement filed with the Commission under the Securities Act for the
      applicable Registration Period pursuant to and in accordance with the Registration Rights Agreement.

   

  Section 6.10. Blue Sky. The Company shall take such action,
      if any, as is necessary by the Company in order to obtain an exemption for or to qualify the Shares for sale by the Company to the Investor pursuant to the Transaction Documents, and at the request of the Investor, the subsequent resale of
      Registrable Securities by the Investor, in each case, under applicable state securities or “Blue Sky” laws and shall provide evidence of any such action so taken to the Investor from time to time following the Closing Date; provided, however,
      that the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 6.11, (y) subject itself to general
      taxation in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction.

   

  Section 6.11. Non-Public Information. Neither the Company
      or any of its Subsidiaries, nor any of their respective directors, officers, employees or agents shall disclose any material non-public information about the Company to the Investor during any VWAP Purchase Period, unless a simultaneous public
      announcement thereof is made by the Company in the manner contemplated by Regulation FD. In the event of a breach of the foregoing covenant by the Company or any of its Subsidiaries, or any of their respective directors, officers, employees and
      agents (as determined in the reasonable good faith judgment of the Investor), (i) the Investor shall promptly provide written notice of such breach to the Company and (ii) after such notice has been provided to the Company and, provided that the
      Company and Investor shall have not concluded within 24 hours that such information does not constitute material, non-public information or the Company shall have failed to publicly disclose such material, non-public information within 24 hours
      following demand therefor by the Investor, in addition to any other remedy provided herein or in the other Transaction Documents, if the Investor is holding any Shares at the time of the disclosure of material, non-public information, the Investor
      shall have the right to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such material, non-public information without the prior approval by the Company, any of its Subsidiaries, or any of their
      respective directors, officers, employees or agents. The Investor shall not have any liability to the Company, any of its Subsidiaries, or any of their respective directors, officers, employees, stockholders or agents, for any such disclosure.

  
    20

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 6.12. Broker/Dealer. The Investor shall use one or
      more broker-dealers to effectuate all sales, if any, of the Shares that it may purchase or otherwise acquire from the Company pursuant to the Transaction Documents, as applicable, which (or whom) shall be a DTC participant (collectively, the “Broker-Dealer”).

      The Investor shall, from time to time, provide the Company and the Transfer Agent with all information regarding the Broker-Dealer reasonably requested by the Company. The Investor shall be solely responsible for all fees and commissions of the
      Broker-Dealer (if any), which shall not exceed customary brokerage fees and commissions and shall be responsible for designating only a DTC participant eligible to receive DWAC Shares.

   

  Section 6.13. Disclosure Schedule. 

   

  (i) The Company may, from time to time, update a disclosure schedule (the
      “Disclosure Schedule”) as may be required to satisfy the conditions set forth in Section 7.2(ii) and Section 7.3(i) (to the extent such condition set forth in Section 7.3(i) relates to the condition in Section 7.2(ii) as of a specific
      VWAP Purchase Condition Satisfaction Time). For purposes of this Section 6.14, any disclosure made in a schedule to the Compliance Certificate shall be deemed to be an update of the Disclosure Schedule. Notwithstanding anything in this Agreement to
      the contrary, no update to the Disclosure Schedule pursuant to this Section 6.14 shall cure any breach of a representation or warranty of the Company contained in this Agreement and made prior to the update and shall not affect any of the Investor’s
      rights or remedies with respect thereto.

   

  (ii) Notwithstanding anything to the contrary contained in the Disclosure
      Schedule or in this Agreement, the information and disclosure contained in any Schedule of the Disclosure Schedule shall be deemed to be disclosed and incorporated by reference in any other Schedule of the Disclosure Schedule as though fully set
      forth in such Schedule for which applicability of such information and disclosure is readily apparent on its face. The fact that any item of information is disclosed in the Disclosure Schedule shall not be construed to mean that such information is
      required to be disclosed by this Agreement. Except as expressly set forth in this Agreement, such information and the thresholds (whether based on quantity, qualitative characterization, dollar amounts or otherwise) set forth herein shall not be used
      as a basis for interpreting the terms “material” or “Material Adverse Effect” or other similar terms in this Agreement.

   

  Section 6.14. Delivery of Bring Down Opinions and Compliance
          Certificates Upon Occurrence of Certain Events. Following the Commencement, within three (3) Trading Days immediately following each time the Company files (i) an annual report on Form 10-K under the Exchange Act (including any Form
      10-K/A containing amended financial information or a material amendment to the previously filed Form 10-K); (ii) a quarterly report on Form 10-Q under the Exchange Act; (iii) a current report on Form 8-K containing amended financial information
      (other than information “furnished” pursuant to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification of certain properties as discontinued operations in accordance with Statement
      of Financial Accounting Standards No. 144) under the Exchange Act; or (iv) the Initial Registration Statement, any New Registration Statement, or any supplement or post-effective amendment thereto, and in any case, not more than once per calendar
      quarter (each, a “Representation Date”), the Company shall (a) deliver to the Investor a Compliance Certificate in the form attached hereto as Exhibit C, dated such date, (b) cause to be furnished to the Investor an opinion and
      10b-5 letter from outside counsel to the Company, substantially in the form mutually agreed to by the Company and the Investor prior to the Closing Date (each such opinion or letter, a “Bring-Down Opinion”) and (c) cause to be furnished
      to the Investor a comfort letter from each independent registered public accounting firm whose report appears in the Registration Statement and the Prospectus, and any Prospectus Supplement (in the case of a post-effective amendment, only if such
      amendment contains amended or new financial information), modified, as necessary, to address such new financial information or relate to such Registration Statement or post-effective amendment, or the Prospectus contained therein as then amended or
      supplemented by such Prospectus Supplement, as applicable (a “Bring-Down Comfort Letter”). The requirement to provide the documents identified in clauses (a), (b) and (c) of this Section 6.15 shall be waived for any Representation Date
      if the Company or the Investor has given notice to the other party in writing (including by email correspondence to the individual(s) of the other party set forth in Section 10.4 hereto, if receipt of such correspondence is actually acknowledged by
      any individual to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence to the individual(s) of the other party set forth in Section 10.4 hereto) of the
      suspension of VWAP Purchases (a “Suspension”), which waiver shall continue until the earlier to occur of the date the Company delivers a VWAP Purchase Notice hereunder (which for such calendar quarter shall be considered a
      Representation Date) and the next occurring Representation Date. Notwithstanding the foregoing, if the Company subsequently decides to deliver a VWAP Purchase Notice following a Representation Date when a Suspension was in effect and did not provide
      the Investor with the documents identified in clauses (a), (b) and (c) of this Section 6.15, then before the Investor accepts such VWAP Purchase Notice, the Company shall provide the Investor with the documents identified in clauses (a), (b) and (c)
      of this Section 6.15, dated as of the date that the VWAP Purchase Notice is accepted by the Investor.

  
    21

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  ARTICLE VII

      CONDITIONS TO CLOSING AND CONDITIONS TO THE SALE AND

      PURCHASE OF THE SHARES

   

  Section 7.1. Conditions Precedent to Closing. The Closing
      is subject to the satisfaction of each of the conditions set forth in this Section 7.1 on the Closing Date.

   

  (i) Accuracy of the Investor’s Representations and Warranties.
      The representations and warranties of the Investor contained in this Agreement (a) that are not qualified by “materiality” shall be true and correct in all material respects as of the Closing Date, except to the extent such representations and
      warranties are as of another date, in which case, such representations and warranties shall be true and correct in all material respects as of such other date and (b) that are qualified by “materiality” shall be true and correct as of the Closing
      Date, except to the extent such representations and warranties are as of another date, in which case, such representations and warranties shall be true and correct as of such other date.

   

  (ii) Accuracy of the Company’s Representations and Warranties.
      The representations and warranties of the Company contained in this Agreement shall be true and correct as of the Closing Date, except to the extent such representations and warranties are as of another date, in which case, such representations and
      warranties shall be true and correct as of such other date.

   

  (iii) Performance of the Company. The Company shall have
      performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Agreement and the Registration Rights Agreement to be performed, satisfied or complied with by the Company at or prior to the
      Closing.

   

  (iv) Closing Deliverables. Prior to the Closing,
      counterpart signature pages of this Agreement and the Registration Rights Agreement executed by each of the parties hereto shall have been delivered as provided in Section 2.2. On the Closing Date, the Investor shall have received: (a) the opinion
      from outside counsel to the Company, dated the Closing Date, in the form mutually agreed to by the Company and the Investor prior to the Closing Date, (b) the secretary’s certificate from the Company, dated the Closing Date, in the form attached as Exhibit

        B hereto (the “Secretary’s Certificate”), (c) the compliance certificate, in the form attached as Exhibit C hereto (the “Compliance Certificate”) and (d) a copy of the irrevocable instructions to the Transfer
      Agent regarding the issuance to the Investor or its designee of the certificate(s) or book-entry statement(s) representing the shares issued pursuant to any Upfront Commitment Fee pursuant to and in accordance with Section 10.1(ii) hereof.

   

  (v) Merger. On or prior to the Closing Date, the
      transactions contemplated by the Merger Agreement, including the Merger, shall have occurred.

   

  (vi) Principal Market Opinion. On or prior to the Closing
      Date, Dentons US LLP shall have provided an opinion to the Principal Market.

  
    22

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 7.2. Conditions Precedent to Commencement. The
      right of the Company to commence delivering VWAP Purchase Notices under this Agreement, and the obligation of the Investor to accept VWAP Purchase Notices delivered to the Investor by the Company under this Agreement, are subject to the initial
      satisfaction, at Commencement, of each of the conditions set forth in this Section 7.2.

   

  (i) Closing. Prior to the Commencement, the Closing shall
      have occurred, and no events that result in the right of the Investor to terminate this Agreement pursuant to Section 8.2 shall be occurring at Commencement.

   

  (ii) Accuracy of the Company’s Representations and Warranties.
      The representations and warranties of the Company contained in this Agreement (a) that are not qualified by “materiality” or “Material Adverse Effect” shall have been true and correct in all material respects when made and shall be true and correct
      in all material respects as of the Commencement Date with the same force and effect as if made on such date, except to the extent such representations and warranties are as of another date, in which case, such representations and warranties shall be
      true and correct in all material respects as of such other date and (b) that are qualified by “materiality” or “Material Adverse Effect” shall have been true and correct when made and shall be true and correct as of the Commencement Date with the
      same force and effect as if made on such date, except to the extent such representations and warranties are as of another date, in which case, such representations and warranties shall be true and correct as of such other date.

   

  (iii) Performance of the Company. The Company shall have
      performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Agreement and the Registration Rights Agreement to be performed, satisfied or complied with by the Company at or prior to the
      Commencement.

   

  (iv) Initial Registration Statement Effective. The Initial
      Registration Statement covering the resale by the Investor of the Registrable Securities included therein required to be filed by the Company with the Commission pursuant to Section 2(a) of the Registration Rights Agreement shall have become
      effective under the Securities Act, and the Investor shall be permitted to utilize the Prospectus therein to resell all of the Commitment Shares and the Shares included in such Prospectus.

   

  (v) No Material Notices. None of the following events shall
      have occurred and be continuing: (a) receipt of any request by the Commission or any other federal or state governmental authority for any additional information relating to the Initial Registration Statement, the Prospectus contained therein or any
      Prospectus Supplement thereto, or for any amendment of or supplement to the Initial Registration Statement, the Prospectus contained therein or any Prospectus Supplement thereto; (b) the issuance by the Commission or any other federal or state
      governmental authority of any stop order suspending the effectiveness of the Initial Registration Statement or prohibiting or suspending the use of the Prospectus contained therein or any Prospectus Supplement thereto, or of the suspension of
      qualification or exemption from qualification of the Shares for offering or sale in any jurisdiction, or the initiation or contemplated initiation of any proceeding for such purpose; (c) the objection of FINRA to the terms of the transactions
      contemplated by the Transaction Documents or (d) the occurrence of any event or the existence of any condition or state of facts, which makes any statement of a material fact made in the Initial Registration Statement, the Prospectus contained
      therein or any Prospectus Supplement thereto untrue or which requires the making of any additions to or changes to the statements then made in the Initial Registration Statement, the Prospectus contained therein or any Prospectus Supplement thereto
      in order to state a material fact required by the Securities Act to be stated therein or necessary in order to make the statements then made therein (in the case of the Prospectus or any Prospectus Supplement, in the light of the circumstances under
      which they were made) not misleading, or which requires an amendment to the Initial Registration Statement or a supplement to the Prospectus contained therein or any Prospectus Supplement thereto to comply with the Securities Act or any other law.
      The Company shall have no Knowledge of any event that could reasonably be expected to have the effect of causing the suspension of the effectiveness of the Initial Registration Statement or the prohibition or suspension of the use of the Prospectus
      contained therein or any Prospectus Supplement thereto in connection with the resale of the Registrable Securities by the Investor.

   

  (vi) Other Commission Filings. The Current Report shall
      have been filed with the Commission as required pursuant to Section 2.3. The final Prospectus included in the Initial Registration Statement shall have been filed with the Commission prior to Commencement in accordance with the Registration Rights
      Agreement.

   

  (vii) No Suspension of Trading in or Notice of Delisting of Common
          Stock. Trading in the Common Stock shall not have been suspended by the Commission, the Principal Market or FINRA (except for any suspension of trading of limited duration agreed to by the Company, which suspension shall be terminated
      prior to the Commencement Date), the Company shall not have received any final and non-appealable notice that the listing or quotation of the Common Stock on the Principal Market shall be terminated on a date certain (unless, prior to such date
      certain, the Common Stock is listed or quoted on any Alternative Market), nor shall there have been imposed any suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by DTC with
      respect to the Common Stock that is continuing, the Company shall not have received any notice from DTC to the effect that a suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry
      services by DTC with respect to the Common Stock is being imposed or is contemplated (unless, prior to such suspension or restriction, DTC shall have notified the Company in writing that DTC has determined not to impose any such suspension or
      restriction).

  
    23

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  (viii) Compliance with Laws. The Company shall have
      complied with all applicable federal, state and local governmental laws, rules, regulations and ordinances in connection with the execution, delivery and performance of this Agreement and the other Transaction Documents to which it is a party and the
      consummation of the transactions contemplated hereby and thereby, including, without limitation, the Company shall have obtained all permits and qualifications required by any applicable state securities or “Blue Sky” laws for the offer and sale of
      the Shares by the Company to the Investor and the subsequent resale of the Registrable Securities by the Investor (or shall have the availability of exemptions therefrom).

   

  (ix) No Injunction. No statute, regulation, order, decree,
      writ, ruling or injunction shall have been enacted, entered, promulgated, threatened or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of or which would materially modify or delay any of the
      transactions contemplated by the Transaction Documents.

   

  (x) No Proceedings or Litigation. No action, suit or
      proceeding before any arbitrator or any court or governmental authority shall have been commenced, and no inquiry or investigation by any governmental authority shall have been commenced, against the Company or any Subsidiary, or any of the officers,
      directors or Affiliates of the Company or any Subsidiary, seeking to restrain, prevent or change the transactions contemplated by the Transaction Documents, or seeking material damages in connection with such transactions.

   

  (xi) Listing of Shares. All of the Shares that have been
      and may be issued pursuant to this Agreement shall have been approved for listing or quotation on the Principal Market as of the Commencement Date, subject only to notice of issuance.

   

  (xii) No Material Adverse Effect. No condition, occurrence,
      state of facts or event constituting a Material Adverse Effect shall have occurred and be continuing.

   

  (xiii) No Bankruptcy Proceedings. No Person shall have
      commenced a proceeding against the Company pursuant to or within the meaning of any Bankruptcy Law. The Company shall not have, pursuant to or within the meaning of any Bankruptcy Law, (a) commenced a voluntary case, (b) consented to the entry of an
      order for relief against it in an involuntary case, (c) consented to the appointment of a Custodian of the Company or for all or substantially all of its property, or (d) made a general assignment for the benefit of its creditors. A court of
      competent jurisdiction shall not have entered an order or decree under any Bankruptcy Law that (1) is for relief against the Company in an involuntary case, (2) appoints a Custodian of the Company or for all or substantially all of its property or
      (3) orders the liquidation of the Company or any of its Subsidiaries.

   

  (xiv) Delivery of Commencement Irrevocable Transfer Agent
          Instructions and Notice of Effectiveness. The Commencement Irrevocable Transfer Agent Instructions shall have been executed by the Company and delivered to the Transfer Agent, and the Notice of Effectiveness relating to the Initial
      Registration Statement shall have been executed by the Company’s outside counsel and delivered to the Transfer Agent, in each case directing the Transfer Agent to issue to the Investor or its designated Broker-Dealer all of the Shares included in the
      Initial Registration Statement as DWAC Shares, if and when such Registrable Securities are issued in accordance with this Agreement and the Registration Rights Agreement.

  
    24

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  (xv) Reservation of Shares. As of the Commencement Date,
      the Company shall have reserved out of its authorized and unissued Common Stock a number of shares of Common Stock equal to the Exchange Cap solely for the purpose of effecting VWAP Purchases under this Agreement.

   

  (xvi) Certificates. On the Commencement Date, the Investor
      shall have received the Secretary’s Certificate and the Compliance Certificate from the Company, dated the Commencement Date.

   

  (xvii) Opinion and Negative Assurance of Company Counsel.
      On the Commencement Date, the Investor shall have received the opinion and 10b-5 letter from outside counsel to the Company, dated the Commencement Date, in the form mutually agreed to by the Company and the Investor prior to the Closing Date.

   

  (xviii) Comfort Letter of Accountant. On the Commencement
      Date, the Investor shall have received a comfort letter dated the Commencement Date addressed to the Investor, in form and substance reasonably satisfactory to the Investor with respect to the audited and unaudited financial statements and certain
      financial information contained in the Registration Statement and the Prospectus, and any Prospectus Supplement, from each independent registered public accounting firm whose report appears therein, except that the specific date referred to therein
      for the carrying out of procedures shall be no more than three (3) business days prior to the Commencement Date.

   

  (xix) Research. Neither the Investor nor any Affiliate of the Investor shall
      have, in the prior thirty (30) days, published or distributed any research report (as such term is defined in Rule 500 of Regulation AC) concerning the Company.

   

  (xx) FINRA. Prior to the Effective Date of the Initial Registration Statement
      and any New Registration Statement, FINRA shall have confirmed in writing that it has no objection with respect to the fairness and reasonableness of the terms and arrangements of the transactions contemplated by the Transaction Documents.

   

  (xxi) Qualified Independent Underwriter. If the Investor
      reasonably determines that a Qualified Independent Underwriter must participate in the transactions contemplated by the Transaction Documents in order for such transactions to be in full compliance with FINRA’s rules, the Company and the Investor
      shall have executed such documentation as may reasonably be required to engage a Qualified Independent Underwriter to participate in such transactions

   

  (xxii) Delivery of Upfront Commitment Fee. The Company
      shall have delivered the Upfront Commitment Fee in accordance with Section 10.1(ii), all of which Upfront Commitment Fee shall be fully earned and non-refundable as of the Merger Closing, regardless of whether any VWAP Purchases are made or settled
      hereunder or any subsequent termination of this Agreement.

   

  Section 7.3. Conditions Precedent to VWAP Purchases after
          Commencement Date. The right of the Company to deliver VWAP Purchase Notices under this Agreement after the Commencement Date, and the obligation of the Investor to accept VWAP Purchase Notices under this Agreement after the Commencement
      Date, are subject to the satisfaction of each of the conditions set forth in this Section 7.3 at the applicable VWAP Purchase Commencement Time for the VWAP Purchase to be effected pursuant to the applicable VWAP Purchase Notice timely delivered by
      the Company to the Investor in accordance with this Agreement (each such time, a “VWAP Purchase Condition Satisfaction Time”).

   

  (i) Satisfaction of Certain Prior Conditions. Each of the
      conditions set forth in subsections (i), (ii), (iii), (viii) through (xv), (xix) and (xx) set forth in Section 7.2 shall be satisfied at the applicable VWAP Purchase Condition Satisfaction Time after the Commencement Date (with the terms
      “Commencement” and “Commencement Date” in the conditions set forth in subsections (i) and (ii) of Section 7.2 replaced with “applicable VWAP Purchase Condition Satisfaction Time”); provided, however, that the Company shall not be
      required to deliver the Compliance Certificate after the Commencement Date, except as provided in Section 6.15 and Section 7.3(v).

   

  (ii) Initial Registration Statement Effective. The Initial
      Registration Statement covering the resale by the Investor of the Registrable Securities included therein filed by the Company with the Commission pursuant to Section 2(a) of the Registration Rights Agreement, and any post-effective amendment thereto
      required to be filed by the Company with the Commission after the Commencement Date and prior to the applicable VWAP Purchase Date pursuant to the Registration Rights Agreement, in each case shall have become effective under the Securities Act and
      shall remain effective for the applicable Registration Period, and the Investor shall be permitted to utilize the Prospectus therein, and any Prospectus Supplement thereto, to resell all of the Commitment Shares and the Shares included in the Initial
      Registration Statement, and any post-effective amendment thereto, that have been issued and sold to the Investor hereunder pursuant to all VWAP Purchase Notices delivered by the Company to the Investor prior to such applicable VWAP Purchase Date and
      all of the Shares included in the Initial Registration Statement, and any post-effective amendment thereto, that are issuable pursuant to the applicable VWAP Purchase Notice delivered by the Company to the Investor with respect to a VWAP Purchase to
      be effected hereunder on such applicable VWAP Purchase Date.

  
    25

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  (iii) Any Required New Registration Statement Effective.
      Any New Registration Statement covering the resale by the Investor of the Registrable Securities included therein, and any post-effective amendment thereto, required to be filed by the Company with the Commission pursuant to the Registration Rights
      Agreement after the Commencement Date and prior to the applicable VWAP Purchase Date, in each case shall have become effective under the Securities Act and shall remain effective for the applicable Registration Period, and the Investor shall be
      permitted to utilize the Prospectus therein, and any Prospectus Supplement thereto, to resell (a) all of the Commitment Shares and the Shares included in such New Registration Statement, and any post-effective amendment thereto, that have been issued
      and sold to the Investor hereunder pursuant to all VWAP Purchase Notices delivered by the Company to the Investor prior to such applicable VWAP Purchase Date and (b) all of the Shares included in such new Registration Statement, and any
      post-effective amendment thereto, that are issuable pursuant to the applicable VWAP Purchase Notice delivered by the Company to the Investor with respect to a VWAP Purchase to be effected hereunder on such applicable VWAP Purchase Date.

   

  (iv) Delivery of Subsequent Irrevocable Transfer Agent Instructions
          and Notice of Effectiveness. With respect to any post-effective amendment to the Initial Registration Statement, any New Registration Statement or any post-effective amendment to any New Registration Statement, in each case becoming
      effective after the Commencement Date, the Company shall have delivered or caused to be delivered to the Transfer Agent (a) irrevocable instructions in the form substantially similar to the Commencement Irrevocable Transfer Agent Instructions
      executed by the Company and acknowledged in writing by the Transfer Agent and (b) the Notice of Effectiveness, in each case modified as necessary to refer to such Registration Statement or post-effective amendment and the Registrable Securities
      included therein, to issue the Registrable Securities included therein as DWAC Shares in accordance with the terms of this Agreement and the Registration Rights Agreement.

   

  (v) No Material Notices. None of the following events shall
      have occurred and be continuing: (a) receipt of any request by the Commission or any other federal or state governmental authority for any additional information relating to the Initial Registration Statement or any post-effective amendment thereto,
      any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto, or for any amendment of or supplement to the Initial Registration Statement or any
      post-effective amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto; (b) the issuance by the Commission or any other
      federal or state governmental authority of any stop order suspending the effectiveness of the Initial Registration Statement or any post-effective amendment thereto, any New Registration Statement or any post-effective amendment thereto, or
      prohibiting or suspending the use of the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto, or of the suspension of qualification or exemption from qualification of the Shares for offering or sale in any jurisdiction,
      or the initiation or contemplated initiation of any proceeding for such purpose; (c) the objection of FINRA to the terms of the transactions contemplated by the Transaction Documents or (d) the occurrence of any event or the existence of any
      condition or state of facts, which makes any statement of a material fact made in the Initial Registration Statement or any post-effective amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus
      contained in any of the foregoing or any Prospectus Supplement thereto untrue or which requires the making of any additions to or changes to the statements then made in the Initial Registration Statement or any post-effective amendment thereto, any
      New Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto in order to state a material fact required by the Securities Act to be stated therein or
      necessary in order to make the statements then made therein (in the case of the Prospectus or any Prospectus Supplement, in the light of the circumstances under which they were made) not misleading, or which requires an amendment to the Initial
      Registration Statement or any post-effective amendment thereto, any New Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto to comply with the
      Securities Act or any other law (other than the transactions contemplated by the applicable VWAP Purchase Notice delivered by the Company to the Investor with respect to a VWAP Purchase to be effected hereunder on such applicable VWAP Purchase Date
      and the settlement thereof). The Company shall have no Knowledge of any event that could reasonably be expected to have the effect of causing the suspension of the effectiveness of the Initial Registration Statement or any post-effective amendment
      thereto, any New Registration Statement or any post-effective amendment thereto, or the prohibition or suspension of the use of the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto in connection with the resale of the
      Registrable Securities by the Investor.

  
    26

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  (vi) Other Commission Filings. The final Prospectus
      included in any post-effective amendment to the Initial Registration Statement, and any Prospectus Supplement thereto, required to be filed by the Company with the Commission pursuant to Section 2.3 and the Registration Rights Agreement after the
      Commencement Date and prior to the applicable VWAP Purchase Date, shall have been filed with the Commission in accordance with Section 2.3 and the Registration Rights Agreement. The final Prospectus included in any New Registration Statement and in
      any post-effective amendment thereto, and any Prospectus Supplement thereto, required to be filed by the Company with the Commission pursuant to Section 2.3 and the Registration Rights Agreement after the Commencement Date and prior to the applicable
      VWAP Purchase Date, shall have been filed with the Commission in accordance with Section 2.3 and the Registration Rights Agreement. All reports, schedules, registrations, forms, statements, information and other documents required to have been filed
      by the Company with the Commission pursuant to the reporting requirements of the Exchange Act, including all material required to have been filed pursuant to Section 13(a) or 15(d) of the Exchange Act, after the Commencement Date and prior to the
      applicable VWAP Purchase Date, shall have been filed with the Commission.

   

  (vii) No Suspension of Trading in or Notice of Delisting of Common
          Stock. Trading in the Common Stock shall not have been suspended by the Commission, the Principal Market or FINRA (except for any suspension of trading of limited duration agreed to by the Company, which suspension shall be terminated
      prior to the applicable VWAP Purchase Date), the Company shall not have received any final and non-appealable notice that the listing or quotation of the Common Stock on the Principal Market shall be terminated on a date certain (unless, prior to
      such date certain, the Common Stock is listed or quoted on any Alternative Market), nor shall there have been imposed any suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry services
      by DTC with respect to the Common Stock that is continuing, the Company shall not have received any notice from DTC to the effect that a suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic trading or
      book-entry services by DTC with respect to the Common Stock is being imposed or is contemplated (unless, prior to such suspension or restriction, DTC shall have notified the Company in writing that DTC has determined not to impose any such suspension
      or restriction).

   

  (viii) Certain Limitations. The issuance and sale of the
      Shares issuable pursuant to the applicable VWAP Purchase Notice shall not (a) exceed the applicable VWAP Purchase Maximum Amount, (b) cause the Aggregate Limit or the Beneficial Ownership Limitation to be exceeded, or (c) cause the Exchange Cap (to
      the extent applicable under Section 3.3) to be exceeded, unless (in the case of this clause (c)) the Company’s stockholders have theretofore approved the issuance of Common Stock under this Agreement in excess of the Exchange Cap in accordance with
      the applicable rules of the Principal Market.

   

  (ix) Shares Authorized and Delivered. All of the Shares
      issuable pursuant to the applicable VWAP Purchase Notice shall have been duly authorized by all necessary corporate action of the Company. All Shares relating to all prior VWAP Purchase Notices required to have been received by the Investor as DWAC
      Shares under this Agreement prior to the applicable VWAP Purchase Condition Satisfaction Time for the applicable VWAP Purchase shall have been delivered to the Investor as DWAC Shares in accordance with this Agreement.

   

  (x) Bring-Down Opinions of Company Counsel, Bring-Down Comfort
          Letters and Compliance Certificates. The Investor shall have received (a) all Bring-Down Opinions which the Company was obligated to instruct its outside counsel to deliver prior to the applicable VWAP Purchase Condition Satisfaction Time
      for the applicable VWAP Purchase, (b) all Bring-Down Comfort Letters which the Company was obligated to instruct delivery of prior to the applicable VWAP Purchase Condition Satisfaction Time for the applicable VWAP Purchase and (c) all Compliance
      Certificates which the Company was obligated to deliver prior to the applicable VWAP Purchase Condition Satisfaction Time for the applicable VWAP Purchase, in each case in accordance with Section 6.15.

  
    27

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  (xi) Material Non-Public Information. Neither the Company
      nor, in the Investor’s sole discretion, the Investor, shall be in possession of any material non-public information concerning the Company.

   

  ARTICLE VIII

      TERMINATION

   

  Section 8.1. Automatic Termination. Unless earlier
      terminated as provided hereunder, this Agreement shall terminate automatically on the earliest to occur of (i) the first (1st) day of the month next following the thirty-six (36)-month anniversary of the Effective Date of the Initial Registration
      Statement, (ii) the date on which the Investor shall have purchased the Total Commitment worth of Shares pursuant to this Agreement, (iii) the date on which the Common Stock shall have failed to be listed or quoted on the Principal Market or any
      Alternative Market, (iv) the date on which, pursuant to or within the meaning of any Bankruptcy Law, the Company commences a voluntary case or any Person commences a proceeding against the Company, (v) the date on which a Custodian is appointed for
      the Company or for all or substantially all of its property, or the Company makes a general assignment for the benefit of its creditors, and (vi) the termination of the Merger Agreement prior to the Merger Closing.

   

  Section 8.2. Other Termination. Subject to Section 8.3, the
      Company may terminate this Agreement after the Commencement Date effective upon ten (10) Trading Days’ prior written notice to the Investor in accordance with Section 10.4; provided, however, that (i) the Company shall have delivered
      the Upfront Commitment Fee to the Investor required to be paid pursuant to Section 10.1(ii) of this Agreement prior to such termination, and (ii) prior to issuing any press release, or making any public statement or announcement, with respect to such
      termination, the Company shall consult with the Investor and its counsel on the form and substance of such press release or other disclosure. Subject to Section 8.3, this Agreement may be terminated at any time by the mutual written consent of the
      parties, effective as of the date of such mutual written consent unless otherwise provided in such written consent. Subject to Section 8.3, the Investor shall have the right to terminate this Agreement effective upon ten (10) Trading Days’ prior
      written notice to the Company, which notice shall be made in accordance with Section 10.4 of this Agreement, if: (a) any condition, occurrence, state of facts or event constituting a Material Adverse Effect has occurred and is continuing; (b) a
      Fundamental Transaction shall have occurred (other than the Merger); (c) the Company is in breach or default in any material respect of any of its covenants and agreements in the Registration Rights Agreement, and, if such breach or default is
      capable of being cured, such breach or default is not cured within fifteen (15) Trading Days after notice of such breach or default is delivered to the Company pursuant to Section 10.4 of this Agreement; (d) while a Registration Statement, or any
      post-effective amendment thereto, is required to be maintained effective pursuant to the terms of the Registration Rights Agreement and the Investor holds any Registrable Securities, the effectiveness of such Registration Statement, or any
      post-effective amendment thereto, lapses for any reason (including, without limitation, the issuance of a stop order by the Commission) or such Registration Statement or any post-effective amendment thereto, the Prospectus contained therein or any
      Prospectus Supplement thereto otherwise becomes unavailable to the Investor for the resale of all of the Registrable Securities included therein in accordance with the terms of the Registration Rights Agreement, and such lapse or unavailability
      continues for a period of forty-five (45) consecutive Trading Days or for more than an aggregate of ninety (90) Trading Days in any three hundred and sixty-five (365)-day period, other than due to acts of the Investor; (e) trading in the Common Stock
      on the Principal Market shall have been suspended and such suspension continues for a period of five (5) consecutive Trading Days; (f) the Company is in material breach or default of any of its covenants and agreements contained in this Agreement,
      and, if such breach or default is capable of being cured, such breach or default is not cured within fifteen (15) Trading Days after notice of such breach or default is delivered to the Company pursuant to Section 10.4 of this Agreement or (g) there
      have been any developments, including any new or amended Contracts between the Company or any of its Subsidiaries and its customers or any changes in applicable law, that would reasonably be expected to result in a violation by the Company or any of
      its Subsidiaries of applicable law. In addition, the Investor shall have the right to terminate this Agreement immediately if, (1) on the seventh (7th) Trading Day following the Merger Closing, the aggregate market value of the outstanding voting and
      non-voting common equity (as defined in Securities Act Rule 405) of the Company, is less than $100 million (calculated by multiplying (x) the price at which the common equity of the Company closed on the Principal Market on such date by (y) the
      number of outstanding shares on such date) as of that date or (2) the Company receives a written notice from the Principal Market notifying the Company of the Principal Market’s intention to de-list the Company for reasons related to the Company’s
      violation of law. Unless notification thereof is required elsewhere in this Agreement (in which case such notification shall be provided in accordance with such other provision), the Company shall promptly (but in no event later than twenty-four (24)
      hours) notify the Investor (and, if required under applicable law, including, without limitation, Regulation FD promulgated by the Commission, or under the applicable rules and regulations of the Principal Market the Company shall publicly disclose
      such information in accordance with Regulation FD and the applicable rules and regulations of the Principal Market) upon becoming aware of any of the events set forth in the immediately preceding sentence.

  
    28

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 8.3. Effect of Termination. In the event of
      termination by the Company or the Investor (other than by mutual termination) pursuant to Section 8.2, written notice thereof shall forthwith be given to the other party as provided in Section 10.4 and the transactions contemplated by this Agreement
      shall be terminated without further action by either party. If this Agreement is terminated as provided in Section 8.1 or Section 8.2, this Agreement shall become void and of no further force and effect, except that (i) the provisions of Article IX
      (Indemnification), Article X (Miscellaneous) and this Article VIII (Termination) shall remain in full force and effect indefinitely notwithstanding such termination, and, (ii) so long as the Investor owns any Shares, the covenants and agreements of
      the Company contained in Article VI (Additional Covenants) shall remain in full force and notwithstanding such termination for a period of thirty (30) days following such termination. Notwithstanding anything in this Agreement to the contrary, no
      termination of this Agreement by any party shall (i) become effective prior to the second (2nd) Trading Day immediately following the date on which the purchase of Shares by the Investor pursuant to any pending VWAP Purchase has been fully settled,
      including, without limitation, the delivery by the Company to the Investor of all Shares purchased by the Investor pursuant to such pending VWAP Purchase as DWAC Shares on the applicable VWAP Purchase Share Delivery Date therefor, and the delivery by
      the Investor to the Company of the aggregate VWAP Purchase Price payable by the Investor for such Shares, in each case in accordance with the settlement procedures set forth in Section 3.2 of this Agreement (it being hereby acknowledged and agreed
      that no termination of this Agreement shall limit, alter, modify, change or otherwise affect any of the Company’s or the Investor’s rights or obligations under the Transaction Documents with respect to any pending VWAP Purchase that has not fully
      settled, and that the parties shall fully perform their respective obligations with respect to any such pending VWAP Purchase under the Transaction Documents), (ii) limit, alter, modify, change or otherwise affect the Company’s or the Investor’s
      rights or obligations under the Registration Rights Agreement, all of which shall survive any such termination, or (iii) affect the Upfront Commitment Fee to the extent payable to the Investor pursuant to Section 10.1(ii), it being hereby
      acknowledged and agreed that the entire amount of the Upfront Commitment Fee shall be fully earned by the Investor and shall be non-refundable as of the Merger Closing, regardless of whether any VWAP Purchases are made or settled hereunder or any
      subsequent termination of this Agreement. Nothing in this Section 8.3 shall be deemed to release the Company or the Investor from any liability for any breach or default under this Agreement, the Registration Rights Agreement or any of the other
      Transaction Documents to which it is a party, or to impair the rights of the Company and the Investor to compel specific performance by the other party of its obligations under this Agreement, the Registration Rights Agreement or any of the other
      Transaction Documents to which it is a party.

   

  ARTICLE IX

      INDEMNIFICATION

   

  Section 9.1. Indemnification of Investor. In consideration of the Investor’s
      execution and delivery of this Agreement and acquiring the Shares hereunder and in addition to all of the Company’s other obligations under the Transaction Documents to which it is a party, subject to the provisions of this Section 9.1, the Company
      shall indemnify, hold harmless and defend the Investor, its Affiliates, each of their respective directors, officers, shareholders, members, partners, employees, representatives and agents (and any other Persons with a functionally equivalent role of
      a Person holding such titles notwithstanding the lack of such title or any other title), each Person, if any, who controls the Investor (within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act), and the respective
      directors, officers, shareholders, members, partners, employees, representatives and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding the lack of such title or any other title) of such
      controlling Persons (each, an “Investor Party”), each of which shall be an express third-party beneficiary of this Article IX, from and against all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses
      (including all judgments, fines, penalties, charges, amounts paid in settlement, court costs, reasonable attorneys’ fees and costs of defense and investigation) (collectively, “Damages”) that any Investor Party may suffer or incur (a)
      as a result of, relating to or arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in any Commission Document (or any amendment thereto), or the omission or alleged omission therefrom of a
      material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included in any Commission Document, or the omission or
      alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that this indemnity in (a) shall not
      apply to any loss, liability, claim, damage or expense to the extent arising out of an untrue statement or omission, or alleged untrue statement or omission in a Commission Document, made in reliance upon and in conformity with information furnished
      in writing to the Company by the Investor expressly for use in connection with the preparation of the Registration Statement, Prospectus or Prospectus Supplement or any such amendment thereof or supplement thereto (it being hereby acknowledged and
      agreed that the written information set forth on Exhibit C to the Registration Rights Agreement is the only written information furnished to the Company by or on behalf of the Investor expressly for use in any Registration Statement,
      Prospectus or Prospectus Supplement), (b) to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any Governmental Authority, commenced or threatened, or of any claim whatsoever based upon any
      such untrue statement or omission, or any such alleged untrue statement or omission; provided that any such settlement is effected with the written consent of the Company, which consent shall not unreasonably be delayed, conditioned or
      withheld, (c) in investigating, preparing or defending against any litigation, or any investigation or proceeding by any Governmental Authority, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any
      such alleged untrue statement or omission (whether or not a party), to the extent that any such expense is not paid under (a) or (b) above, (d) as a result of, relating to or arising out of any breach by the Company of its representations,
      warranties, covenants or agreements under this Agreement, or (e) as a result of, relating to or arising out of any other action, suit, claim or proceeding against an Investor Party arising out of or otherwise in connection with the Transaction
      Documents (except in the case of this subsection (e), solely to the extent any Damage is determined by a court of competent jurisdiction, not subject to further appeal, to have resulted primarily and directly from the bad faith or gross negligence of
      such Investor Party). Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Investor Party.

  
    29

    
      
 

  

   

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  The Company shall reimburse any Investor Party promptly upon demand (with accompanying
      presentation of documentary evidence) for all legal and other costs and expenses reasonably incurred by such Investor Party in connection with (i) any action, suit, claim or proceeding, whether at law or in equity, to enforce compliance by the
      Company with any provision of the Transaction Documents or (ii) any other action, suit, claim or proceeding, whether at law or in equity, with respect to which it is entitled to indemnification under this Section 9.1.

   

  To the extent that the foregoing undertakings by the Company set forth in this Section 9.1
      may be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Damages which is permissible under applicable law, provided that in no event shall the Investor be obligated to
      contribute any amount in excess of the fees it actually receives pursuant to this Agreement.

   

  Section 9.2. Indemnification of the Company. In
      consideration of the Company’s execution and delivery of this Agreement and sale of the Shares hereunder and in addition to all of the Investor’s other obligations under the Transaction Documents to which it is a party, subject to the provisions of
      this Section 9.2, the Investor shall indemnify and hold harmless the Company, each of its directors, each of its officers who signs the Registration Statement and each Person, if any, who controls the Company within the meaning of Section 15 of the
      Securities Act or Section 20(a) the Exchange Act (each, a “Company Party”), from and against Damages that any Company Party may suffer or incur in connection with the claims described in clauses (a), (b), (c), (d) and (e) of Section
      9.1; provided that, such indemnity shall only be required to the extent the Damages occurred as a result of an untrue statement or omission, or alleged untrue statement or omission in a Commission Document, made in reliance upon and in
      conformity with information furnished in writing to the Company by the Investor expressly for the Company’s use in connection with the preparation of the Registration Statement, Prospectus or Prospectus Supplement or any such amendment thereof or
      supplement thereto (it being hereby acknowledged and agreed that the written information set forth on Exhibit C to the Registration Rights Agreement is the only written information furnished to the Company by or on behalf of the Investor
      expressly for use in any Registration Statement, Prospectus or Prospectus Supplement).

   

  Section 9.3. Indemnification Procedures. 

   

  (i) Promptly after an Investor Party receives notice of a claim or the commencement of an
      action for which the Investor Party intends to seek indemnification under Section 9.1, the Investor Party will notify the Company in writing of the claim or commencement of the action, suit or proceeding; provided, however, that
      failure to notify the Company will not relieve the Company from liability under Section 9.1, unless and solely to the extent it has been materially prejudiced by the failure to give such notice as evidenced by the forfeiture of by the Company of
      substantive rights or defenses. The Company will be entitled to participate in the defense of any claim, action, suit or proceeding as to which indemnification is being sought, and if the Company acknowledges in writing the obligation to indemnify
      the Investor Party against whom the claim or action is brought, the Company may (but will not be required to) assume the defense against the claim, action, suit or proceeding with counsel satisfactory to the Investor Party. After the Company notifies
      the Investor Party that the Company wishes to assume the defense of a claim, action, suit or proceeding, the Company will not be liable for any further legal or other expenses incurred by the Investor Party in connection with the defense against the
      claim, action, suit or proceeding unless (a) the employment of counsel by the Investor Party has been authorized in writing by the Company, (b) the Investor Party has reasonably concluded (based on advice of counsel) that there are legal defenses
      available to it or another Investor Party that are different from or in addition to those available to the Company, (c) a conflict or potential conflict exists (based on advice of counsel to the Investor Party) between an Investor Party and the
      Company (in which case the Company will not have the right to direct the defense of such action on behalf of the indemnified party) or (d) the Company has not in fact employed counsel to assume the defense of such action or counsel reasonably
      satisfactory to the indemnified party, in each case, within a reasonable time after receiving notice of the commencement of the action; in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the expense of
      the Company. The Company shall keep the Investor Party reasonably apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. It is understood that the Company shall not, in connection with any
      proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm (plus local counsel) admitted to practice in such jurisdiction at any one time for all such
      similarly situated Investor Parties. The Company will not be liable for any settlement of any action effected without its prior written consent, which consent shall not be unreasonably withheld, delayed or conditioned. The Company shall not, without
      the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this section (whether or not any
      indemnified party is a party thereto), unless such settlement, compromise or consent (x) includes an express and unconditional release of each indemnified party, in form and substance reasonably satisfactory to such indemnified party, from all
      liability arising out of such litigation, investigation, proceeding or claim and (y) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.

  
    30

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  (ii) In order to provide for just and equitable contribution in
      circumstances in which the indemnification provided for in the foregoing paragraphs of this Article IX for any reason is held to be unavailable or insufficient to hold an Investor Party harmless, the Company and the Investor Party will contribute to
      the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted) to
      which the Company and the Investor Party may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Investor on the other hand. The relative benefits received by the
      Company on the one hand and the Investor Party on the other hand shall be deemed to be in the same proportion as the total net proceeds from the aggregate of all VWAP Purchase Amounts (before deducting expenses) received by the Company bear to the
      total proceeds received by the Investor for the sale of Shares to bona fide third parties net of the aggregate VWAP Purchase Price paid to the Company under this Agreement. If, but only if, the allocation provided by the foregoing sentence is not
      permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one
      hand, and the Investor Party, on the other hand, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with
      respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information
      supplied by the Company or the Investor Party, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Investor agree that it would not be
      just and equitable if contributions pursuant to this Section 9.3(ii) were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or
      payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred to above in this Section 9.3(ii) shall be deemed to include, for the purpose of this Section 9.3(ii), any legal or
      other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with Section 9.3(i) hereof. Notwithstanding the foregoing provisions of this Section 9.3(ii),
      the Investor shall not be required to contribute any amount in excess of the aggregate discount to the VWAP for all purchases made under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
      the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 9.3(ii), any person who controls a party to this Agreement within the meaning of the Securities
      Act, any Affiliates of the Investor Party and any officers, directors, partners, employees or agents of the Investor Party or any of its Affiliates, will have the same rights to contribution as that party, and each director of the Company and each
      officer of the Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement
      of any action against such party in respect of which a claim for contribution may be made under this Section 9.3(ii), will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that
      party or parties from whom contribution may be sought from any other obligation it or they may have under this Section 9.3(ii) except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or
      defenses of the party from whom contribution is sought. No party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to Section 9.3(i) hereof.

  
    31

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  The remedies provided for in this Article IX are not exclusive and shall not limit any
      rights or remedies which may otherwise be available to any Investor Party at law or in equity.

   

  ARTICLE X

      MISCELLANEOUS

   

  Section 10.1. Certain Fees and Expenses; Upfront Commitment Fee;
          Commencement Irrevocable Transfer Agent Instructions. 

   

  (i) Certain Fees and Expenses. Each party shall bear its
      own fees and expenses related to the transactions contemplated by this Agreement except that the Company will reimburse the fees and disbursements of legal counsel to the Investor in an amount not to exceed $75,000 in connection with the entry into
      this Agreement and not to exceed $25,000 per fiscal quarter in connection with the Investor’s ongoing due diligence and review of deliverables subject to Section 6.15. The Company shall pay all U.S. federal, state and local stamp and other similar
      transfer and other taxes and duties levied in connection with issuance of the Shares pursuant hereto.

   

  (ii) Upfront Commitment Fee. In consideration for the Investor’s execution and
      delivery of this Agreement, the Company shall deliver or cause to be delivered to the Investor the Upfront Commitment Fee on or prior to the Commencement, in accordance with instructions provided by the Investor on or prior to such date. For the
      avoidance of doubt, the entire amount of the Upfront Commitment Fee shall be fully earned by the Investor and shall be non-refundable as of the Merger Closing, regardless of whether any VWAP Purchases are made or settled hereunder or any subsequent
      termination of this Agreement.

   

  (iii) Irrevocable Transfer Agent Instructions; Notice of Effectiveness. On the
      Effective Date of the Initial Registration Statement and prior to Commencement, the Company shall deliver or cause to be delivered to its Transfer Agent (including delivery to any successor thereof), (a) irrevocable instructions executed by the
      Company to be acknowledged in writing by the Transfer Agent (the “Commencement Irrevocable Transfer Agent Instructions”) and (b) the notice of effectiveness in the form attached as an exhibit to the Registration Rights Agreement (the “Notice

          of Effectiveness”) relating to the Initial Registration Statement executed by the Company’s outside counsel, in each case directing the Transfer Agent to issue to the Investor or its designated Broker-Dealer at which the account or
      accounts to be credited with the Shares being purchased by the Investor are maintained any Registrable Securities included in the Initial Registration Statement as DWAC Shares, if and when such Registrable Securities are issued in accordance with
      this Agreement and the Registration Rights Agreement. With respect to any post-effective amendment to the Initial Registration Statement, any New Registration Statement or any post-effective amendment to any New Registration Statement, in each case
      becoming effective after the Commencement Date, the Company shall deliver or cause to be delivered to its Transfer Agent (including delivery to any successor thereof) (x) irrevocable instructions in the form substantially similar to the Commencement
      Irrevocable Transfer Agent Instructions executed by the Company and to be acknowledged in writing by the Transfer Agent and (y) the Notice of Effectiveness, in each case modified as necessary to refer to such Registration Statement or post-effective
      amendment and the Registrable Securities included therein, to issue the Registrable Securities included therein as DWAC Shares in accordance with the terms of this Agreement and the Registration Rights Agreement. For the avoidance of doubt, all
      Shares to be issued in respect of any VWAP Purchase Notice delivered to the Investor pursuant to this Agreement shall be issued to the Investor in accordance with Section 3.2 by crediting the Investor’s account at DTC as DWAC Shares, and the Company
      shall not take any action or give instructions to any Transfer Agent of the Company otherwise. The Company represents and warrants to the Investor that, while this Agreement is effective, no instruction other than those referred to in this Section
      10.1(iii) will be given by the Company to its Transfer Agent with respect to the Shares from and after Commencement, and the Registrable Securities covered by the Initial Registration Statement or any post-effective amendment thereof, or any New
      Registration Statement or post-effective amendment thereof, as applicable, shall otherwise be freely transferable on the books and records of the Company and no stop transfer instructions shall be maintained against the transfer thereof. The Company
      agrees that if the Company fails to fully comply with the provisions of this Section 10.1(iii) within three (3) Trading Days after the date on which the Investor has provided any deliverables that the Investor may be required to provide to the
      Company or its Transfer Agent (if any), the Company shall, at the Investor’s written instruction, purchase from the Investor all shares of Common Stock purchased or acquired by the Investor pursuant to this Agreement that contain any restrictive
      legend or that have any stop transfer orders maintained that prohibit or impede the transfer thereof in any respect at the greater of (i) the purchase price paid by the Investor for such shares of Common Stock (as applicable) and (ii) the Closing
      Sale Price of the Common Stock on the date of the Investor’s written instruction.

  
    32

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 10.2. Specific Enforcement; Consent to Jurisdiction; Waiver
          of Jury Trial. 

   

  (i) The Company and the Investor acknowledge and agree that irreparable
      damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that either party shall be entitled to an injunction or
      injunctions to prevent or cure breaches of the provisions of this Agreement by the other party and to enforce specifically the terms and provisions hereof (without the necessity of showing economic loss and without any bond or other security being
      required), this being in addition to any other remedy to which either party may be entitled by law or equity.

   

  (ii) Each of the Company and the Investor (a) hereby irrevocably submits
      to the jurisdiction of the U.S. District Court and other courts of the United States sitting in the State of New York for the purposes of any suit, action or proceeding arising out of or relating to this Agreement, and (b) hereby waives, and agrees
      not to assert in any such suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or
      proceeding is improper. Each of the Company and the Investor consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address in effect for notices to it under this Agreement and agrees
      that such service shall constitute good and sufficient service of process and notice thereof. Nothing in this Section 10.2 shall affect or limit any right to serve process in any other manner permitted by law.

   

  (iii) EACH OF THE COMPANY AND THE INVESTOR HEREBY WAIVES TO THE FULLEST
      EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR DISPUTES RELATING
      HERETO. EACH OF THE COMPANY AND THE INVESTOR (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE
      FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 10.2.

   

  Section 10.3. Entire Agreement. The Transaction Documents
      set forth the entire agreement and understanding of the parties with respect to the subject matter hereof and supersede all prior and contemporaneous agreements, negotiations and understandings between the parties, both oral and written, with respect
      to such matters. There are no promises, undertakings, representations or warranties by either party relative to subject matter hereof not expressly set forth in the Transaction Documents. All exhibits to this Agreement are hereby incorporated by
      reference in, and made a part of, this Agreement as if set forth in full herein.

  
    33

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 10.4. Notices. Any notice, demand, request, waiver
      or other communication required or permitted to be given hereunder shall be in writing and shall be effective (a) upon hand delivery or electronic mail delivery at the address or number designated below (if delivered on a business day during normal
      business hours where such notice is to be received), or the first (1st) business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second (2nd)
      business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The address for such communications shall be:

   

  If to the Company: 

  

    Tuatara Capital Acquisition Corporation 

  655 Third Avenue, 8th Floor 

  New York, NY 10017 

  Telephone Number: [***] 

  Email: [***] 

  Attention: [***]

   

  With a copy (which shall not constitute notice) to: 

  Davis, Polk & Wardwell, LLP 

  450 Lexington Avenue 

  New York, NY 10017 

  Email: [***] 

  Attention: Derek Dostal and Leonard Kreynin

   

  and:

   

  SpringBig, Inc. 

  621 NW 53rd Street, Suite 250 

  Boca Raton, FL 33487 

  Email: [***] 

  Attention: [***]

   

  With a copy (which shall not constitute notice) to:

   

  Benesch, Friedlander, Coplan & Aronoff, LLP 

  71 South Wacker Drive, Suite 1600 

  Chicago, IL 60606 

  Email: [***]

   

  Attention: Sarah Hesse

   

  If to the Investor:

   

  CF Principal Investments LLC 

  499 Park Avenue 

  New York, NY 10022 

  Attention: COO 

  Email: [***]

   

  and:

   

  CF Principal Investments LLC 499 Park Avenue 

  New York, NY 10022 

  Attention: General Counsel 

  Facsimile: (212) 829-4708 

  Email:[***]

  
    34

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  With a copy (which shall not constitute notice) to:

   

  Covington & Burling LLP 

  The New York Times Building 

  620 Eighth Avenue 

  New York, NY 10018 

  Email: [***] 

  Attention: Matthew T. Gehl; Charlotte May

   

  Either party hereto may from time to time change its address for notices by giving at least
      five (5) days’ advance written notice of such changed address to the other party hereto.

   

  Section 10.5. Waivers. No provision of this Agreement may
      be waived by the parties from and after the date that is one (1) Trading Day immediately preceding the filing of the Initial Registration Statement with the Commission. Subject to the immediately preceding sentence, no provision of this Agreement may
      be waived other than in a written instrument signed by the party against whom enforcement of such waiver is sought. No failure or delay in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single
      or partial exercise of any such power, right or privilege preclude other or further exercises thereof or of any other right, power or privilege.

   

  Section 10.6. Amendments. No provision of this Agreement
      may be amended by the parties from and after the date that is one (1) Trading Day immediately preceding the filing of the Initial Registration Statement with the Commission. Subject to the immediately preceding sentence, no provision of this
      Agreement may be amended other than by a written instrument signed by both parties hereto.

   

  Section 10.7. Headings. The article, section and subsection
      headings in this Agreement are for convenience only and shall not constitute a part of this Agreement for any other purpose and shall not be deemed to limit or affect any of the provisions hereof. Unless the context clearly indicates otherwise, each
      pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms “including,” “includes,” “include” and words of like import shall be construed broadly as if followed by the words “without
      limitation.” The terms “herein,” “hereunder,” “hereof” and words of like import refer to this entire Agreement instead of just the provision in which they are found.

   

  Section 10.8. Construction. The parties agree that each of
      them and their respective counsel has reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be
      employed in the interpretation of the Transaction Documents. In addition, each and every reference to share prices (including the Threshold Price) and number of shares of Common Stock in any Transaction Document shall, in all cases, be subject to
      adjustment for any stock splits, stock combinations, stock dividends, recapitalizations, reorganizations and other similar transactions that occur on or after the date of this Agreement. Any reference in this Agreement to “Dollars” or “$” shall mean
      the lawful currency of the United States of America. Any references to “Section” or “Article” in this Agreement shall, unless otherwise expressly stated herein, refer to the applicable Section or Article of this Agreement. The use of the word
      “including” herein shall not be considered to limit the provision which it modifies but instead shall mean “including, without limitation.”

   

  Section 10.9. Binding Effect. This Agreement shall be
      binding upon and inure to the benefit of the parties hereto and their respective successors. Neither the Company nor the Investor may assign this Agreement or any of their respective rights or obligations hereunder to any Person, except as provided
      in this paragraph. Following the Merger, this Agreement shall be deemed to have been assigned to the publicly listed company resulting from the Merger, and all references herein to the Company shall be deemed to refer to such publicly listed company.

   

  Section 10.10. No Third Party Beneficiaries. Except as
      expressly provided in Article IX, this Agreement is intended only for the benefit of the parties hereto and their respective successors, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

  
    35

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  Section 10.11. Governing Law. This Agreement shall be
      governed by and construed in accordance with the internal procedural and substantive laws of the State of New York, without giving effect to the choice of law provisions of such state that would cause the application of the laws of any other
      jurisdiction.

   

  Section 10.12. Survival. The representations, warranties,
      covenants and agreements of the Company and the Investor contained in this Agreement shall survive the execution and delivery hereof until the termination of this Agreement; provided, however, that (i) the provisions of Article VIII
      (Termination), Article IX (Indemnification) and this Article X (Miscellaneous) shall remain in full force and effect indefinitely notwithstanding such termination, and, (ii) so long as the Investor owns any Shares, the covenants and agreements of the
      Company and the Investor contained in Article VI (Additional Covenants), shall remain in full force and effect notwithstanding such termination for a period of thirty (30) days following such termination.

   

  Section 10.13. Counterparts. This Agreement may be executed
      in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile
      signature or signature delivered by e-mail in a “.pdf” format data file, including any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and
      shall be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.

   

  Section 10.14. Publicity. The Company shall afford the
      Investor and its counsel a reasonable opportunity to review and comment upon, shall consult with the Investor and its counsel on the form and substance of, and shall give due consideration to all such comments from the Investor or its counsel on, any
      press release, Commission filing or any other public disclosure made by or on behalf of the Company relating to the Investor, its purchases hereunder or any aspect of the Transaction Documents or the transactions contemplated thereby, prior to the
      issuance, filing or public disclosure thereof. For the avoidance of doubt, the Company shall not be required to submit for review any such disclosure (i) contained in periodic reports filed with the Commission under the Exchange Act if it shall have
      previously provided the same disclosure to the Investor or its counsel for review in connection with a previous filing or (ii) any Prospectus Supplement if it contains disclosure that does not reference the Investor, its purchases hereunder or any
      aspect of the Transaction Documents or the transactions contemplated thereby.

   

  Section 10.15. Severability. The provisions of this
      Agreement are severable and, in the event that any court of competent jurisdiction shall determine that any one or more of the provisions or part of the provisions contained in this Agreement shall, for any reason, be held to be invalid, illegal or
      unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision of this Agreement, and this Agreement shall be reformed and construed as if such invalid or illegal or
      unenforceable provision, or part of such provision, had never been contained herein, so that such provisions would be valid, legal and enforceable to the maximum extent possible.

   

  Section 10.16. Further Assurances. From and after the date
      of this Agreement, upon the request of the Investor or the Company, each of the Company and the Investor shall execute and deliver such instrument, documents and other writings as may be reasonably necessary or desirable to confirm and carry out and
      to effectuate fully the intent and purposes of this Agreement.

  
    36

    
      
 

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective
      authorized officer as of the date first above written.

   

  	 	Tuatara Capital Acquisition Corporation

  	 	 	 
	 	By:	/s/ Albert Foreman

  	 	Name: Albert Foreman
	 	Title: Chief Executive Officer

  	 	 
	 	CF Principal Investments LLC

  	 	 	 
	 	By:	/s/ Mark Kaplan

        

  	 	Name: Mark Kaplan
	 	Title: Global Chief Operating Officer

          

   

  

  [Signature Page to Equity Line Agreement]

  

  

  
    
      
 

  

  

   

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  ANNEX I TO THE 

  

  COMMON STOCK PURCHASE AGREEMENT 

  

  DEFINITIONS 

   

  “Affiliate” shall mean any Person that, directly or indirectly through one or more intermediaries,
      controls, is controlled by, or is under common control with a Person, as such terms are used in and construed under Rule 144.

   

  “Aggregate Limit” shall have the meaning assigned to such term in Section 2.1 of this Agreement.

   

  “Agreement” shall have the meaning assigned to such term in the introductory paragraph hereto.

   

  “Alternative Market” shall mean the New York Stock Exchange, the NYSE American, the Nasdaq Global
      Select Market or the Nasdaq Capital Market.

   

  “Anti-Corruption Laws” shall have the meaning assigned to such term in Section 5.23 of this
      Agreement.

   

  “Bankruptcy Law” shall mean Title 11, U.S. Code, or any similar U.S. federal or state law for the
      relief of debtors.

   

  “Beneficial Ownership Limitation” shall have the meaning assigned to such term in Section 3.4 of
      this Agreement.

   

  “Block” shall mean any trade in excess of 100,000 Shares on a single Trading Day to a single
      purchaser, as reported on Bloomberg through its “VWAP” function.

   

  “Bloomberg” shall mean Bloomberg, L.P.

   

  “Bring-Down Comfort Letter” shall have the meaning assigned to such term in Section 6.15 of this
      Agreement.

   

  “Bring-Down Opinion” shall have the meaning assigned to such term in Section 6.15 of this
      Agreement.

   

  “Broker-Dealer” shall have the meaning assigned to such term in Section 6.13 of this Agreement.

   

  “Bylaws” shall have the meaning assigned to such term in Section 5.4 of this Agreement.

   

  “Cannabis Laws” shall have the meaning assigned to such term in Section 5.23 of this Agreement.

   

  “CCPA” shall have the meaning assigned to such term in Section 5.39(i) of this Agreement.

   

  “CF&CO” shall have the meaning assigned to such term in the recitals of this Agreement.

   

  “Charter” shall have the meaning assigned to such term in Section 5.4 of this Agreement.

   

  “Closing” shall mean the closing of the transactions contemplated by this Agreement.

   

  “Closing Date” shall mean the date mutually agreed to by the Company and the Investor on which the
      Closing shall occur, which date shall be on or following the Merger Closing and no later than one business day prior to the date the Initial Registration Statement is filed with the Commission, and on which date the conditions set forth in Section
      7.1 shall have been satisfied.

   

  “Closing Sale Price” shall mean, for the Common Stock as of any date, the last closing trade price
      for the Common Stock on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing trade price for the Common Stock, then the last trade price for the
      Common Stock prior to 4:00 p.m., New York City time, as reported by Bloomberg. All such determinations shall be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions during
      such period.

   

  

  
     

    
      
 

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  “Code” shall have the meaning assigned to such term in Section 5.29 of this Agreement.

   

  “Commencement” shall have the meaning assigned to such term in Section 3.1 of this Agreement.

   

  “Commencement Date” shall have the meaning assigned to such term in Section 3.1 of this Agreement.

   

  “Commencement Irrevocable Transfer Agent Instructions” shall have the meaning assigned to such term
      in Section 10.1(iii).

   

  “Commission” shall mean the U.S. Securities and Exchange Commission or any successor entity.

   

  “Commission Documents” shall mean (i) with respect to any date prior to the Commencement Date, the
      Company’s S-4 Registration Statement and any proxy statement or prospectus filed by the Company with the Commission, including all documents incorporated or deemed incorporated therein by reference, whether or not included in a registration statement
      on Form S-4, in the form in which such proxy statement or prospectus has most recently been filed with the Commission pursuant to Rule 424(b) under the Securities Act, (ii) all reports, schedules, registrations, forms, statements, information and
      other documents filed with or furnished to the Commission by the Company pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act since February 11, 2021, including, without limitation, the current report, and (iii) with respect to the
      Commencement Date and any date thereafter, each effective Registration Statement, as the same may be amended from time to time, the Prospectus contained therein and each Prospectus Supplement thereto and all information contained in such filings and
      all documents and disclosures that have been and or may in the future be incorporated by reference therein.

   

  “Common Stock” shall have the meaning assigned to such term in the recitals of this Agreement.

   

  “Common Stock Equivalents” shall mean any securities of the Company or its Subsidiaries which
      entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or
      otherwise entitles the holder thereof to receive, Common Stock.

   

  “Company” shall have the meaning assigned to such term in the introductory paragraph of this
      Agreement.

   

  “Compliance Certificate” shall have the meaning assigned to such term in Section 7.2(v) of this
      Agreement.

   

  “Confidential Data” shall have the meaning assigned to such term in Section 5.39(i) of this
      Agreement.

   

  “Contract” shall mean any written or oral legally binding contract, agreement, understanding,
      arrangement, subcontract, loan or credit agreement, note, bond, indenture, mortgage, purchase order, deed of trust, lease, sublease, instrument, or other legally binding commitment, obligation or undertaking.

   

  “Cover Price” shall have the meaning assigned to such term in Section 3.2 of this Agreement.

   

  “Current Report” shall have the meaning assigned to such term in Section 2.3 of this Agreement.

   

  “Custodian” shall mean any receiver, trustee, assignee, liquidator or similar official under any
      Bankruptcy Law.

   

  “Damages” shall have the meaning assigned to such term in Section 9.1 of this Agreement.

   

  “Disclosure Schedule” shall have the meaning assigned to such term in Section 6.14 of this
      Agreement.

   

  “DTC” shall mean The Depository Trust Company, a subsidiary of The Depository Trust & Clearing
      Corporation, or any successor thereto.

   

  

  
     

    
      
 

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  “DWAC” shall have the meaning assigned to such term in Section 5.36 of this Agreement.

   

  “DWAC Shares” shall mean shares of Common Stock issued pursuant to this Agreement that are (i)
      issued in electronic form, (ii) freely tradable and transferable and without restriction on resale and without stop transfer instructions maintained against the transfer thereof and (iii) timely credited by the Company to the Investor’s or its
      designated Broker-Dealer at which the account or accounts to be credited with the Shares being purchased by Investor are maintained specified DWAC account with DTC under its Fast Automated Securities Transfer (FAST) Program, or any similar program
      hereafter adopted by DTC performing substantially the same function.

   

  “EDGAR” shall mean the Commission’s Electronic Data Gathering, Analysis and Retrieval System.

   

  “Effective Date” shall mean, with respect to the Initial Registration Statement filed pursuant to
      Section 2(a) of the Registration Rights Agreement (or any post-effective amendment thereto) or any New Registration Statement filed pursuant to Section 2(c) of the Registration Rights Agreement (or any post-effective amendment thereto), as
      applicable, the date on which the Initial Registration Statement (or any post-effective amendment thereto) or any New Registration Statement (or any post-effective amendment thereto) becomes effective.

   

  “Entity” shall have the meaning assigned to such term in Section 5.38 of this Agreement.

   

  “Environmental Laws” shall have the meaning assigned to such term in Section 5.21 of this
      Agreement.

   

  “ERISA” shall have the meaning assigned to such term in Section 5.29 of this Agreement.

   

  “ERISA Affiliate” shall have the meaning assigned to such term in Section 5.29 of this Agreement.

   

  “Excess Shares” shall having the meaning assigned to such term in Section 3.1 of this Agreement.

   

  “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and
      regulations of the Commission thereunder.

   

  “Exchange Cap” shall have the meaning assigned to such term in Section 3.3(i) of this Agreement.

   

  “Exempt Issuance” shall mean the issuance of (i) Common Stock, options or other equity incentive
      awards to employees, officers, directors or vendors of the Company pursuant to any equity incentive plan duly adopted for such purpose, by the Company’s Board of Directors or a majority of the members of a committee of the Board of Directors
      established for such purpose, (ii) (a) any Shares issued to the Investor pursuant to this Agreement, (b) any securities issued upon the exercise or exchange of or conversion of any shares of Common Stock or Common Stock Equivalents held by the
      Investor at any time, or (c) any securities issued upon the exercise or exchange of or conversion of any Common Stock Equivalents issued and outstanding on the date of this Agreement, provided that such securities referred to in this clause (c) have
      not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities, (iii) securities issued pursuant to acquisitions, divestitures,
      licenses, partnerships, collaborations or strategic transactions approved by the Company’s Board of Directors or a majority of the members of a committee of directors established for such purpose, which acquisitions, divestitures, licenses,
      partnerships, collaborations or strategic transactions can have a Variable Rate Transaction component, provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries, an
      operating company or an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing
      securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities, (iv) Common Stock issued by the Company to the Investor or an Affiliate of the Investor in connection with any “equity line of
      credit” or other continuous offering or similar offering of Common Stock pursuant to a written agreement between the Company and the Investor or an Affiliate of the Investor, whereby the Company may sell Common Stock to the Investor or an Affiliate
      of the Investor at a future determined price, or (v) Common Stock issued by the Company by any method deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act, exclusively to or through CF&CO, as the
      Company’s sales agent, pursuant to one or more written agreements between the Company and CF&CO.

   

  

  
     

    
      
 

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  “FINRA” shall have the meaning assigned to such term in Section 4.3 of this Agreement.

   

  “Fundamental Transaction” shall mean that (i) the Company shall, directly or indirectly, in one or
      more related transactions, (a) consolidate or merge with or into (whether or not the Company is the surviving corporation) another Person, with the result that the holders of the Company’s capital stock immediately prior to such consolidation or
      merger together beneficially own less than 50% of the outstanding voting power of the surviving or resulting corporation, (b) sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets
      of the Company to another Person, (c) take action to facilitate a purchase, tender or exchange offer by another Person that is accepted by the holders of more than 50% of the outstanding shares of Common Stock (excluding any shares of Common Stock
      held by the Person or Persons making or party to, or associated or affiliated with the Persons making or party to, such purchase, tender or exchange offer), (d) consummate a stock or share purchase agreement or other business combination (including,
      without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held
      by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination), or (e) reorganize, recapitalize or reclassify its
      Common Stock, or (ii) any “person” or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act) is or shall become the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly,
      of 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock.

   

  “GAAP” shall have the meaning assigned to such term in Section 5.7(ii) of this Agreement.

   

  “GDPR” shall have the meaning assigned to such term in Section 5.39(i) of this Agreement.

   

  “Governmental Authority” shall mean (i) any federal, provincial, state, local, municipal, national
      or international government or governmental authority, regulatory or administrative agency, governmental commission, department, board, bureau, agency or instrumentality, court, tribunal, arbitrator or arbitral body (public or private); (ii) any
      self-regulatory organization; or (iii) any political subdivision of any of the foregoing.

   

  “HIPAA” shall have the meaning assigned to such term in Section 5.39(i) of this Agreement.

   

  “Initial Registration Statement” shall have the meaning assigned to such term in the Registration
      Rights Agreement.

   

  “Intellectual Property” shall have the meaning assigned to such term in Section 5.13 of this
      Agreement.

   

  “Investment Period” shall mean the period commencing on the Effective Date of the Initial
      Registration Statement and expiring on the date this Agreement is terminated pursuant to Article VIII.

   

  “Investor” shall have the meaning assigned to such term in the introductory paragraph of this
      Agreement.

   

  “Investor Party” shall have the meaning assigned to such term in Section 9.1 of this Agreement.

   

  “IT Systems” shall have the meaning assigned to such term in Section 5.39(i) of this Agreement.

   

  “Knowledge” shall mean the actual knowledge of the Company’s Chief Executive Officer and the
      Company’s Chief Financial Officer, in each case after reasonable inquiry.

   

  “Material Adverse Effect” shall have the meaning assigned to such term in Section 5.1 of this
      Agreement.

   

  “Material Contracts” shall mean any other Contract that is expressly referred to in or filed or
      incorporated by reference as an exhibit to a Commission Document or that, if terminated or subject to default by a party thereto would, individually or in the aggregate, have a Material Adverse Effect.

   

  

  
     

    
      
 

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  “Merger” shall have the meaning assigned to such term in the introductory paragraph of this
      Agreement.

   

  “Merger Agreement” shall have the meaning assigned to such term in the introductory paragraph of
      this Agreement.

   

  “Merger Closing” shall have the meaning assigned to such term in the recitals of this Agreement.

   

  “Money Laundering Laws” shall have the meaning assigned to such term in Section 5.23 of this
      Agreement.

   

  “New Registration Statement” shall have the meaning assigned to such term in the Registration
      Rights Agreement.

   

  “Notice of Effectiveness” shall have the meaning assigned to such term in Section 10.1(iii).

   

  “OFAC” shall have the meaning assigned to such term in Section 5.38 of this Agreement.

   

  “Permits” shall have the meaning assigned to such term in Section 5.20 of this Agreement.

   

  “Person” shall mean any person or entity, whether a natural person, trustee, corporation,
      partnership, limited partnership, limited liability company, trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.

   

  “Personal Data” shall have the meaning assigned to such term in Section 5.39(i) of this Agreement.

   

  “Policies” shall have the meaning assigned to such term in Section 5.39(ii) of this Agreement.

   

  “Post-Effective Amendment Period” shall mean the period commencing at 9:30 a.m., New York City
      time, on the fifth (5th) Trading Day immediately prior to the filing of any post-effective amendment to the Initial Registration Statement or any New Registration Statement, and ending at 9:30 a.m., New York City time, on the Trading Day immediately
      following, the Effective Date of such post-effective amendment.

   

  “Principal Market” shall mean the Nasdaq Global Market; provided,
        however, that in the event the Company’s Common Stock is ever listed or traded on an Alternative Market, then the “Principal Market” shall mean such Alternative Market on which the Company’s Common Stock is then listed or traded.

   

  “Privacy Laws” shall have the meaning assigned to such term in Section 5.39(ii) of this Agreement.

   

  “Prospectus” shall mean the prospectus in the form included in a Registration Statement, as
      supplemented from time to time by any Prospectus Supplement, including the documents incorporated by reference therein.

   

  “Prospectus Supplement” shall mean any prospectus supplement to the Prospectus filed with the
      Commission from time to time pursuant to Rule 424(b) under the Securities Act, including the documents incorporated by reference therein.

   

  “Qualified Independent Underwriter” shall have the meaning assigned to such term in FINRA Rule
      5121(f)(12).

   

  “Registrable Securities” shall have the meaning assigned to such term in the Registration Rights
      Agreement.

   

  “Registration Period” shall have the meaning assigned to such term in the Registration Rights
      Agreement.

   

  “Registration Rights Agreement” shall have the meaning assigned to such term in the recitals of
      this Agreement.

   

  “Registration Statement” shall have the meaning assigned to such term in the Registration Rights
      Agreement.

   

  “Regulation D” shall have the meaning assigned to such term in the recitals of this Agreement.

   

  “Representation Date” shall have the meaning assigned to such term in Section 6.15 of this
      Agreement.

   

  

  
     

    
      
 

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  “Restricted Period” shall have the meaning assigned to such term in Section 6.9(i) of this
      Agreement.

   

  “Restricted Persons” shall have the meaning assigned to such term in Section 6.9(i) of this
      Agreement.

   

  “Rule 144” shall mean Rule 144 promulgated by the Commission pursuant to the Securities Act, as
      such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect.

   

  “S-4 Registration Statement” shall mean the Company’s registration statement on Form S-4 (File No.
      333-262628) initially filed with the Commission on February 10, 2022, including any related prospectus or prospectuses, for the registration of the Common Stock to be issued pursuant to the Merger Agreement, as amended and on file with the Commission
      at the time such registration statement became effective, including the financial statements, schedules, exhibits and all other documents filed as a part thereof or incorporated therein and all information deemed to be a part thereof as of the
      effective date of such registration statement under the Securities Act.

   

  “Sale Price” shall mean any trade price for the shares of
        Common Stock on the Principal Market during normal trading hours, as reported by the Principal Market.

   

  “Sanctioned Countries” shall have the meaning assigned to such term in Section 5.38 of this
      Agreement.

   

  “Sanctions” shall have the meaning assigned to such term in Section 5.38 of this Agreement.

   

  “Sarbanes-Oxley Act” shall have the meaning assigned to such term in Section 5.7(iii) of this
      Agreement.

   

  “Secretary’s Certificate” shall have the meaning assigned to such term in Section 7.2(v) of this
      Agreement.

   

  “Section 4(a)(2)” shall have the meaning assigned to such term in the recitals of this Agreement.

   

  “Securities Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations
      of the Commission thereunder.

   

  “Share Delivery Deadline” shall have the meaning set forth in Section 3.2 of this Agreement.

   

  “Shares” shall mean the shares of Common Stock that are and/or may be purchased by the Investor
      under this Agreement pursuant to one or more VWAP Purchase Notices.

   

  “Short Sales” shall mean “short sales” as defined in Rule 200 promulgated under Regulation SHO
      under the Exchange Act.

   

  “Subsidiary” shall mean any corporation or other entity, of which at least a majority of the
      securities or other ownership interest having ordinary voting power for the election of directors or other persons performing similar functions are at the time owned directly or indirectly by the Company and/or any of its other Subsidiaries.

   

  “Suspension” shall have the meaning assigned to such term in Section 6.15 of this Agreement.

   

  “Threshold Price” shall mean with respect to any particular VWAP Purchase Notice, the Sale Price on
      the VWAP Purchase Date equal to the greater of (i) 90% of the Closing Sale Price on the Trading Day immediately preceding the VWAP Purchase Date or (ii) such higher price as set forth by the Company in the VWAP Purchase Notice.

   

  “Total Commitment” shall have the meaning assigned to such term in Section 2.1.

   

  “Trading Day” shall mean any day on which the Principal Market is open for trading (regular way),
      including any day on which the Principal Market is open for trading (regular way) for a period of time less than the customary time.

   

  

  
     

    
      
 

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  “Transaction Documents” shall mean, collectively, this Agreement (as qualified by the Commission
      Documents) and the exhibits hereto, the Registration Rights Agreement and the exhibits thereto, and each of the other agreements, documents, certificates and instruments entered into or furnished by the parties hereto in connection with the
      transactions contemplated hereby and thereby.

   

  “Transfer Agent” shall mean Continental Stock Transfer & Trust Company or any successor thereof
      as the Company’s transfer agent.

   

  “Upfront Commitment Fee” shall mean a number of shares of Common Stock equal to the quotient
      obtained by dividing (1) $1,500,000 and (ii) the VWAP over the five Trading Days immediately preceding the filing of the Initial Registration Statement with the Commission.

   

  “Variable Rate Transaction” shall mean a transaction in which the Company (i) issues or sells any
      equity or debt securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock or Common Stock Equivalents either (a) at a conversion price, exercise price, exchange rate or
      other price that is based upon and/or varies with the trading prices of or quotations for the Common Stock at any time after the initial issuance of such equity or debt securities, or (b) with a conversion, exercise or exchange price that is subject
      to being reset at some future date after the initial issuance of such equity or debt security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock
      (including, without limitation, any “full ratchet” or “weighted average” anti-dilution provisions, but not including any standard anti-dilution protection for any reorganization, recapitalization, non-cash dividend, stock split or other similar
      transaction), (ii) issues or sells any equity or debt securities, including without limitation, Common Stock or Common Stock Equivalents, either (a) at a price that is subject to being reset at some future date after the initial issuance of such debt
      or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock (other than standard anti-dilution protection for any reorganization,
      recapitalization, non-cash dividend, stock split or other similar transaction), or (b) that are subject to or contain any put, call, redemption, buy-back, price-reset or other similar provision or mechanism (including, without limitation, a
      “Black-Scholes” put or call right, other than in connection with a “fundamental transaction”) that provides for the issuance of additional equity securities of the Company or the payment of cash by the Company, or (iii) enters into any agreement,
      including, but not limited to, an “equity line of credit” or “at the market offering” or other continuous offering or similar offering of Common Stock or Common Stock Equivalents, whereby the Company may sell Common Stock or Common Stock Equivalents
      at a future determined price.

   

  “VWAP” shall mean, for the Common Stock for a specified period, the dollar volume-weighted average
      price for the Common Stock on the Principal Market, for such period, as reported by Bloomberg through its “AQR” function. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization
      or other similar transaction during such period.

   

  “VWAP Purchase” shall have the meaning assigned to such term in Section 3.2 of this Agreement.

   

  “VWAP Purchase Amount” shall have the meaning assigned to such term in Section 3.2 of this
      Agreement.

   

  “VWAP Purchase Commencement Time” shall mean, with respect to a VWAP Purchase made pursuant to
      Section 3.1, 9:30:01 a.m., New York City time, on the applicable VWAP Purchase Date, or such later time on such VWAP Purchase Date publicly announced by the Principal Market as the official open (or commencement) of trading (regular way) on the
      Principal Market on such VWAP Purchase Date; provided, however, that if a VWAP Purchase Notice is delivered after 9:00 a.m., New York City time, on a VWAP Purchase Date, then the VWAP Purchase Commencement Time shall start only upon
      receipt by the Company of written confirmation (which may be by email) of acceptance by the Investor, and which confirmation shall specify the VWAP Purchase Commencement Time.

   

  “VWAP Purchase Condition Satisfaction Time” shall have the meaning assigned to such term in Section
      7.3 of this Agreement.

   

  

  
     

    
      
 

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  “VWAP Purchase Date” shall mean, with respect to a VWAP Purchase made pursuant to Section 3.1, the
      Trading Day on which the Investor receives, on such Trading Day, a valid VWAP Purchase Notice for such VWAP Purchase in accordance with this Agreement.

   

  “VWAP Purchase Maximum Amount” shall mean, with respect to a VWAP Purchase made pursuant to Section
      3.1, a number of shares of Common Stock equal to the lesser of (i) a number of shares of Common Stock which, when aggregated with all other shares of Common Stock then beneficially owned by the Investor and its Affiliates (as calculated pursuant to
      Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Investor of more than the Beneficial Ownership Limitation and (ii) a number of Shares equal to (a) the VWAP Purchase Share
      Percentage multiplied by (b) the total number (or volume) of shares of Common Stock traded on the Principal Market (or, if the Common Stock is then listed on an Alternative Market, on such Alternative Market) during the applicable VWAP Purchase
      Period on the applicable VWAP Purchase Date for such VWAP Purchase and (iii) the VWAP Purchase Share Estimate.

   

  “VWAP Purchase Notice” shall mean, with respect to a VWAP Purchase made pursuant to Section 3.1, an
      irrevocable written notice delivered by the Company to the Investor in the form set forth in Exhibit D hereto.

   

  “VWAP Purchase Period” shall mean, with respect to a VWAP Purchase made pursuant to Section 3.1,
      the period on the applicable VWAP Purchase Date for such VWAP Purchase beginning at the applicable VWAP Purchase Commencement Time and ending at the applicable VWAP Purchase Termination Time.

   

  “VWAP Purchase Price” shall mean the purchase price per Share to be purchased by the Investor in
      such VWAP Purchase on such VWAP Purchase Date equal to ninety-seven percent (97.0%) of the VWAP over the applicable VWAP Purchase Period on such VWAP Purchase Date for such VWAP Purchase.

   

  “VWAP Purchase Share Amount” means, with respect to a VWAP Purchase made pursuant to Section 3.1,
      the number of Shares to be purchased by the Investor in such VWAP Purchase as specified by the Company in the applicable VWAP Purchase Notice, which number of Shares shall not exceed the applicable VWAP Purchase Maximum Amount.

   

  “VWAP Purchase Share Delivery Date” shall mean the date of the VWAP Purchase Notice, or such later
      date on which the Shares are actually delivered to the Investor (it being acknowledged and agreed that the Company may not deliver any additional VWAP Purchase Notice to the Investor until all such Shares subject to such VWAP Purchase, and all Shares
      subject to all prior VWAP Purchase Notices, have been received by the Investor as DWAC Shares in accordance with this Agreement).

   

  “VWAP Purchase Share Estimate” means the number of shares of
        Common Stock constituting a good faith estimate by the Company of the number of Shares that the Investor shall have the obligation to buy pursuant to the VWAP Purchase Notice.

   

  “VWAP Purchase Share Percentage” means, with respect to a VWAP Purchase made pursuant to Section
      3.1, twenty percent (20%).

   

  “VWAP Purchase Share Request Percentage” shall mean the percentage set forth in any VWAP Purchase
      Notice.

   

  “VWAP Purchase Termination Time” means, with respect to a VWAP Purchase made pursuant to Section
      3.1, 4:00 p.m., New York City time, on the applicable VWAP Purchase Date, or such earlier time publicly announced by the Principal Market as the official close of trading (regular way) on the Principal Market on such applicable VWAP Purchase Date.

   

  
     

    
      
 

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  EXHIBIT A

   

  REGISTRATION RIGHTS AGREEMENT

   

  
     

    
      
 

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  EXHIBIT B

   

  SECRETARY’S CERTIFICATE 

   

  
     

    
      
 

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  EXHIBIT C

   

  COMPLIANCE CERTIFICATE 

   

  
     

    
      
 

  

  Certain confidential information contained in this document, marked by [***], has been
        omitted because the Tuatara Capital Acquisition Corporation (the “Company”) has determined that the information (i) is not material and (ii) contains personal information.

   

  EXHIBIT D

   

  FORM OF VWAP PURCHASE NOTICE

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}]]